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Synaptotagmin (p65), a transmembrane glycoprotein of synaptic and
endocrine secretory vesicles, is thought to be one of the proteins
responsible for mediating Ca2+ control of regulated exocytosis. Extensive
work has been carried out in neuronal tissue but the protein's role in
endocrine cells is not clear. This thesis reports work on synaptotagmin I,
the isoform that occurs in adrenal chromaffin granules.
Background work on synaptotagmin has been hindered to a certain extent
by the difficulty in obtaining the protein in sufficient quantities and purity.
This problem can be overcome by adopting molecular cloning and a
bacterial expression system. DNA encoding the cytoplasmic domain of
synaptotagmin I was amplified from a cDNA library and ligated to part of
the S.aureus protein A gene in an E.coli expression vector so that the fused
gene could be expressed as a chimaeric protein in bacterial cells. The
protein A segment assisted purification and detection of the protein and
has highly antigenic properties, enabling easy preparation of polyclonal
antibodies. A thrombin cleavage site was incorporated into the design of
the chimaeric protein so that digestion with thrombin released the isolated
cytoplasmic domain of synaptotagmin.
The construct was characterised in terms of control of gene expression,
solubility in the bacterial cytoplasm and optimal conditions for thrombin
digestion. A simple purification strategy for the cytoplasmic domain of
synaptotagmin was developed and the purified protein was then used for in
vitro studies of both Ca2+-dependent structural changes and interactions
with other biological molecules.
The existence of a Ca2+-dependent conformational change in
synaptotagmin was initially established by analysing the change in
sensitivity of the protein to proteolytic digestion with trypsin in the
presence and absence of Ca2+. An attempt was also made to investigate
the Ca2+-binding activity of the protein with the lanthanide terbium (Tb3+),
as a fluorescent probe for the Ca2+-binding sites but this approach proved
to be of limited use, due to protein aggregation. Interaction of
m
synaptotagmin with phospholipids was also found to be Ca2+-dependent
and the protein was found to show selectivity for certain phospholipids.
The interaction of the protein with calmodulin was tested using in vitro
binding to immobilised calmodulin and also to calmodulin modified with a
fluorescent dansyl group to act as a reporter. Both types of measurement
indicated a Ca2+-dependent interaction between the proteins most
probably due to affinity changes in calmodulin upon binding to Ca2+.
Structural changes in synaptotagmin as a possible mechanism of action
were investigated further using the biophysical techniques of circular
dichroism (CD) and light scattering. Changes in quaternary structure from
multimer to monomer were detected upon addition of Ca2+ alone whereas
secondary structural changes were not detectable by CD unless
phospholipid vesicles were also mixed with the protein. Gel exclusion
chromatography and native gel electrophoresis were used to support the
data and indicated changes in quaternary structure. These techniques also
suggested that the native protein, isolated from chromaffin granules, exists
as a multimeric form.
This study has demonstrated that synaptotagmin shows Ca2+-dependent
interactions with calmodulin and phospholipids and also that it undergoes
measurable structural changes in the presence and absence of Ca2+. This
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Cells in multicellular organisms communicate by releasing chemical signals
from secretory vesicles into the extracellular space which are subsequently
detected and interpreted by other nearby cells. Synaptotagmin, the
subject of this thesis, is a transmembrane protein of secretory vesicles and
has been implicated in the process of regulated exocytosis which is a
specialised form of secretion from cells controlled by intracellular levels of
Ca2+. In order to explain the possible role of synaptotagmin, the features of
regulated exocytosis will be described briefly followed by a more detailed
analysis of the theories and experimental work involving synaptotagmin
which form the basis and context of the work carried out in this thesis.
1.2 Exocytosis
Eukaryotic cells deliver proteins to the cell membrane or the extracellular
space by a sequence of vesicle-mediated transport steps beginning at the
endoplasmic reticulum and passing through the Golgi complex until, from
the trans Golgi network, vesicles finally arrive at the plasma membrane.
Each step requires the formation of vesicles, their targeting to an acceptor
membrane and subsequent fusion with that membrane. Fusion with the
acceptor membrane results in incorporation of vesicle lipids and proteins
into the membrane and in the case of the plasma membrane, release of the
vesicle contents into the extracellular space. The process of fusion with the
plasma membrane is known as exocytosis and may occur in a constitutive
or regulated form. Constitutive exocytosis is the immediate fusion of
vesicles from the trans Golgi network with the plasma membrane and is
exhibited by many eukaryotic cell types. Regulated exocytosis involves the
accumulation in the cytoplasm of vesicles which will only fuse with the
plasma membrane when an appropriate signal is given (usually a rise in
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intracellular Ca2+). Although all cells carry out constitutive exocytosis,
cells such as endocrine and neuronal cells will, in addition, carry out
regulated exocytosis in large amounts.
The concept of a ubiquitous cellular membrane fusion mechanism for small
vesicles involved in intracellular membrane traffic and in secretion has
become more plausible in recent years. It seems likely that the same basic
machinery is used in all cell types, with slight variations dependent on
specific cell functions (O'Connor et al. 1994). This idea is supported by the
discovery that NSF and a-SNAP, originally identified in studies of
intracisternal vesicular traffic in the Golgi, can form a 20S complex
containing the synaptic vesicle proteins VAMP (synaptobrevin) and
synaptotagmin with syntaxin and SNAP-25 located in the synaptic plasma
membrane (Sollner et al. 1993a). This has led to the formation of the so-
called SNAP/SNARE hypothesis which describes binding between a vesicle
SNARE (SNAP receptor) and the presynaptic membrane SNARE,
mediated by the soluble factors NSF and SNAP (Sollner et al. 1993b). The
authors propose that the interaction of synaptic vesicle protein
synaptobrevin (v-SNARE)with plasma membrane proteins syntaxin and
SNAP-25 (t-SNAREs) forms a docking complex which targets vesicles to
release sites at the plasma membrane and that SNAPs and NSF
subsequently bind to this complex and drive membrane fusion as a result of
the ATPase activity of NSF (see figure 1.1)
The SNARE hypothesis can be applied to any vesicular transport step and
has become a central theme of much work in this area. The importance for
exocytosis of the proteins in this complex is supported by the fact that
each of the SNARE proteins is a target for lethal clostridial toxins; tetanus
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toxins which cause paralysis by blocking transmission in inhibitory
neurons of the spinal cord and botulinum toxins which inhibit synaptic
transmission at the neuromuscular junction (Goda 1997). However, some
findings cast doubt on the model. The speed of exocytosis, especially in
neurons is too fast to involve the slow ATPase activity of NSF (Morgan and
Burgoyne 1995). In addition, exocytosis can be triggered by Ca2+ in
chromaffin cells and mast cells in the absence of MgATP (Neher and
Zucker 1993, Holz et al. 1989, Lindau and Gomperts 1991). Furthermore,
evidence now favours a role for synaptobrevin in vesicle fusion rather than
docking (Hunt et al. 1994).
This model marks the union of knowledge acquired from two sources:
reconstitution of intracellular membrane traffic and synaptic membrane
structural studies. Although some of the details may be inaccurate, the
prospects are good for the general applicability of this mechanism to all cell
types and cell locations particularly since homologues of syntaxin and
synaptobrevin are found throughout the yeast secretory pathway and in
vertebrate and invertebrate tissues and mutations of these homologues
cause disruption of vesicle fusion (Bennet et al. 1993). It is particularly
interesting to note that the similarities between the homologues becomes
more striking if they are functionally located toward the plasma membrane
suggesting that neuronal secretion is an evolutionary modification of an
existing exocytotic system.
Although it now appears that the same proteins are involved in the
targeting, docking and fusion ofvesicles in both constitutive and regulated
exocytosis, there are a number of differences in the process. Apart from
the obvious sensitivity to Ca2+ found in cells undergoing regulated
exocytosis compared to constitutive, there are also differences in the
kinetics of regulated secretion among different cell types, which may point
to the involvement of some unique proteins or perhaps the differential
regulation of the same exocytotic machinery according to the requirements
of each particular tissue.
1.2.1 Dense granules and synaptic vesicles
Two different types of secretory vesicle are involved in Ca2+-triggered
exocytosis (Morgan and Burgoyne 1997). Large dense-core vesicles or
granules (LDCV) are the main type of vesicle in endocrine cells and are
thought to be produced by the budding and fusion of immature granules
from the trans Golgi network (Bauerfeind and Huttner 1993). A proportion
of these granules undergo exocytosis when the cytosolic Ca2+ concentration
increases and some evidence suggests that the granule membrane is
recycled by endocytosis and transported back to the trans Golgi network
(Patzak and Winkler 1986). Small synaptic-like vesicles (SSLV) are also
present in endocrine cells but in much smaller quantities and resemble
synaptic secretory vesicles.
Synaptic vesicles are the main type of vesicle present in neurons and are
thought to be created from constitutive secretory vesicles which are
recycled from the plasma membrane to a specialised endosome (Calakos
and Scheller 1996) which sorts synaptic vesicle membrane proteins and
contents into the vesicles. These vesicles also undergo exocytosis upon a
rise in cytosolic Ca2+ and are thought to be recycled via the same
endosome. Some evidence suggests these vesicles are also able to fuse
briefly with the plasma membrane to allow discharge of their contents
before reforming by pinching off and reloading with small molecule
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neurotransmitters (but not peptide neurotransmitters) without returning
to the endosome (Fesce et al. 1994).
1.2.2 Stages of exocytosis
Secretion is intrinsically a multi-stage process because it involves the
passage of substances formed deep within the cell through various
membrane compartments finally to the cell surface. Evidence is now
accumulating that the final process of membrane fusion in regulated
exocytosis is in itself a complex, multi-step process. Capacitance increases
in neuronal cells are used as a highly sensitive and rapid measurement of
membrane expansion due to exocytosis and have been very useful for the
study of the process. Using this type of measurement, it has been shown
that cells upon stimulation exhibit a rapid exocytotic burst which
presumably corresponds to the exocytosis of vesicles already competent
for fusion (Parsons et al. 1995) followed by a slower component which may
correspond to fusion of vesicles which have to be first prepared in some
way before undergoing exocytosis. If stimulation is continued, the
exocytotic response has a further late component due to recruitment of
vesicles to the plasma membrane during the stimulation (Gillis et al. 1996).
Figure 1.3 shows a schematic representation of the typical changes in
capacitance measured from secreting chromaffin cells and the time scale of
events including an illustration of capacitance change in the first second
after stimulation. Chromaffin cells were loaded with a caged calcium
compound and patch-clamp capacitance measurements were made after
inducing secretion by release of the calcium (Neher and Zucker 1993). The
authors reported exceptionally fast exocytosis responses to [Ca2+] in the
range of 50-200pM when the Ca2+ spike lasted for more than a few ms
(arrow no. 1). It is possible that the fast response represents release from
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a pool of secretory vesicles which are immediately ready for release and the
necessity for a long Ca2+ signal may be due to the fact that vesicles are
relatively distant from the membrane and must move toward it before
fusing. The capacitance continues to increase at a slower rate after the
fast response in the absence of a further Ca2+ stimulus and continues to do
so after another Ca2+ stimulus (arrow no. 2). The slower exocytotic s
response visualised with this technique may represent release from
vesicles which have to be first prepared for fusion with the membrane and
hence the secretory response is slower. The further action of Ca2+ in the
later phase of the release could indicate Ca2+-dependent steps, apart from
fusion itself, required to mobilise other pools of vesicles.
1.2.3 The releasable pool of vesicles
Secretory granules in endocrine cells such as chromaffin cells are not
docked at the plasma membrane but are held distant by a cytoskeletal
actin network (Trifaro and Vitale 1993). This work illustrated that
disassembly of the cortical cytoskeleton allowed the movement of granules
to the membrane at discrete sites where their contents was released and
that this process involved the Ca2+-dependent actin-severing protein
scinderin. In addition to this, a protein kinase C substrate is implicated
because phorbol esters cause disassembly of the cytoskeleton.
Cytoskeletal disassembly alone however is not sufficient for exocytosis to
occur so it is apparent that fusion of vesicles is yet another Ca2+-dependent
step.
In neuronal cells, synaptic vesicles are not directly bound to actin. A small
proportion are docked at release sites on the plasma membrane while
others are cross-linked to actin through the vesicle protein synapsin I
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(Trifaro and Vitale 1993, Valtorta et al. 1992). The docked vesicles undergo
exocytosis within 200 (is in response to high Ca2+ concentrations at the
membrane. Diffusion of Ca2+ creates lower Ca2+ concentrations a short
distance away from the membrane. This activates Ca2+ /calmodulin
dependent protein kinase II which phosphorylates synapsin I allowing
release of more vesicles to the membrane.
1.2.4 Kinetics of exocytosis
Fusion of synaptic vesicles can occur within 200 ps of a stimulus which is
ten times faster than granule exocytosis in neuroendocrine cells where the
fastest fusion events measured are between 2-50 ms after the release of
caged Ca2+ (Burgoyne and Morgan 1995). The faster kinetics in neurons is
probably due to the fact that most vesicles are already physically docked
at the membrane whereas in chromaffin cells all but a few granules are
held in the actin network. Even the granules which are free and closer to
the membrane have rarely been seen actually docked except by electron
microscopy of frozen cells (Parsons et al. 1995). It is also a possibility that
the higher degree of surface tension associated with the high curvature of
synaptic vesicles simply makes membrane fusion more energetically
favourable.
1.2.5 Ca2+ requirements of exocytosis
There is a large difference in the Ca2+ concentrations required for
exocytosis in neurons and chromaffin cells. Flash photolysis studies of
caged Ca2+ showed that exocytosis was half-maximal in adrenal chromaffin
cells at 10-20 pM Ca2+ but at 190 pM in retinal neurons (Heinemann et al.
1994, Heidelberger et al. 1994). Intracellular dialysis of Ca2+ via a patch
pipette indicated that the threshold for activation of exocytosis was 0.3 pM
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in adrenal chromaffin cells and 20-50 |iM in neurons (Augustine and Neher
1992, Burgoyne 1991). The great difference in Ca2+ sensitivities of the two
cell types implies that a different Ca2+-binding proteins may be involved in
granule and synaptic vesicle exocytosis.
As well as regulating exocytosis, Ca2+ regulates secretory granule
recruitment (von Ruden and Neher 1993) and priming for exocytosis.
Priming is the phenomenon whereby exposure to MgATP increases the
extent of subsequent exocytosis (Bittner and Holz 1992) and is discussed
below. The requirement for Ca2+ for priming in chromaffin cells is
consistent with the existence of a high-affinity Ca2+ sensor implied by the
Ca2+ affinities measured in other experiments.
1.2.6 Vesicle recruitment
ATP seems to be required for vesicle recruitment before docking as well as
for some ATP- dependent priming which occurs after docking. Studies in
permeabilised adrenal chromaffin cells show that only 4% of vesicles
undergo Ca2+-activated exocytosis in the absence of ATP whereas a much
larger fraction undergo exocytosis in the presence ofATP (Holz et al.
1989). Capacitance measurements showed that 4% of vesicles,
corresponding to those morphologically docked, could undergo exocytosis
when cells were depleted of ATP (Parsons et al. 1995) suggesting that ATP-
dependent steps had already occurred just before or immediately after
docking. Since it has been shown that vesicles in chromaffin cells must be
mobilised by release from an actin cortex (Roth and Burgoyne 1995, Vitale
et al. 1995) it is possible that the ATP requirement for recruitment involves
an ATP-dependent motor such as myosin II or protein kinases such as
Ca2+-regulated myosin light chain kinase. After vesicles are recruited, they
must dock with the plasma membrane. The SNAP/SNARE hypothesis
suggests that docking of vesicles is mediated by interactions between
vesicle and membrane proteins but this has been questioned because
clostridial neurotoxin treatment which destroys these proteins results in
more morphologically docked vesicles than before (Broadie et al. 1995). It
therefore seems that, although these proteins are probably important for
targeting vesicles and certainly for their eventual fusion with the
membrane, the interactions which specifically drive or maintain docking
have yet to be dissected.
1.2.7 Priming
ATP-dependent reactions also occur after vesicle docking but before fusion
(Banerjee et al. 1996). ATP was found to be important as a substrate for
two lipid kinases that act sequentially in phospholipid phosphorylation
(Hay et al. 1995, Wiedemann et al. 1996). Production of
phosphatidylinositol 4,5-bisphosphate by these kinases seems to be
important because destruction of this compound inhibits Ca2+-triggered
fusion although its mechanism of involvement is not yet known.
ATP also serves as a substrate for the ATPase NSF the importance of
which in regulated fusion is undisputed since the original characterisation of
the SNAP/SNARE complex. Originally, it was shown that NSF catalysed
the ATP-dependent dissociation of the SNARE complex and this was
thought to occur after docking to drive membrane fusion. However, NSF
has recently been shown to have a role in constitutive fusion before docking
(Mayer et al. 1996) and more evidence is now accumulating from studies of
cells undergoing regulated exocytosis that NSF is involved in a priming
reaction prior to, or at the same time as, docking (Burgoyne et al. 1996).
This study shows that a-SNAP, identified as one of the soluble factors
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important in the assembly of the vesicle docking complex along with NSF,
stimulates ATP-dependent but not ATP-independent secretion. A previous
study had already illustrated that a-SNAP acts at an early Mg-ATP-
requiring stage of exocytosis rather than the late Ca2+-triggered steps
immediately prior to membrane fusion (Chamberlain et al 1995). In
addition, the reported presence of NSF on free synaptic vesicles in complex
with SNARE proteins suggests that it has a role before docking (Walch-
Solmena et al 1995).
1.2.8 Fusion, the final Ca2+-triggered step of regulated exocytosis
Many proteins have been identified as being involved in constitutive and
regulated membrane traffic. There are so many potential actors on the
stage that the exocytosis plot is becoming amazingly complicated. Table
1.1 summarises the proteins identified, grouped in broad categories of
possible function although many of the proteins listed are not discussed
further.
The final stage of exocytosis, fusion of the secretory vesicle with the
plasma membrane, is likely to be the point at which regulated exocytosis
diverges from constitutive secretion and where regulated secretory cells
differ from each other since this is the point at which sensitivity to Ca2+
becomes important. The ubiquitous SNARE proteins have been found to
be essential for this stage since neurotoxin action on these proteins
abolishes Ca2+-activated fusion. In addition the ATP-dependent action of
NSF in assembling the complex of proteins is also found to be necessary.
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Table 1.1 Proteins involved in regulated exocytosis
Proteins implicated in recruitment of vesicles or
mobilisation from cytoskeletal anchorage.
kinesin, 14-3-3, myosin II, myosin light chain kinase, scinderin,
synapsin, calmodulin dependent protein kinase II, rab3, rabphilin,
actin
Proteins with uncharacterised roles
synaptophysin, synaptoporin, SV2, synaptogyrin, SCAMP,
pp60src, cysteine string proteins, calmodulin
Proteins with unknown sites of action
Rab3, rabphilin, RabGDI, MSS4, Doc-2, complexin, Hrs-2, unc-41p,
unc-18p (muncl8, Seel, rop), unc-13p, aex-3p,rSec6, rSec8,
annexin, GAP-43, neurexin, VAP-33
Proteins required for ATP-dependent priming
phosphatidyl inositol transfer protein (PEP 3), phosphatidyl inositol
4-kinase, phosphatidyl inositol 4 phosphate 5-kinase (PEP1), NSF,
oc/p/y -SNAP
Proteins required for late stages proximal to fusion
synaptobrevin, syntaxin, SNAP-25, synaptotagmin, CAP
adapted from Martin 1997
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Figure 1.1 Model of the fusion complex
assembly
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Figure 1.3 The stages of exocytosis measured by
capacitance change in single cells
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1.3 Specialisation for regulated exocytosis
There are some proteins which seem to be present only in cells which carry
out regulated exocytosis and as such are probably involved in the Ca2+-
dependent stages of the process. Synaptotagmin is a candidate for the
mediator in the control of Ca2+-regulated exocytosis. Theories about its role
suggest it is either directly responsible for Ca2+-dependent fusion or that it
behaves as a Ca2+-sensitive 'clamp' which prevents the normal course of
constitutive fusion until the signal is given for fusion to occur. The protein
has been studied extensively using both in vitro and in vivo techniques.
1.4 In vitro studies of synaptotagmin function
1.4.1 Structure and structural modifications
Synaptotagmin was first identified as a component of synaptic vesicles
(Matthew et al. 1981) and antibodies against it were found to precipitate
chromaffin granules (Lowe et al. 1988). Later it was shown that
synaptotagmin was the same as the 65 kDa calmodulin-binding protein
identified in granule membranes (Fournier and Trifaro 1988a and b,
Fournier et al. 1989). The amino acid sequence was deduced by sequencing
a cDNA clone (Perin et al. 1990) and suggested a single transmembrane
span with a small intravesicular N-terminal domain including a putative N-
glycosylation site. The larger cytoplasmic domain contained two repeated
sequences similar to the C2 regulatory domain of protein kinase C and are
therefore referred to as the C2 domains.
The predicted transmembrane topography of the protein in chromaffin
granules was further supported by work using monoclonal antibodies,
protease and endoglycosidase treatments (Tugal et al. 1991) and by the use
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of proteolytic cleavage, sucrose density gradients and antibodies to various
epitopes of the protein (Perin et al. 1991a). The latter work also suggested
that the protein forms a higher molecular weight complex with
synaptotagmin dimers as a basic unit. The authors suggest that a region
of the protein between the transmembrane portion and the first C2 domain
may form an amphipathic a helix and cause stable dimerization. The
structural features of the protein are summarised in figure 1.2. Some other
work has also suggested that the protein may form a homotetramer (Brose
et al. 1992).
Synaptotagmin was shown to be structurally and functionally conserved
from Drosophila to humans (Perin, et al. 1991b). Rat and human
synaptotagmins show 97% identity whereas rat and Drosophila are only
57% identical but conservation in the C2 domains is particularly significant
at 78% between all three species. The two C2 repeats are only slightly
more homologous to each other than to protein kinase C but the differences
in the two C2 domains are conserved suggesting they are important
differences and that the two domains may not be functionally equivalent.
This particular study also showed that recombinant cytoplasmic domains
of human and Drosophila synaptotagmins bound specifically to
phosphatidylserine as does the rat protein. These proteins also caused
agglutination of erythrocytes which was inhibited by negatively-charged
phospholipids. It has been proposed that the C2 domains confer Ca2+- and
phospholipid-binding properties to synaptotagmin and evidence is
accumulating to suggest this is the case. Ca2+ and phospholipid binding
appear to be interdependent and together cause conformational change
when measured using partial proteolysis (Davletov and Siidhof 1994)
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whereas crystallographic measurements of the first C2 domain showed
only a small structural change when Ca2+ alone was introduced into the
protein crystal (Sutton et al. 1995).
In brain homogenates, synaptotagmin was shown to be a major substrate
for casein kinase II, which phosphorylates a single conserved threonine
(Davletov et al. 1993a). The phosphorylation was dependent on a lysine-
rich sequence in the protein which, if removed, made the phosphorylation
dependent on exogenous polylysine. Furthermore, several presynaptic
proteins including synaptotagmin have been found to be substrates for
Ca2+/calmodulin-dependent protein kinase II (CaMKII) in vitro (Popoli
1993). Although the significance of this phosphorylation has not been
investigated, phosphorylation by an endogenous kinase suggests that it
may also occur in vivo and implies a possible modulatory role for
synaptotagmin in synaptic function. It was recently shown that if 5-HT
reuptake is blocked, for example by the use of some antidepressant drugs,
CaMKII activity and auto-phosphorylation is increased, resulting in a 2-3
fold increase specifically in the phosphorylation of synaptotagmin (Popoli et
al. 1997). This establishes a link between synaptotagmin phosphorylation
and levels of neurotransmitter release and is of possible functional
relevance.
Synaptotagmin has been shown to be palmitoylated at a cysteine-rich
region adjacent to the transmembrane region (Chapman et al. 1996a).
Acylation of soluble proteins could have the function of anchoring the
protein to the membrane but it is not clear why a transmembrane protein
should need this modification. Palmitoylation has been shown to regulate
the rate of internalisation of other proteins such as the transferrin receptor
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(Alvarez et al. 1996) so it is possible that the phosphorylation of
synaptotagmin may similarly regulate endocytotic vesicle membrane
traffic. This idea has some support from the findings that synaptotagmin
binds AP-2 (Zhang et al. 1994) and that synaptotagmin-deficient C.elegans
seems to have endocytosis defects (Jorgensen et al. 1995).
1.4.2 Distribution and regulation of expression
Synaptotagmin has been found in neural and endocrine tissue of many
vertebrate and invertebrate species but no homologue is present in yeast.
Study of neurogenesis in Drosophila embryos has shown that it is very
quickly localised to the synapse during axonogenesis and accumulates at
synaptic contact sites, suggesting a general role in synapse function
(Littleton et al. 1993a). In the rat nervous system synaptotagmin I (one of
the more currently-studied isoforms of the protein) was found principally in
adrenergic and sensory neurons and was absent from motoneurons (Li et
al. 1994). It has also been detected at the neuromuscular junctions of
crayfish (Cooper et al. 1995). The protein was initially detected in bovine
chromaffin granules (Lowe et al. 1988) but has also been found in bovine
posterior pituitary (Egger et al. 1994) in the large dense core granules
although its presence in anterior pituitary is more variable, being positively
identified in only a limited number of adenohypophyseal endocrine cells
(Redecker 1995). All the variations in the distribution of the protein may
reflect differential requirements for synaptotagmin in these cell types but
in light of the number of novel isoforms of the protein now uncovered, it is
also possible that the cells apparently lacking synaptotagmin I contain
other isoforms which were not detected by the antibodies used.
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1.4.3 Isoforms of synaptotagmin
A second isoform (synaptotagmin II) was discovered in 1991 (Geppert et al.
1991). This protein is highly homologous to the first isoform especially in
the C2 repeats where they show 88% sequence identity. The two isoforms
show complementary patterns of expression in brain, with synaptotagmin
I present in rostral regions and synaptotagmin II in caudal regions.
Synaptotagmin II has been shown to be incorporated into the axon plasma
membrane after exocytosis (Angaut-Petit et al. 1995) indicating its
involvement in the membrane fusion process. Since the discovery of the
second isoform, it has been found that mammalian brain expresses at least
eight isoforms of the protein (Li et al. 1995), all of which show similar AP-2
binding properties (suggesting a role in endocytosis) but show different
Ca2+-dependent interactions within each C2 domain, with phospholipids
and syntaxins, also consistent with a general role in exocytosis. Three of
the isoforms (VI, VII and VIII) are widely expressed in non-neural tissues
whereas isoforms I, II and III are exclusively neural.
The synaptotagmins divide into three classes (Li et al. 1995) depending on
their Ca2+-dependent interactions. Isoforms IV, VI and VIII are not
affected by Ca2+, III and VII bind phospholipids and syntaxin at low Ca2+
concentrations and synaptotagmins I, II and V bind phospholipids at low
[Ca2+1 and syntaxin at high [Ca2+] (see table 2). The Ca2+-dependent
syntaxin-binding of synaptotagmins II and V is the same as the Ca2+
dependence of synaptic vesicle exocytosis (Heidelberger et al. 1994) and
suggests that these synaptotagmins are involved in the fast
neurotransmitter release that is brought about by high Ca2+



















































































synaptotagmin I which show a defect in fast neurotransmitter release
(Geppert at al 1994). An analogous role for other synaptotagmins in other
membrane fusion reactions is suggested by the fact that they are able to
bind to non-neural forms of syntaxins.
The expression of the various isoforms of synaptotagmin in brain is
confusing and seems not to be governed by any common principle (Ullrich
and Sudhof 1995). Isoforms I, II and VI are expressed highly differentially
whereas II, IV and VII are relatively uniformly expressed. This suggests
that, in some cases, the different isoforms may perform separate functions
in the same cell, a conclusion which is supported by the finding that cells
with synaptotagmin I mutations are defective in fast neurotransmitter
release even though other isoforms are present in the same cell (Ullrich et
al. 1994). Clearly, therefore, the other isoforms cannot replace the
function of synaptotagmin I.
No specific functions have been assigned to the different synaptotagmin
isoforms and work on them is at an early stage. Indeed, even the role of
synaptotagmin I is not well understood and although a large body of work
and information on the protein is available, its precise role in exocytosis is
elusive. Recent work has suggested that synaptotagmin IV may be
involved in modulation and adaptation of synaptic structure and function in
response to neural activity because expression of the gene is induced by
depolarisation and sustained exocytotic activity in PC 12 cells, brought
about by such methods as potential depolarisation, Ca2+ ionophore, ATP
and forskolin as well as kainic acid-induced seizures in rat brain (Vician et
al. 1995, Tocco et al. 1996). In contrast, growth factors, which might affect
the level of expression due to cell growth, and phorbol 12-myristate 13
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acetate, which would affect exocytosis via protein kinase C (Bittner and
Holz 1990) do not affect expression of the synaptotagmin IV gene. Since
this isoform does not appear to bind Ca2+ and phospholipids yet still binds
to AP-2 (table 2) , it may be that the modulatory role of the protein
involves rapid endocytotic reuptake of vesicle material to compensate for
increased exocytotic activity.
1.4.4 Nature and structure of C2 domains
Protein kinase C has four highly conserved regions known as C1-C4.
Whilst C3 and C4 contain catalytic activity, the CI and C2 domains are
regulatory (Newton 1995). The two regulatory domains are of great
interest particularly because they appear in many other apparently
unrelated proteins (Newton 1997). The C2 domain, present in
phospholipase AS, phospholipase Cy, the GTPase activating protein GAP,
rabphilin 3A, Doc2 and synaptotagmin, has been extensively studied
because it is known to confer phospholipid- and Ca2+-binding activity on
protein kinase C, and this implies a role for synaptotagmin in Ca2+-
regulated membrane fusion. Elucidation of the structure of the C2 domains
from synaptotagmin (Sutton et al. 1995) and phospholipase C (Grobler et
al. 1996, Essen et al. 1996) revealed a (3-sheet rich domain with a novel
Ca2+-binding pocket consisting of two loops formed by the amino and
carboxyl termini of the C2 core sequence, which come together to form an
aspartate-lined mouth which coordinates Ca2+. NMR spectroscopy has
shown that this pocket coordinates two metal ions (Shao et al. 1996).
Synaptotagmin has two C2 domains in its structure termed C2A (amino
terminal) and C2B (carboxyl terminal). In general experimental
investigations, the C2 domains of synaptotagmin have been shown to bind
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phospholipids in a Ca2+-dependent manner. It is now emerging that the two
C2 domains may have distinct activities. The C2A domain appears to
exhibit Ca2+-dependent binding of phospholipids and syntaxin (Sugita et al.
1996) whereas the C2B domain is inactive in similar assays but binds the
interacting molecules in a Ca2+-independent manner. The C2B domain,
however, seems to cause Ca2+-dependent self-association, which can also
be stimulated by Sr2+ or Ba2+. Some work has shown that the protein
forms a dimer at an EC50 of 3-10 pM Ca2+ (Darner and Creutz 1996,
Chapman et al. 1996b) and then exhibits Ca2+-dependent syntaxin binding
at higher Ca2+ concentrations (EC50 = 100 |iM Ca2+) suggesting that this
reflects a two-step Ca2+-dependent process, involving synaptotagmin, in
exocytosis.
Studies of exocytosis from giant squid axons using antibodies directed
against C2A or C2B domains of synaptotagmin suggest that the C2A
domain is directly related to the fusion of synaptic vesicles (Mikoshiba et al.
1995) and the C2B domain may be involved in vesicle recycling (Fukuda et
al. 1995a). Similar work with antibodies in permeabilised chromaffin cells
seems to confirm the direct involvement of C2A in Ca2+-triggered vesicular
fusion but suggests a more subtle role for C2B. Antibodies against the
second C2 domain have no effect on Ca2+-triggered exocytosis but do
increase the spontaneous Ca2+-independent release which is also seen in
regulated cells. Inositol polyphosphates bind to the C2B domain and inhibit
both Ca2+-dependent and Ca2+-independent release in a dose-dependent
manner, but this could be totally reversed by the addition of the antibody
and substantially reversed by high concentrations of Ca2+ (50 pM). This
suggests that the interaction of inositol polyphosphates with C2B might
have a role in the prevention of spontaneous fusion of docked or primed
vesicles until the binding of Ca2+ to C2A releases the suppression allowing
fusion to proceed. Similar experiments were also carried out in cultured rat
sympathetic neurons (Mochida et al. 1997) and the same conclusions
drawn.
1.4.5 Phospholipid and inositol high polyphosphate binding
a. Phospholipids
Synaptotagmin I was found to cause aggregation of erythrocytes (Perin et
al. 1990) and so the phospholipid-binding properties of the protein were
investigated by a haemagglutination assay. The cytoplasmic domain alone
of native synaptotagmin was found to bind acidic phospholipids and
sphingolipids with high affinity and specificity resembling that of protein
kinase C. Similar experiments with recombinant whole synaptotagmin
show that it also demonstrates specificity for negative charges on lipid
headgroups and also that it only binds phospholipids with two acyl chains
rather than one. It is suggested that this implies that the protein makes
contact with the hydrophobic portion of the phospholipid, perhaps inserting
partially into the bilayer.
Subsequent work concentrated on recombinant single C2 domains of the
protein and showed that the first C2 domain of synaptotagmin I (C2A) was
able to bind Ca2+ and phospholipids alone with high affinity (half maximal
at 4-6 pM free Ca2+) and displayed positive cooperativity in binding the ion
and specificity for charged phospholipids (Davletov and Siidhof 1993). The
C2A domain also showed similar binding to other divalent cations (Sr2+ and
Ba2+) known to stimulate exocytosis, but had much lower affinity for Mg2+
which does not stimulate vesicle release. Further evidence to support this
24
was found using a proteolytic fragment of synaptotagmin I containing both
C2 domains, which was able to bind to various natural membranes in a
Ca2+-dependent manner (EC50 = 30 pM Ca2+). The binding was insensitive
to proteolysis of the membranes suggesting the interaction was with lipids
(Chapman and Jahn 1994). A recombinant protein containing the two C2
domains also exhibited the same effect and the interaction was located to
the C2A domain. Mutational analysis further narrowed the functional
region to a highly-conserved motif of nine aminoacids, disruption of which
was sufficient to abolish the Ca2+-dependent lipid binding of the domain.
Other work using aggregation of proteinase-treated chromaffin granules as
a lipid-binding assay suggested that both domains were needed for binding
granule membranes, although each separate C2 domain did bind artificial
PS/PC vesicles containing 10-40% PS. The C2A domain showed Ca2+-
dependent binding to vesicles whilst the second C2 domain (C2B) bound
vesicles independently of Ca2+. The two domains together, however, bound
vesicles in much larger amounts than either of the two individual domains,
suggesting synergistic action of the two domains (Darner and Creutz 1994).
Other isoforms of synaptotagmin (II-VI) have also been found to bind
negatively-charged phospholipids in a Ca2+- dependent manner with
positive cooperativity (Fukuda et al. 1996). Synaptotagmin IV showed two
EC50 values of 5 and 120 pM free Ca2+ and a Hill coefficient of 2 whereas
all the other isoforms showed high affinity binding (EC50 0.3-1.0 pM) and a
Hill coefficient of 3-3.5. Synaptotagmin IV was also unique in that binding
to negatively charged phospholipids was inhibited by PC or PE. This effect
of lipid composition was found to be due to the substitution of the amino
acid aspartate for serine at position 244. When the whole cytoplasmic
domain of synaptotagmin IV was tested it also showed this unique lipid
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binding but the Ca2+-dependence and cooperativity measurements became
the same as the other isoforms. Recently, synaptotagmin III has also
been found to have unusual properties in that it shows a Mg2+-dependent
interaction with PS comparable to that of Sr2+ or Ba2+ (Fukuda et al.
1997). This property is specific to synaptotagmin III and is also not found
in other C2-containing proteins such as rabphilin 3A, Doc2a/[3 or Gaplm.
This suggests that synaptotagmin may be involved in different presynaptic
functions.
b. Inositol polyphosphate
Preinjection of inositol 3,4,5, tetrakisphosphate, inositol 1,3,4,5,6,
pentakisphosphate or 1,2,3,4,5,6, hexakisphosphate into squid giant
synapse blocked synaptic transmission (Llinas et al. 1994). Inositol 1,4,5
trisphosphate did not produce this effect. Both Ca2+-stimulated (evoked)
and spontaneous transmitter release were blocked although the inward
Ca2+ current was not affected. Repeated stimulation of the axon showed
that there was a gradual reduction in the postsynaptic response
demonstrating that vesicular fusion was being prevented. Synaptotagmin
III was found to bind these compounds via the C2B domain which had
previously been found to bind phospholipids independently of Ca2+.
Scatchard analysis of the binding indicated a single binding site with a of
30 nM (Niinobe et al. 1994). Thirty amino acids at the centre of the C2B
domain and specifically three lysine residues which are not conserved in the
C2A domain were found to be essential for inositol polyphosphate binding
(Fukuda et al. 1995b). This binding is not found in rabphilin 3A, another
protein with C2 domains implicated in regulated exocytosis. The effect of
inositol polyphosphates on synaptic transmission coupled with the binding
to synaptotagmin III suggests that these two elements are directly
26
involved in the process of fusion of vesicles with the plasmalemma.
Recently, the C2B domain of synaptotagmin I has been shown to bind
phosphatidyl inositol 4,5-bisphosphate, its isomer inositol 3,4-bisphosphate
and phosphatidyl inositol 3,4,5-trisphosphate (Schiavo et al. 1996). Ca2+
ions switch the specificity of binding from trisphosphate at low Ca2+
concentrations (< 30 pM), to 4,5-bisphosphate at the higher Ca2+
concentrations required for transmitter release (20-1000 jiM). Inositol
polyphosphates inhibit this binding and this could be one possible cause for
their inhibitory effect on neurotransmitter release. The authors of this
paper propose a scheme in which a rise in Ca2+ levels switches
synaptotagmin I from a resting conformation (bound to phosphatidyl
inositol trisphosphate) to a fusion-competent conformation (bound to
phosphatidyl inositol 4,5- bisphosphate). This is also supported by the
finding that phosphatidyl inositol 4-kinase, phosphatidyl inositol-specific
transfer protein and phosphatidyl inositol 4-phosphate 5-kinase are all
needed for fusion to be triggered by Ca2+ (Hay et al. 1995, Wiedemann et al.
1996) since these proteins would be required to maintain the pool of
phosphatidyl inositol bisphosphate needed to bind the C2B domain in the
fusion-competent conformation.
1.4.6 Ca2+ binding
The Ca2+ binding properties of synaptotagmin I were first demonstrated
using equilibrium dialysis techniques (Brose et al. 1992). The binding was
shown to be dependent on the presence of phospholipids and was half-
maximal at 10-5 M Ca2+. Mg2+, Ba2+ or Sr2+ did not produce the same
effect. Increasing concentration of acidic phospholipids shifted the Ca2+
sensitivity to lower concentrations giving a response within the range
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expected at the synapse during exocytosis. The total Ca2+ binding reached
4 moles/mole synaptotagmin at a free Ca2+ concentration of 10-4 M
indicating more than one Ca2+-binding site per molecule or perhaps
cooperative binding of a synaptotagmin multimer. Most of the other
synaptotagmin isoforms also show affinity for Ca2+ in a lipid-dependent
manner as shown in table 2 (Li et al. 1995) and so are all potential
candidates for involvement in Ca2+-dependent exocytosis.
Most other work has not focused on the direct binding of Ca2+ to the protein
but has looked at the Ca2+-dependent interactions of the protein and its
effect on exocytosis in various cell systems. The methodology used to
investigate this generally involves the use of biochemical assays, analysis
of genetic mutants and transfected cell lines as well as the introduction of
peptides and antibodies into cells. Such studies have uncovered numerous
interactions associated with synaptotagmin and in vivo work has generally
implicated synaptotagmin in Ca2+-dependent exocytosis although there
have also been contradictory findings.
1.4.7 Interactions with other proteins
Synaptotagmin was originally discovered as a calmodulin-binding protein
(Fournier and Trifaro 1988) and has since been found to bind at least eight
other proteins as well as forming an oligomer itself. Synaptotagmin was
shown to co-purify with the Ca2+-dependent a-latrotroxin receptor
(neurexin) on immobilised a-latrotroxin (Petrenko et al. 1991). a-latrotoxin
causes massive spontaneous synaptic vesicle exocytosis in the presence or
absence of Ca2+ so neurexin, its putative target protein, is implicated in the
process. No other synaptic protein was found to interact with neurexin (a
plasma membrane protein) in this way and the interaction seemed to be
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through the cytoplasmic region of synaptotagmin. Neurexin also inhibited
phosphorylation of synaptotagmin I in a dose-dependent manner and so it
is suggested that an interaction between the two proteins along with the
modulation of synaptotagmin phosphorylation plays a role in vesicle fusion.
Interaction between these two proteins was corroborated by evidence from
PC 12 mutant cells lacking synaptotagmin I and synaptotagmin II (Shoji-
Kasai et al. 1994). These cells do not exhibit Ca2+-dependent release of
neurotransmitter induced by a-latrotoxin which implies that the
mechanism of action of the toxin is through disruption of the
synaptotagmin/neurexin complex rather than through neurexin alone. The
site of interaction of the two proteins was located to the cytoplasmic
domain of neurexin (Hata et al. 1993) and was found to be Ca2+-
independent. A highly conserved 40 amino acid sequence which makes up
most of the cytoplasmic tail of neurexin was found to be essential for the
binding. This evidence was taken to imply a vesicle-docking or targeting
role for the two proteins, the interaction has been further dissected and
found to rely on as little as 34 amino acids from the carboxyl terminal of
synaptotagmin (Perin 1994). The other synaptotagmin isoforms (except
III and VIII) and rabphilin 3A which shows conservation in this region,
displayed the interaction (Perin 1996). Deletion analysis of the sequence
led the author to submit that the mirror image motif Leu-X-His-Trp-Xi3-
Trp-His-X-Leu was responsible for the binding and that this sequence also
mediated in the interaction of synaptotagmin with calmodulin. The
importance of the synaptotagmin interaction with neurexin has been called
into question by the discovery that neurexin is not the only a-latrotoxin
receptor. An additional a-latrotoxin receptor which binds the toxin in a
Ca2+-independent manner has been isolated (Davletov et al. 1996) which
appears to be a G-protein-coupled receptor found in brain tissue
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(Krasnoperov et al. 1997). Since neurexin only binds the toxin in the
presence of Ca2+, it cannot be responsible for the stimulation of exocytosis
caused by the toxin in calcium-free medium and so may not have such a
central role in maintaining a docked complex or triggering exocytosis as was
previously imagined. However, the interaction of neurexin with
synaptotagmin may still be significant especially in the light of further
protein interactions discovered involving these two proteins with other
proteins thought to be involved in exocytosis as discussed below.
Up to this point, only synaptotagmin and neurexin had been found to co-
purify on immobilised a-latrotoxin. One group, however, found that
syntaxin also co-purified in this system (O'Connor et al. 1993). In addition,
it was shown that a-latrotoxin was immunoprecipitated with anti-syntaxin
antibodies and that the same antibodies as well as antibodies against
neurexin also immunoprecipitated co-conotoxin-binding proteins (Ca2+
channels). This work has led to the theory of an exocytosis-organising
complex made of these proteins and perhaps additional factors which
together would be known as the 'synaptosecretosome'. The interaction of
synaptotagmin with Ca2+ channels was supported by the discovery that
synaptotagmin was a specific auto-antigen associated with N-type Ca2+
channels in Lambert-Eaton Myasthenic Syndrome (El Far et al. 1993) a
disease which causes muscle weakness, autonomic dysfunction and
decreased Ca2+ currents in motor nerve terminals (Smith et al. 1995)
through down-regulation of Ca2+ channels. In addition, repeated injection of
a peptide consisting of residues 20-58 of synaptotagmin has been found to
produce a model of the disease in rats (Takamori et al. 1994) but its
presence as an antigen in the disease has also been disputed (Hajela and
Atchison 1995).
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Similar methodology of immunoprecipitation and binding to immobilised
proteins was used to further investigate the interaction between
synaptotagmin and syntaxin (Chapman et al. 1995). Ca2+ was found to
increase the affinity of this interaction by two orders of magnitude. The
Ca2+-dependence had two components with EC50 values of 0.7 and 180 jiM
Ca2+ and the binding could also be stimulated by Ba2+ or Sr2+ but not by
Mg2+. The interaction was mediated by the carboxyl terminal region of
syntaxin and was not abolished by mutations in the Ca2+-dependent lipid
binding site of synaptotagmin I (in the C2A domain) although this is not
conclusive because the C2A domain has also been found to be responsible
for the interaction in other work (Li et al. 1995, Kee and Scheller 1996).
The two components of the interaction with different Ca2+-affinities have
been suggested to represent a conformational change in one or both
proteins and since the lower-affinity component (EC50 = 180 jiM)
corresponds to the dependence of transmitter release reported in neurons
(Heidelberger et al. 1994) it is possible that the putative conformational
change functions in the late steps of exocytosis. Recently, NMR analysis
and site-directed mutagenesis of the C2A domain of synaptotagmin (Shao
et al. 1997) showed that the interaction is mediated by the cooperative
action of basic residues surrounding the Ca2+-binding region. The binding of
Ca2+ causes the electrostatic potential of the domain to change and so the
authors propose a mechanism in which synaptotagmin acts as an
electrostatic switch, promoting a structural rearrangement in the fusion
machinery through its interaction with syntaxin.
Many other interactions are proposed for synaptotagmin and have some
experimental work to support them. Synaptotagmin was placed in the
correct context for a Ca2+ sensor in exocytosis when it was shown to
31
associate with the cytosolic region of N-type Ca2+ channels (Leveque et al.
1992, Wiser et al. 1997) and also to restore the kinetic properties of the
channel in a Ca2+-dependent manner when the channel kinetics were
modified by its association with syntaxin. Synaptotagmin has also been
found to associate with the synaptic vesicle protein SV2 via the C2B
domain (Schivell et al. 1996). The binding was inhibited by Ca2+ with an
EC50 value of 10 |lM. In addition, synaptotagmin I has been identified as
the target for clostridial botulinum B neurotoxin (Nishiki et al. 1994, Nishiki
et al. 1996) in association with gangliosides Grrib/GDia- The neurotoxin is a
potent inhibitor of exocytosis through proteolysis of synaptobrevin 2; this
finding implicates synaptotagmin as necessary for the entry of toxin into
susceptible cells. Exocytosis is often followed by the rapid assembly of
clathrin-coated pits and this is preceded by the binding of the
heterooligomeric complex, clathrin/AP-2 to the inside surface of the plasma
membrane (Anderson 1993). It has been suggested that one of the
functions of synaptotagmin is as a membrane recycling protein after the
discovery that AP-2 interacts with the C2B domain of synaptotagmin.
One further molecular interaction of synaptotagmin has raised much
interest recently. The SNAP/SNARE hypothesis already outlined
emphasises the role of SNAP-25 (a plasma membrane protein) as a key
constituent of the vesicle docking complex. Experiments with a cell-free
system which relies on exocytosis occurring from docked and primed
vesicles, show that blocking SNAP-25 with antibodies prevents Ca2+-
triggered exocytosis from the membranes (Mehta et al. 1996) suggesting
that SNAP-25 is involved at a very late stage of exocytosis. It was
therefore quite an interesting indication of the importance of
synaptotagmin to find that it binds to SNAP-25 in the absence of Ca2+
although the binding was promoted slightly by addition of Ca2+ (Schiavo et
al. 1997). This work also showed that although synaptotagmin binds
syntaxin in a Ca2+-dependent manner, it was able to do so in the absence of
Ca2+ if SNAP-25 was present. This suggests that the docking complex
may actually be promoted by SNAP-25 and synaptotagmin at resting Ca2+
concentrations. Thus in effect, SNAP-25 and synaptotagmin are
respectively an additional t-SNARE and v-SNARE.
1.4.8 Interaction with calmodulin
The role of calmodulin in exocytosis has long been a mystery and has not
been studied to the same extent as other proteins implicated in exocytosis.
Recent work has shown that antibodies to calmodulin and calmodulin
antagonists decreased Ca2+-induced noradrenalin release from
permeabilized synaptosomes, although exogenous calmodulin had no effect
(Hens et al. 1996). In adrenal chromaffin cells, calmodulin was found to
have an effect on rapid endocytosis after release but not on exocytosis
itself (Axtalejo et al. 1996). However, other work using patch-clamp
measurements of chromaffin cells dialysed with calmodulin indicated that
calmodulin regulated late steps in Ca2+-dependent exocytosis, because the
introduction of the protein into cells increased initial rates of exocytosis
two-fold (Kibble and Burgoyne 1996). Calmodulin was shown to bind
adrenal chromaffin membranes via a polypeptide complex (Hikita et al.
1984) and so was implicated in stimulus-secretion coupling. When the
granule-binding sites for calmodulin were investigated further they were
found to be of high affinity, displaying Ca2+-dependent binding at lO4 M free
Ca2+ and due to a 65 kDa protein (Bader et al. 1985).
The 65 kDa protein recognised as a calmodulin-binding protein in
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chromaffin cells was identified as synaptotagmin which was, at the same
time, described as a granule membrane protein (Fournier and Trifaro
1988a and b). The protein in granules also appeared to bind calmodulin
since the subcellular distribution of calmodulin, measured by density
gradients, resembled that of granules when Ca2+ was present but became
diffuse in the absence of Ca2+. Although there is quite a lot of evidence to
show binding between synaptotagmin and calmodulin, it has not been the
subject of many studies and is regarded by some as an artifact which,
considering the number of other synaptotagmin interactions considered
significant, is somewhat illogical. However, since the importance of
calmodulin in exocytosis has become more apparent it is likely that the
interaction will be investigated more thoroughly in the future.
The number of interactions described for synaptotagmin and the
importance ascribed to them all should be a matter for debate and further
experiment. It has become increasingly clear that synaptotagmin is what
is euphemistically known as a 'sticky' protein and it is possible that some of
the interactions are actually misleading artifacts that do not occur under
physiological conditions. It is particularly important to note that the same
methodology has nearly always been used to uncover these interactions
and so a method that originally claimed to show only one protein interacting
with synaptotagmin has now revealed many others. It is comforting to
believe that amidst so many reported interactions, some at least are
significant and of course it is not impossible that synaptotagmin is a multi
functional protein. Finding new interactions is useful for maintaining a flow
of fresh hypotheses but the secrets of a complicated process such as
exocytosis are unlikely to be revealed by one more synaptotagmin-binding
partnership yet to be discovered. One should perhaps be wary of placing
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too much emphasis on binding studies until the hypothesis is supported by
more functional studies which test the protein in a cellular context.
1.5 In vivo studies of synaptotagmin function
Since the number of potential roles proposed for synaptotagmin, based on
in vitro work, is large, it has also become a subject for in vivo studies of
function. The techniques adopted for this area of work fall into three
categories; genetic manipulations ofwhole organisms, transfection of cell
lines and injection or introduction of antibodies and synaptotagmin peptides
into cells which exhibit regulated exocytosis.
1.6 Genetic manipulations
1.6.1 Rat
Genetic manipulation in rat cells has exclusively involved the use of the
phaeochromocytoma-derived cell line PC12. Uninduced PC12 cells from a
line selected to be deficient in synaptotagmin I and synaptotagmin II were
still able to release dopamine and ATP (Shoji-Kasai et al. 1992) and so it
seemed the protein has no essential role in these cells. However, these cells
were later discovered to produce synaptotagmin III in abundance (Mizuta
et al. 1994) and this has been suggested to compensate for the lack of other
isoforms. This deficient cell line was further studied and although secretion
from secretory granules was unaffected as found previously, the
acetylcholine release from synaptic-like vesicles was no longer Ca2+ -
dependent (Bauerfeind et al. 1995). The results have been taken to indicate
the possibility of two exocytosis mechanisms for small vesicles, one of
which is Ca2+-dependent and is no longer viable without synaptotagmins I
and II.
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More direct evidence that synaptotagmin plays an important role in
neurotransmission comes from genetic disruptions of the synaptotagmin
gene (syt locus) in Drosophila, C.elegans and mouse.
1.6.2 Drosophila
Only one isoform of synaptotagmin has so far been identified in Drosophila.
Most embryos that lacked synaptotagmin I failed to hatch at all (Littleton
et al. 1993b) and displayed very reduced, uncoordinated muscle
contractions. Measurements from larvae with partial lack of function were
possible and showed that they exhibited almost no evoked exocytotic
response at 0.4 mM Ca2+ and a very reduced response at 1 mM Ca2+. The
spontaneous vesicle fusion rate had increased. These experiments showed
the importance of synaptotagmin activation of exocytosis by Ca2+ and the
authors conclude that there must also be separate pathways for evoked
and spontaneous exocytosis since they were differentially affected by the
mutation. However, it is possible that the differential effect on the two
types of exocytosis was simply the two sides of one pivotal control point.
Spontaneous fusion may be a manifestation of an event which is
energetically favourable, particularly in a subset of vesicles already
competent for fusion, but mostly held in check by a control protein in cells
which exhibit regulated exocytosis. Thus spontaneous fusion might be due
to 'escapee' vesicles. A protein (or group of proteins) responsible for
restraining vesicles from fusion must also be able to detect Ca2+ in order to
release them at the appropriate signal. Such a 'fusion clamp' would have a
role in Ca2+-stimulated fusion through its ability to detect [Ca2+], It is
therefore consistent with the data that synaptotagmin prevents fusion.
The mutant Drosophila cells show a reduced Ca2+ response because there
is no Ca2+ sensor to control exocytotic events and consequently, without
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such control, spontaneous fusion increases. Further electrophysiological
studies by this group (Littleton et al. 1994) showed that defects in fly
embryos were consistent with the idea that synaptotagmin acts as a
barrier to vesicle fusion but that its activity was not entirely due to this. In
addition, this work supported the idea that synaptotagmin functions as a
Ca2+ sensor in an oligomeric complex.
Many syt mutations are found to be lethal in Drosophila, but one group
isolated homozygotes for an apparent null allele which did hatch (DiAntonio
et al. 1993). Electrophysiological recordings in embryonic cultures showed
that synaptic transmission persisted even in null mutants showing that
synaptotagmin is not absolutely required for the process. There were
however some interesting deficiencies in the synaptic transmission of the
null mutants assayed at the neuromuscular synapse. Evoked vesicle
release was reduced by a factor of 10 and the fidelity of excitation-secretion
coupling was impaired so that any given stimulus gave a variable release
(Broadie et al. 1994). Spontaneous vesicle fusion had increased by a factor
of 5 but contrary to the previous work, the Ca2+-dependence of the residual
evoked exocytosis was similar to that in normal embryos. This work
suggests that synaptotagmin is not the sole Ca2+ sensor for exocytosis but
that the protein plays an important role in increasing the efficiency of
synaptic transmission and regulating spontaneous fusion.
1.6.3 C.elegans
Similar mutational analysis of nematodes has been carried out (Nonet et
al. 1993). Mutants defective in the gene snt-1 exhibit behavioural
abnormalities that are characteristic of deficiencies in synaptic function
such as problems with locomotion, feeding and defaecation. The worms
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also accumulate acetylcholine, showing an impairment in exocytosis, but
are still capable of coordinated motor movements showing that there is not
a complete blockade of neurotransmitter release. It was proposed from
this that synaptotagmin either controls one of several independent
pathways to vesicle release or that it controls endocytosis. The latter point
was supported by the finding that synaptic vesicles are depleted in these
mutants (Jorgensen et al. 1995) and the depletion was due to defects in
vesicle recycling rather than vesicle transport or an increase in vesicle
release.
1.6.4 Mice
Mutations in sytl were produced in mice (Geppert et al. 1994). At birth,
there was no phenotypic difference between homozygous and heterozygous
mutants. Homozygous pups were capable of breathing, responding to
tactile stimuli and showing pain avoidance reflexes. However, after a few
hours, the homozygotes show weakness, have not suckled and are often
neglected by their mothers and die within 48 hours of birth. Heterozygotes
show no abnormalities. Autopsies of dead mice reveal no major congenital
malformations. Cultured hippocampal neurons from homozygous mice
revealed that the synchronous, fast component of Ca2+-dependent
neurotransmitter release is decreased whereas asynchronous release such
as spontaneous vesicle fusion and the release triggered by hypertonic
solution or a-latrotoxin were unaffected. A study by Goda and Stevens
(1994) described two components of transmitter release; a fast component
mediated by an efficient, low-affinity Ca2+ receptor, and a slower
component with a less efficient, higher-affinity receptor. The work on
mouse mutations has been interpreted in the light of this study and this
would mean that synaptotagmin is the low-affinity receptor for fast
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transmitter release. This interpretation would explain the data well and
may also explain why measurements in mutant non-neuronal cells (which
have an overall much slower exocytotic response) are more variable as
they can perhaps accommodate a mutation in the putative fast Ca2+
sensor to a greater degree.
1.7 Cell transfections
CHO fibroblast cells which have taken up acetylcholine by endocytosis
show spontaneous quantal and Ca2+-evoked acetylcholine release. Cells
transfected with synaptotagmin I show the formation of actin-rich filopodal
processes (Feany and Buckley 1993), a reduced spontaneous release and
an enhanced evoked release of acetylcholine compared to control markers
(Morimoto et al. 1995). The endocytotic function of these cells was normal,
as assessed by the use of a separate marker for endocytosis. Either of the
popular theories for synaptotagmin function would be consistent with this
work, namely, that synaptotagmin is a 'fusion clamp' that inhibits
exocytosis at resting intracellular Ca2+ concentrations or alternatively that
synaptotagmin is a positive effector of exocytosis
1.8 Introduction of antibodies and peptides into cells
Antibodies to synaptotagmin were injected into PC 12 cells and found to
decrease the Ca2+/K+ - mediated dopamine (3 hydroxylase surface staining
which was used as a measure of secretion (Elferink et al. 1993). Injection
of peptides from corresponding to the C2 domains of synaptotagmin I into
the squid giant axons resulted in a rapid and reversible inhibition of
neurotransmitter release (Bommert et al. 1993). Introduction of peptides
into cells which already contain the endogenous protein is a technique
which assumes the peptides will bind to sites in competition with the native
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protein and thus have an inhibitory effect. Reversal of the effect of the
peptides in the squid axon was slower ifmore peptide was added which is
consistent with a competitive mechanism of inhibition in which the
peptide's action would depend on diffusion to and away from binding sites.
The inhibition of Ca2+-evoked release suggests that Ca2+ probably initiates
exocytosis by regulating the interaction of synaptotagmin with an acceptor
protein.
The introduction of either of the C2 domains or the whole cytoplasmic
domain of synaptotagmin into AtT-20 mouse pituitary cells albeit by
transfection (Wendland and Scheller 1994) relies on the same principle of
competitive effect. In this experiment, the transfected cells showed no
effect. Vesicle targeting, regulated ACTH secretion, constitutive secretion
and endocytosis, monitored by the uptake of transferrin, all seemed to be
normal. The authors suggest that there is redundancy in the process of
exocytosis with several pathways possible to the same endpoint so that
dysfunctional synaptotagmin is simply bypassed by alternatives. It is also
possible that exocytosis in endocrine cells is under slightly different control
even though the same protein machinery is present since the kinetics of
the process in these cells is quite different from that in neurons (Morgan
and Burgoyne 1997). Furthermore, the introduction of smaller peptides (as
in the first experiment described) may be more efficient at producing an
effect because a particular binding site may be fully exposed. A whole
domain of a protein, as used in AtT-20 cells, may have binding sites
concealed within its structure and depend on more complex interactions to
allow them to be exposed or alternatively may not be correctly folded.
Either way, it is possible that competitive interactions from such
introduced proteins will not actually occur.
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Exocytosis is a complex process involving many proteins, some of which
have probably not yet been identified. Synaptotagmin is a major candidate
for the Ca2+-sensor in the process and, as such, has been the subject of a
phenomenal amount of work in the last four years. For some time, the role
of synaptotagmin was disputed because of contradictory results, confusing
differences between cell types and because the protein has never actually
been shown to be essential for exocytosis. This probably says more about
the flexibility of exocytosis than about the protein itself and has been a
useful lesson in that it has forced us to think in terms of redundant
pathways, alternative and interchangeable Ca2+-sensors and
multifunctional proteins rather than one protein, one function, one
mechanism. It is now becoming accepted that synaptotagmin is a low-
affinity Ca2+-receptor, involved in modulating the fast step of exocytosis
and that it controls the spontaneous fusion of vesicles by virtue of the fact
that it only allows fusion to proceed when a critical Ca2+ concentration is
achieved. There is also some evidence that it has a secondary role in the
recycling of vesicle material in endocytosis. Clearly, there must be
additional factors responsible for Ca2+ threshold and kinetic variations in
different cell types but it is in the fast fusion process, which occurs in all
these cells, that synaptotagmin is implicated. The most interesting area
still to be explored in more depth is the role of synaptotagmin isoforms with
unusual Ca2+ affinities or binding properties and especially the isoforms
being discovered in non-neural cells. Perhaps the neuronal isoform is a
modification of a fusion-control protein existing in most cells and even
constitutive fusion has more of an element of control than its basic
description implies.
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1.9 The aims of the project
Most of the information on synaptotagmin presented was not available at
the beginning of this project and a few subjects of this study were published
by other groups whilst my experiments were being carried out. The main
direction of enquiry, however, is one that has only recently become more
popular. It was originally suggested that ATP hydrolysis by NSF could
drive membrane fusion (Rothman 1994, Sollner et al. 1993a and b) but the
speed of exocytosis, especially in neurons is too fast to involve the slow
ATPase activity of NSF (Morgan and Burgoyne 1995). In addition,
exocytosis can be triggered by Ca2+ in chromaffin cells in the absence of
MgATP (Neher and Zucker 1993). Fusion is far more likely to involve a
conformational change of a protein or proteins. Synaptotagmin is ideally
placed to promote fusion by undergoing a Ca2+-dependent conformational
change and all the evidence suggesting it is involved in the final fast fusion
step give weight to this argument. The possibility of a conformational
change in synaptotagmin was therefore studied by various biochemical






2.1 Chemicals and biochemicals
All general chemicals were obtained from Sigma Chemical Co., BDH
Chemicals, Fisher Ltd, Calbiochem or Boehringer Mannheim, a- [35S] -
dATP was obtained from Amersham International pic. Media components
were from Difco Laboratories. Enhanced chemiluminescence (ECL) kit
and Hyperfilm - MP for western blotting was obtained from Amersham
International. IgG Sepharose (Fast Flow) was from Pharmacia LKB.
Calmodulin-agarose was from Sigma Chemical Co. Ni-NTA agarose and
kits for plasmid DNA preparation and purification of DNA from agarose
gels were from Qiagen Ltd. 0.02pm nylon filters for molecular dynamics
sample treatment were obtained from Millipore.
2.2 Enzymes, proteins and antibodies
Calmodulin, lysozyme, trypsin and thrombin were all obtained from Sigma
Chemical Co. All DNA modification enzymes were from BRL or NEB.
Taq polymerase was from Promega and high fidelity DNA polymerase was
from Boehringer Mannheim Biochemicals. Monoclonal antibody cgm67
was obtained from Dr Biilent Tugal, previously a postgraduate student in
this laboratory, and other antibodies not raised in this study were from
Sigma Chemical Co. and the Scottish Antibody Production Unit.
2.3 Bacterial strains and plasmids
The strains of E. coli used in this study are listed in Appendix 1.
Transformants are denoted by listing the strain, followed by the plasmid
with which it has been transformed in parenthesis. All plasmids that were
used in this study are described in Table A2a (Appendix 2).
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2.4 Media
Bacterial cultures were grown in complete medium (Luria broth; L-broth)
containing 1% (w/v) Bacto tryptone, 0.5% (w/v) Bacto yeast extract and
0.5% (w/v) NaCl. Bacto agar was added to the above to 1.5% (w/v) when
solid medium was required. Liquid and solid media were supplemented
where necessary with ampicillin to 100 pg/ml or kanamycin to 50 ug/ml.
Solid medium for blue/white selection also contained 0.015% Xgal (w/v) and
100 pM IPTG.
In order to maintain the F' plasmid, the bacterial strain NM522 was stored
on M9 minimal plates which contain 2% agar, 0.4% glucose, M9 salts (0.7%
(w/v) sodium phosphate (dibasic), 0.3% (w/v) potassium phosphate
(monobasic), 0.05% (w/v) sodium chloride, 0.1% (w/v) ammonium chloride),





General DNA manipulation techniques including PCR amplification,
ligation, extraction with phenol, precipitation with ethanol, and restriction
endonuclease cleavage were performed as described by Sambrook et al
(1989).
Plasmid DNA was isolated from bacterial cells using the method described
by Birnboim & Doly (1979). When extremely pure plasmid DNA was
required for DNA sequence analysis, a purification kit supplied by Qiagen
Ltd was used and the manufacturer's instructions followed. Purification of
DNA from agarose gels was also carried out with a kit from Qiagen Ltd and
the manufacturer's method used.
Initial cloning of PCR products involved the use of the commercial vector
pGEM-T obtained from Promega. Ligation was carried out as suggested in
the manufacturer's product instructions. Gel electrophoresis, for the
separation and visualisation of DNA fragments, was routinely carried out
using agarose gels of 0.8% (w/v) agarose; the size of fragments of DNA was
estimated by comparing their mobility through an agarose gel with that of
fragments of known size present in a commercially available product (1
kbp DNA ladder - Gibco-BRL).
2.6 Transformation of bacterial cells
Bacterial cells which had been treated with CaCl2 were transformed with
DNA as described by Sambrook et al (1989).
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2.7 Stock preservation
All bacterial cultures were preserved in 15% (v/v) glycerol and stored at -
70°C.
2.8 DNA sequence analysis
DNA sequences were analysed using double stranded plasmid DNA
(produced in DH5a E.coli cells) and the USB Sequenase version 2.0 DNA
sequencing kit. The dideoxy chain termination method of Sanger et al
(1977) was employed in the presence of a-[35S] - dATP. A sequencing
reaction was prepared as follows:
5 pi plasmid DNA (1 pg/pl)
1 pi primer (10 ng/pl)
1 pi 1M NaOH
These were mixed and incubated at 37°C for 10 min to allow the DNA to
denature. 1 pi 1M HC1 and 2 pi 5x Sequenase reaction buffer (200mM
Tris.HCl pH 7.5, 100 mM MgCU, 250 mM NaCl) was then added and the
primer allowed to anneal for 5 min at 37°C.
The polymerisation reaction was initiated by adding in order
lplO.lMDTT
2 pi labelling mixture (containing 1.5 mM dGTP, 1.5 mM dCTP, 1.5 mM
dTTP) diluted five fold with distilled water
0.5 pi a-[35S] - dATP (Bq)
2 pi Sequenase diluted eight fold with enzyme dilution buffer (10 mM
Tris.HCl pH 7.5, 5 mM DTT, 0.5 mg/ml BSA.
47
After incubation at room temperature for 5 min, 3.5 pi of the reaction was
transferred to each of 4 pre-warmed tubes containing 2.5 pi of one of the
dideoxynucleotide mixtures (80 pM dNTP and 8 pM ddNTP). This was
incubated at 37°C for 5 min before adding 4 pi of stop solution (95%
formamide, 20 mM EDTA, 0.5% bromophenol blue and 0.05% Xylene
Cyanol FF)
The sequencing reactions were analysed by electrophoresis on 6 - 8%
acrylamide wedge gels containing 8 M urea.
2.9 Production of hybrid proteins from E.coli
2.9a Induction of expression from the lac promoter
A culture of bacteria harbouring a plasmid containing a gene under the
control of the lac promoter (eg pKpra) was grown in selective medium at
37°C to an ODeoo of 0-8. Expression was then induced by adding IPTG to a
final concentration of 0.1 mM and the culture was grown for a further 3 h.
2.9b Fractionation of a bacterial culture by differential
centrifugation
Cells were harvested by centrifugation for 10 min at 10000 rpm in a
Beckman JA14 rotor. The cells were then washed by resuspension and
centrifugation and then finally resuspended in one twentieth of the original
culture volume of 100 mM Tris.HCl pH 7.4. Lysozyme was added to a final
concentration of 1 mg/ml and a protease inhibitor mixture added (1 pg/ml
each of aprotinin, leupeptin, pepstatin, antipain, 1 mM benzamidine, 1 mM
PMSF) and the mixture left on ice for 20 min. The cells were then
sonicated on ice (five bursts of 30 s with 2 min cooling intervals) and the
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lysate clarified by centrifugation at 3000 rpm for 5 min in a Beckman
JA20 rotor. The pellet P3 was retained and the supernatant centrifuged
again in the same rotor at 20000rpm for 20 min to yield the soluble S20
and the insoluble P20 fractions. The P3 and P20 fractions were then
resuspended in one twentieth of the original culture volume of 100 mM
Tris.HCl pH 7.4 to facilitate comparison of protein composition of each
fraction. The fractions were then analysed by SDS-PAGE.
2.9c Use of IgG-Sepharose in the purification of protein A fusion
proteins
A 10 ml soluble fraction from all bacterial culture containing a protein A
fusion protein (chapter 3) was prepared in TST buffer (50 mM Tris.HCl pH
7.4, 150 mM NaCl, 0.05% Tween - 20) and was incubated overnight at 4°C
on a Denley Spiramix with 2 ml IgG-Sepharose which had been previously
equilibrated by resuspension in TST buffer followed by brief centrifugation
and removal of the used buffer. After overnight incubation, the Sepharose
was pelleted by centrifugation at 1000 rpm for 30 s in a MSE bench-top
centrifuge and the soluble extract removed. The IgG-Sepharose was
washed twelve times in 20 ml TST buffer and five times in 20 ml
ammonium acetate pH 5.0. The Sepharose was then resuspended in 4 ml
0.2 M glycine.HC1 pH 2.8. The bound material was eluted by gentle mixing
at 4°C for 20 min. The eluate was removed by pelleting the Sepharose as
previously described and removing the buffer. A second elution was
performed for a further 10 min and the two eluates pooled. The eluates
were neutralised immediately by addition of an equal volume of 0.2 M
Tris,HCl pH 8.0. The IgG-Sepharose was then reequilibrated by washing
with TST until the pH reached 7.4 and was then stored in 20% ethanol in
TST at 4°C.
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2.9d Use of Ni-NTA agarose in the purification of oligohistidine
fusion proteins
A 10 ml soluble fraction from all bacterial culture containing a
oligohistidine fusion protein (Chapter 3) was prepared in phosphate buffer
A (50 mM NaH2PC>4 pH 8.0, 300 mM NaCl) and incubated overnight at
4°C on a rotating mixer with 1 ml Ni-agarose which had been equilibrated
with the same buffer. The soluble fraction was removed after
centrifugation at 1000 rpm for 1 min in a MSE benchtop centrifuge and
the agarose washed in 10 ml buffer A by resuspension and centrifugation
until the used buffer had an A280 of 0.01. The washing was then repeated
with buffer B (50 mM NaH^PCh pH 6.0, 300 mM NaCl, 10% (v/v) glycerol).
The Ni-agarose was then washed in buffer B containing 50 mM imidazole
until the A28O was 0.01 and final elution of bound material was achieved by
resuspending in 3 ml buffer B containing 250 mM imidazole and mixing
gently for 10 min at 4°C. This elution was repeated twice more and the
eluates pooled. The Ni-agarose was reequilibrated in buffer A with 0.1%
(w/v) NaN3 and stored at 4°C
2.10 Electrophoretic separation and detection of proteins
Electrophoretic separation of proteins was performed using SDS
polyacrylamide gels following the basic procedures described by Laemmli
(1970) using the solutions detailed below.
Separating gel buffer 1.5 M Tris.HCl pH 8.8, 0.4% SDS
Stacking gel buffer 0.5 M Tris.HCl pH 6.5, 0.4% SDS
Acrylamide stock solution 30% (w/v) acrylamide, 0.8% (w/v) N,N'
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methylene bisacrylamide
Electrophoresis buffer 0.125 M Tris, 0.2 M glycine, 0.1% (w/v) SDS
(gives pH 8.3 without adjustment)
SDS sample buffer 50 mM Tris.HCl pH 6.5, 5% (w/v) SDS, 10% (v/v)
glycerol, 10 mM DTT, 50 pg/ml bromophenol blue
Routinely, separating gels of 10% (w/v), 12% (w/v) or 13% (w/v) acrylamide
with a 5% (w/v) stacking gel were used to achieve separation of proteins.
2.10a Coomassie Blue R staining
Following electrophoretic separation, protein bands were visualised by
staining with Coomassie Blue: the gel was covered with a solution of 0.25%
(w/v) Coomassie Brilliant Blue R dissolved in 50% (v/v) methanol, 7% (v/v)
acetic acid for 10-15 minutes. The stain was then poured off and
destaining of the gel was achieved by gently agitating the gel in 10% (v/v)
methanol, 7% (v/v) acetic acid.
2.10b Silver staining
Silver staining was carried out as outlined in Wray (1981). Gels were
soaked in 50% (v/v) methanol overnight. The stain solution was made
fresh as follows: 0.8 g of AgNC>3 was dissolved in 4 ml distilled water
(solution 1); 21 ml of 0.36% NaOH was added to 1.4 ml of 14.8 M NH3
(solution 2). Solution 1 was added dropwise to solution 2 with constant
stirring and the final volume was made up to 100 ml with distilled water.
The gel was soaked in the stain solution for 15 min with gentle agitation.
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The stain was then poured off and the gel washed in distilled water for a
minimum of 5 min after which the gel was covered with freshly-made
developer solution (0.005% (w/v) citric acid, 0.019% (v/v) formaldehyde).
When bands had appeared on the gel, the development was stopped by
washing the gel with distilled water and then placing it in 50% (v/v)
methanol, 10% (v/v) acetic acid.
2.11 Transfer of proteins onto nitrocellulose
2.11a Semi-dry blotting
Proteins were transferred from gels, after electrophoresis, onto
nitrocellulose filter by a semi-dry blotting procedure using an LKB semi-dry
blotting apparatus and the following buffers:
Anode buffer 1 0.3 M Tris, 20% (v/v) methanol, 0.1% SDS (pH 10.4
without adjustment)
Anode buffer 2 25 mM Tris, 20% (v/v) methanol (pH 10.4 without
adjustment)
Cathode buffer 25 mM Tris, 20% (v/v) methanol, 0.1% SDS, 40mM 6-
amino-N-hexanoic acid (pH 9.4 without adjustment)
Six pieces of Whatman 3MM paper and one piece of nitrocellulose
membrane were cut to the same size as the gel to be blotted. Two pieces of
Whatman 3MM were soaked in anode buffer 1 and placed on the anode
plate. Another piece of 3MM paper, soaked in anode buffer 2, was placed
on top of this , followed by the nitrocellulose which had been soaked in
water and the gel, soaked in cathode buffer. The remaining three pieces of
3MM were soaked in cathode buffer and layered on top of the gel. The
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cathode plate was secured on top of the gel sandwich and a current of 0.8
mA/cm2 gel area was applied for 1 h.
2.11b Wet blotting
Some proteins, especially those of high molecular weight do not transfer
well in 1 h. For this, it was necessary to use a wet blotting procedure which
allows transfer for long periods of time. The gel was placed next to a sheet
of nitrocellulose which had been soaked in blotting buffer (20 mM
Na2HPC>4, 0.02% (w/v) SDS,20% (v/v) methanol) and sandwiched on either
side by three sheets of 3MM and a pad of Scotchbrite sponge also soaked in
blotting buffer. The assembly was then encased in a cassette and slotted
into a tank so that it was completely submerged in blotting buffer and the
nitrocellulose was closest to the anode. A cm-rent of 0.5 A was then applied
for up to 12 h.
2.11c Ponceau S staining
The presence of proteins on nitrocellulose filters was detected using
Ponceau S. The nitrocellulose was immersed in 0.2% (w/v) Ponceau S
dissolved in 3% (w/v) TCA, 3% (w/v) 5-sulphosalicylic acid for 10-15 min.
The stain was then poured away and destaining achieved by washing the
nitrocellulose repeatedly with distilled water until bands appeared.
2.12 Immunoblot analysis
After transfer of proteins onto nitrocellulose membrane, the unfilled
binding sites on the filter were filled by gentle agitation for 1 h in blocking
buffer (5% (w/v) non-fat dried milk, 1% Tween-20 in TBS; 10 mM Tris.HCl
pH 7.4, 150 mM NaCl). The filter was then exposed to primary antibody
for 2 h with gentle agitation. Antibodies were diluted in TBS containing 5
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mg/ml BSA, 5% new born calf serum and 0.5% Tween-20 as described in
the text. Following exposure to primary antibody, the filter was washed
five times for 5 min with washing buffer (0.5% (v/v) Tween-20 in TBS). If
necessary, the filter was then exposed to a secondary antibody; an anti-
mouse IgM-HRP (p chain specific) conjugate was used at a dilution of
1:4000 in wash buffer for 1 h when the monoclonal antibody cgm67 was
used as a primary antibody, anti-rabbit IgG-HRP was used in the same
way when polyclonal antibodies were used as the primary antibody. The
filter was then washed as before and developed using enhanced
chemiluminescence (ECL) with ECL reagent in accordance with the
manufacturer's instructions or by immersing in a developer solution
containing 12.5 mM luminol, 4.5 mMp-coumaric acid, 0.15% H2O2 in 0.1 M
Tris.HCl pH 8.5.
2.13 Production of polyclonal antibodies from rabbits
2.13a Immunisation and serum collection
For immunisation with the protein A fusion protein, 100 pg of the protein
(in a 250 pi volume) was emulsified with an equal volume of Freund's
complete adjuvant. This was then administered to New Zealand White
rabbits by subcutaneous injection. Twelve weeks after the initial injection,
a booster of the same amount of the protein was administered in Freund's
incomplete adjuvant. A second boost was given in this way, six weeks
after the first and 5 ml of blood was collected from the animal ten days
later. The blood was allowed to stand at room temperature for 1 h and
then at 4°C for 24 h. The serum was then separated from clotted material
by centrifugation for 10 min at 10000 rpm in a Beckman JA-20 rotor and
finally filtered through a 0.22 pm Millipore membrane. The serum was
tested for the desired antibodies by checking for recognition of the
oligohistidine fusion protein and for recognition of the protein in chromaffin
granule membranes. The animal was then sacrificed (not more than
fourteen days after the last boost) and serum prepared from the blood.
The serum was stored in 1 ml aliquots at -20°C with 0.1% (w/v) sodium
azide.
2.13b Affinity purification of antibodies using purified protein.
Purified SytC protein (200 fig) was subjected to electrophoretic separation
on an acrylamide gel with a single well across the top. This was then
transferred to nitrocellulose and stained briefly with Ponceau-S. The large
band of protein was cut out and the antigen bearing face of the strip was
marked. The membrane was then washed in TBS to remove the Ponceau-
S and incubated in blocking buffer (previously described) for 90 min. The
strip was then placed on a piece of parafilm and the rabbit serum applied
so that as much serum is used as will stay on the strip by surface tension.
The serum was then left for 2 h before removing and washing the
nitrocellulose three times for 5 min in TBS. Antibodies bound to the
antigen strip were then recovered by applying 0.2 M glycine pH 2.8 in the
same way as the serum. After 20 min, the glycine was removed and
neutralised by adding an equal volume of 0.2 M Tris.HCl pH 8.5. The
affinity purified antibody was was stored at 4°C with the addition of 0.5%
(w/v) NaN3 and was used for immunoblot analysis at a dilution of 1:100.
2.14 Hybridoma culture - production of monoclonal antibody
In order to use the monoclonal antibody to synaptotagmin (cgm67), it was
necessary to culture secreting hybridoma cells from a frozen stock culture.
The medium used for hybridoma culture was made as follows:
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RPM I - 1640 (with 25 mM Hepes.NaOH pH 7.2) 500 ml
Foetal calf serum
50x HT supplement (hypoxathine,thymidine)
50 mM mercaptoethanol 0.5 ml
lOOx glutamine
Penicillin/streptomycin (5 mg/ml)






Cells were cultured at 37°C in a sterile incubator containing 5% (v/v) CO2,
100% humidity.
A 0.5 ml aliquot of frozen hybridoma culture (preserved in liquid N2) was
thawed and added to 5 ml medium (pre-warmed to 37°C) and left to grow
for several days at 37°C. When the cells were growing strongly, most of
the medium was poured off and kept. The cells were shaken off the flask in
2 ml of the used medium and transferred to a larger flask containing 30 ml
of fresh medium and incubated again for two to three days. The cells were
allowed to establish exponential growth and then divided into two flasks
containing 30 ml fresh medium, grown and again moved to larger flasks
containing 150 ml fresh medium. Each time the cells had grown, the used
medium was kept, filtered through a 0.45 |im filter, neutralised with a few
drops of 2 M Tris and stored at 4°C with 0.1% (w/v) NaN3 added. The
medium was tested for cgm67 activity by using it as a primary antibody
(at a 1:5 dilution) with a western blot of chromaffin granule membranes
and purified cytoplasmic domain of synaptotagmin.
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2.15 Protein purification
2.15a Gel exclusion chromatography
Gel exclusion chromatography was carried out as the second step in the
purification of the cytoplasmic domain of synaptotagmin after the initial
step involving affinity chromatography with IgG-Sepharose.
Biogel P100 (exclusion limit 100,000 Da) was equilibrated in distilled water
at room temperature for 24 h and was then resuspended in fresh water and
allowed to settle several times to allow aspiration of the fine particulate
material which may otherwise distort the flow in the column. The 50%
water/gel mixture was degassed under vacuum for 15 min. The Biogel
slurry was then used to pack a 40 ml column (1 m in length and 0.75 cm
diameter) as follows: the column was clamped in an upright position and a
few ml of distilled water poured into the column; with the bottom tap
closed, a few ml of slurry was gently poured in and when the gel could be
seen settling to a few centimetres depth, the column was filled completely
with the gel; once the gel had settled again, the bottom outlet was opened
and the water allowed to drain a little whilst topping up the gel to the
desired level.
The packed column was kept and used at 4°C. Before use, the column was
equilibrated in the buffer to be used (normally 50 mM Tris.HCl pH 7.6, 100
mM NaCl supplemented with either 1 mM CaCl2 or 1 mM EGTA) and run
with a hydrostatic pressure giving a flow rate of 2.5 ml/h. The protein was
applied to the column in a volume not more than 0.5 ml by removing
excess buffer and gently layering on top of the gel. When the protein
solution had run into the gel, buffer was applied again and the column
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allowed to run for 20 h. The flow-through was collected in 0.5 ml fractions.
Protein content in the fractions was estimated by reading the A280 and the
protein composition of the fractions was analysed by gel electrophoresis.
2.15b Concentration of protein sample
Freeze drying
Freeze drying was used for large volumes of protein. The protein solution
was placed in a round bottom Quickfit flask and rapidly frozen by swirling
in a -40°C bath. The flask was then attached with a 24/29 Quickfit
adaptor to a Edwards Modulyo freeze-dryer and dried at -70°C, 10-2
atmospheres for 6-8 h. Once the protein had been freeze-dried, it was
resuspended in distilled water or 20 mM Tris.HCl pH 7.4 depending on the
buffer and salt content of the dialysed protein solution.
Spin columns
Amicon spin columns with cutoff 12,000 Da were used for concentration of
smaller volumes following the manufacturer's instructions
Precipitation with ammonium sulphate
Precipitation was achieved by adding 0.516 mg/ml (NH^SC^ gradually to
the protein solution on ice, stirring constantly, whilst measuring and
maintaining the pH of the solution throughout by titration with HC1. When
all the salt had been added, the solution was stirred on ice for a further 15
min to allow complete equilibration and then centrifuged at 20000 rpm for
20 min in a Beckman JA20 rotor. The resultant pellet was resuspended in
a small volume (less than 0.5 ml) of 20mM Tris.HCl pH 7.4.
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2.15c Desalting
Two techniques were employed to desalt protein solutions. Dialysis tubing
with a 12,000 Da cutoff (previously boiled in distilled water/EDTA for 1 h
and stored in 50% (v/v) ethanol at 4°C) was clipped at one end, filled with
protein solution, sealed and submerged in 2 1 of buffer or water depending
on the final solvent required for the protein solution. This was then placed
at 4°C and and stirred for at least 2 h. The external buffer was replaced a
further three times. The protein solution was then removed from the
membrane and freeze-dried as previously described.
Desalting was also achieved by using Biogel P6DG. A column was
prepared on a small scale using an Eppendorf tube. A hole was pierced in
the top and bottom of the tube and a small amount of glass wool pushed
into the bottom. Biogel P6DG, equilibrated in distilled water, was pipetted
into the tube and allowed to settle to three quarters of the way up the
tube. Several ml of the final required buffer was allowed to drip through the
mini column which was suspended in a conical glass tube and the residual
buffer removed by centrifugation at 1500 rpm for 1 min in a MSE bench-
top centrifuge. The column was then transferred to a fresh glass tube and
the protein solution applied (200-400 pi per column containing 1 ml Biogel)
and allowed to soak into the gel for 2 min. The protein solution was then
recovered by centrifugation as before.
2.16 Estimation of protein concentration
Protein was routinely detected using the value for absorbance at 280 nm.
The concentration of protein used in in vitro interaction studies was
measured using a combination of spectrophotometry and densitometric
techniques. The spectrophotometry method used was Peterson's
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simplification of the method by Lowry et al (1951) and is outlined below.
Stock solutions
Copper tartrate carbonate (CTC) was made by adding 45 ml solution A
(20% (w/v) sodium carbonate) dropwise to 45 ml solution B (0.4% (w/v)
potassium sodium tartrate, 0.2% (w/v) copper sulphate pentahydrate) and
the final volume made up to 100 ml with distilled water. BSA (lmg/ml),
10% (w/v) sodium deoxycholate and Folin-Ciocalteau reagent (available
commercially) were also kept as stock solutions. Working solutions were
made from stocks as follows:
reagent A equal volumes of CTC, NaOH, SDS and distilled water
reagent B one volume of Folin Ciocalteau with five volumes of
distilled water
Precipitation of protein
The protein sample to be measured (containing between 10 and 60 jig
protein) was brought to a volume of 400 pi with distilled water. 40 pi of
0.15% deoxycholate was added and the protein allowed to stand at room
temperature for 10 min and a further 40 pi of 72% (w/v) TCA was then
added and again incubated at room temperature for 5 min. The sample
was then centrifuged at 6000 rpm for 10 min in a MSE MicroCentaur, the
supernatant discarded and the pellet used for the next step.
2.16c Spectrophotometry
Distilled water (400 pi) was added to the TCA pellet along with 400 pi of
reagent A was then added and left for 10 min at room temperature.
Reagent B (200 pi) was added and the absorbance at 700 nm was read
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after 30 min. In order to calibrate the spectrophotometric response of the
assay, duplicates containing 0 pg, 10 |ig, 25 pg, 40 pg, 60 pg BSA were
used and treated similarly.
This protein assay was often supplemented by running and staining a SDS
PAGE gel of the protein sample along with known quantities of BSA and
then scanning the resultant protein bands using a Joyce-Loebl
densitometer following manufacturer's instructions. The intensities for the
bands of BSA were then used to create a calibration curve for stain
intensity which could be used to quantify the unknown protein.
For more accurate protein measurement, freeze-dried samples of the
protein were subjected to acid hydrolysis and total amino acid analysis at
the facility at Department of Molecular and Cell Biology, Marischal
College, The University of Aberdeen.
2.17 Preparation of chromaffin granule membranes
Chromaffin granule membranes were prepared using bovine adrenal tissue
by first dissecting the medulla from the cortex of twenty whole glands.
This was placed in 0.3 M sucrose, 10 mM Hepes.NaOH, 2 mM EDTA pH
7.0 at 4°C, passed through a steel mincer and then homogenised with a
loose fitting pestle at speed 5-6 in an automatic homogeniser. The
homogenate was diluted to 750 ml with the same buffered sucrose and
centrifuged at 4,000 rpm for 5 min in a Beckman JA14 rotor. The pellet
was discarded and the supernatant centrifuged at 14000 rpm for 30 min in
the same rotor. The resultant supernatant was discarded and the upper
mitochondrial pellet washed away with buffered sucrose. The lower pink
pellet was then resuspended by gentle homogenisation and centrifuged for
20 min at 15000 rpm in a Beckman JA20 rotor. The supernatant was
discarded, the upper mitochondria removed again and the lower pellet
resuspended in 50 - 80 ml of buffered sucrose.
To purify the granules further, 20 ml portions of the resuspended pellet
were overlaid on 50 ml of 1.6 M sucrose, 10 mM Hepes.NaOH pH 7.0 and
centrifuged at 45000 rpm for 60 min in a Beckman Ti45 rotor. The pellet
of purified granules was resuspended by gentle homogenisation in 0.3 M
sucrose, 10 mM Hepes.NaOH pH 7.0 and stored in 2 ml aliquots at -20°C.
2.18 Fractionation of membrane proteins with Triton X-114
Triton X-114, pre-condensed by the method of Bordier (1981), was made up
as a 10% (w/v) solution for this procedure. Its concentration was assayed
by the method of Garewal (1973). Chromaffin granule membranes were
resuspended in TBS with 2% (w/v) cold Triton X-114 at 0°C to a protein
concentration of 4 mg/ml and incubated on ice for a further 5 min. The
solubilised membranes were then centrifuged at 100000 rpm for 15 min at
2°C in a Beckman TL-100.3 rotor to remove the precipitate formed by
insoluble proteins. The pellet (PI) was washed twice at 0°C by
resuspension to the original volume in TBS, 2% (w/v) Triton X-114 and
stored in one fifth the original volume TBS.
The supernatant was layered over 1 ml cushions of 0.25 M sucrose
containing TBS and 0.06% (w/v) Triton X-114 in conical glass tubes and
incubated at 30°C for 5 min to separate the detergent and aqueous phases.
These were then centrifuged at 4000 rpm for 5 min in a MSE bench-top
centrifuge. The aqueous phase was removed from above the sucrose
cushion, the sucrose cushion discarded and the detergent-rich phase taken
/
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up in ice cold TBS to its original volume. This process was repeated twice
more with the individual phases. The detergent phase was then stored in
one fifth the original volume of TBS.
Residual detergent was removed from the aqueous phase by dialysis
against TBS containing 1% (w/v) Amberlite XAD-2, 0.2 mM PMSF, ImM
benzamidine at 4 °C for five days. The dialysed fraction was then diluted
with three volumes of TBS and centrifuged at 100000 rpm in a Beckman
TL100.3 rotor for 15 min at 2°C. The pellet, which is rich in glycoproteins,
was resuspended in one fifth the original volume 10 mM Hepes.NaOH pH
7.2 with 0.1% (w/v) Triton X-114. All fractions were stored at -70°C.
2.19 Preparation of synaptosomes
Synaptosomes were prepared following the method of Krueger et al (1979).
Whole brains were dissected from rats and placed in 50 mM NaCl at 4°C.
The brains were then weighed and made to 10% (w/v) with 25 mM
Hepes.KOH pH 7.0, 0.32 M sucrose. The brain tissue was homogenised
and then centrifuged at 6000 rpm for 10 min in a Beckman JA20 rotor.
The supernatant was layered onto equal volumes of 1.2 M sucrose
(buffered as before) and centrifuged at 31000 rpm for 15 min in a Beckman
SW41 rotor. The interface material from this step was collected in as
small a volume as possible, diluted with two volumes of buffered 0.32 M
sucrose and layered onto equal volumes of buffered 0.8 M sucrose. These
were then centrifuged at 31000 rpm for 15 min in a Beckman SW41 rotor.
The synaptosomal pellet was finally resuspended by gentle homogenisation
in 25 mM Hepes.KOH pH 7.0 containing 125 mM potassium acetate, 25
mM magnesium acetate, 1 mg/ml glucose and 0.1 mM EGTA.
/
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2.20 Preparation of phospholipid vesicles
To prepare phospholipid vesicles ofvolume V ml, 2V/3 ml of settled
Calbiosorb resin was equilibrated in the buffer required (usually 25 mM
Hepes.NaOH pH 7.4 for this study). Phospholipid solutions of 20 mg/ml in
2:1 (v/v) chloroform / methanol were measured to the correct concentration
and percentage weight composition for each lipid in the final vesicle
preparation. The lipids were then dried under a gentle stream of nitrogen
gas and redispersed in the buffer used containing 2% (w/v) octylglucoside
by constant stirring for approximately 15 min.
The equilibration buffer was removed from the Calbiosorb and the
dispersed lipids added. After 5 min at 4°C, the solution became turbid due
to vesicle formation and the whole mixture was pipetted into an Eppendorf
tube which had been pierced at the top and bottom and plugged with glass
wool. The Eppendorf tube was placed in a conical glass tube and
centrifuged for 30 s at 1000 rpm in a MSE bench-top centrifuge.
2.21 Phospholipid vesicle binding assay
Phospholipid vesicles were prepared at a concentration of 10 mg/ml total
lipid content. The vesicles always contained 20% (w/v) cholesterol and
either 80% (w/v) of a single phospholipid or 40% (w/v) each of two
phospholipids (all possible combinations of PS, PI, PC and PE were used)
The purified recombinant cytoplasmic domain of synaptotagmin (15 j_ig)
was mixed with 400 pg of phospholipid vesicles in a 100 pi volume of 50
mM Hepes.NaOH pH 7.2 , 100 mM NaCl supplemented with either 2 mM
EGTA or 100 pM Ca2+ . This was incubated at room temperature for 15
min and centrifuged at 100,000 rpm for 30 min in a Beckman TL -100.2
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rotor. The pellets were resuspended directly in 50 pi of SDS-PAGE sample
buffer. The protein in the supernatants was precipitated by adding 10 pi
of 0.15% (w/v) sodium deoxycholate and 10 pi of 72% (w/v) TCA and
incubating overnight at 4°C. The precipitates were centrifuged for 10 min
at 13000 rpm in a MSE MicroCentaur and resuspended in 50 pi of SDS-
PAGE sample buffer.
The protein compositions of the lipid and aqueous fractions were analysed
by gel electrophoresis followed by Western blotting using the
synaptotagmin-specific antibody cgm67.
2.22 Binding to immobilised calmodulin
Recombinant synaptotagmin was dialysed extensively ( 3 changes of
1000-volumes 10 mM Hepes.NaOH pH 7.2) to remove salts and Ca2+.
This was then lyophilised and resuspended in one twentieth of the original
volume 10 mM Hepes.NaOH pH 7.2) and then treated with Chelex resin,
equilibrated in the same buffer, following manufacturer's instructions, to
remove any further Ca2+. The protein was clarified by centrifugation for
10 min at 13000 rpm in a MSE MicroCentaur. 20 pi packed volume of
calmodulin-agarose was washed 3 times by pelleting (600 rpm in MSE
MicroCentaur for 30 sec) and resuspension in Eppendorf tubes. After the
final wash the calmodulin-agarose was mixed with 800 pi protein samples
of 0.4 mg/ml. The following experimental conditions were used:
100 pM Ca2+;
100 pM Ca2+ and 5 mM EGTA.NaOH pH 7.2;
100 pM Ca2+ and anti-synaptotagmin antibody (protein preincubated with
antibody for 30 min at room temperature prior to mixing with calmodulin).
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Bovine synaptotagmin from the glycoprotein-rich fraction of CGM
fractionation with TX-114 was used as a positive control. The samples
were incubated by rotating for 30 min at room temperature and the
reaction terminated by pelleting the calmodulin-agarose as previously.
The supernatants were removed and the pellets were washed four times
with 1 ml of 10 mM Hepes.NaOH pH 7.2. Elution of bound material was
carried out by resuspending in 500 pi of the buffer with 10 mM
EGTA.NaOH pH 7.2 and incubating for 10 min at room temperature. The
eluates were collected after centrifugation, lyophilised, resuspended in
sample buffer and analysed by SDS-PAGE and Western blotting.
2.23 Fluorimetry
2.23a Titrations with terbium ions
Protein solution, ranging in concentration from 10 pg/ml - 200 pg/ml in
20 mM Hepes.NaOH pH 7.5 was placed in a Perkin-Elmer 3000 with
excitation wavelength set to 290 nm and emission wavelength at 585 nm.
Additions of 2 pi of 1 mM or 10 mM TbCl2 were made to the protein
solution so that final Tb3+ concentrations ranged from 4 pM to 1 mM and
fluorescence emissions were recorded after each addition by integration of
the signal over 5 s periods. Where required, the buffer was supplemented
with 2 mM CaCl2 or 2 mM EGTA.NaOH pH 7.5 . The experiment was
performed using the purified cytoplasmic domain of synaptotagmin.
Lysozyme was used as a negative control and calmodulin as a positive
control.
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2.23b Titrations with calmodulin
Production of dansyl calmodulin
Dansyl calmodulin was produced according to the method of Vorherr et al
(1990). Calmodulin (obtained from Sigma) was dissolved at a
concentration of 1.2 mg/ml in 20 mM NH4HCO3 pH 7.5. The
concentration, assessed by its absorbance at 276 nm, was 51 pM. CaCl2
was added to a final concentration of 1 mM. A 3 mg/ml stock solution of
dansylchloride was made in acetone and enough was added to the
calmodulin to give 74 pM dansylchloride. The reaction mixture was
incubated at room temperature for 2 h and vortexed every 20 min. At the
end of the reaction time the mixture was centrifuged at 100,000 rpm for 15
min in a Beckman TL-100.2 rotor to remove solids. Residual
dansylchloride was removed from the supernatant by passing it through a
4 ml column containing Biogel P6DG equilibrated in the reaction buffer.
Fractions of 0.5 ml were collected and assessed for calmodulin content by
measuring A280- The A320 was used to calculate the dansyl content of the
fractions from the molar extinction coefficient for the dansyl moiety which
is 3400 M-i cm-i. A molar ratio of 1:1 for calmodulin:dansyl was obtained.
Fluorescence spectra and titrations
All dilutions were carried out in 50 mM Hepes.NaOH pH 7.2, 100 mM
NaCl. Dansyl calmodulin was diluted to 150 nM and the emission
spectrum of the solution was recorded from 400 - 550 nm with the
excitation wavelength adjusted to 340 nm. The spectrum was also
measured with the addition of 100 pM EGTA.NaOH pH 7.2 or 100 pM
CaCl2 and by including SytC in various molar ratios. Titrations of Ca2+,
Ba2+ and Mg2+ were carried out with solutions of Dansyl calmodulin alone
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(concentration as above) and with a mixture of dansyl calmodulin and
SytC in a 1:1 molar ratio. In this case, 1 mM NTA.NaOH pH 7.2 was
included so that free Ca2+ concentrations of 1-200 pM were obtained.
2.24 N-terminal peptide sequencing
N-terminal sequencing of the recombinant cytoplasmic domain of
synaptotagmin was carried out by separation of SDS-PAGE followed by
electroblotting onto PVDF membrane as described by Matsudaira (1987)
with the particular modifications suggested by Dunbar and Wilson (1993).
After the electroblotted protein had been stained and destained, the band of
interest was excised and taken to the Welmet protein facility at the
University of Edinburgh for automated peptide sequencing.
2.25 Circular dichroism
Measurements of UV and far UV circular dichroism spectra were carried
out in a JASCO J-600 spectropolarimeter using purified synaptotagmin at
a concentration of 0.5 mg/ml in 10 mM Tris.H2S04 pH 7.4, ImM
NTA.NaOH pH 7.4. Additions of CaCl2 were made to this solution so that
free Ca2+ concentrations ranged from 1 - 200 pM and successive spectra
were measured and then compared to see whether Ca2+ had any effect of
the peptide secondary structure. This was also performed with TbCl3 to
give Tb2+ concentrations of up to 90 pM. Similar Ca2+ titrations were also
carried out in the presence of equimolar concentrations of calmodulin and
in the presence of 100 pg/ml phospholipid vesicles.
2.26 Molecular dynamics
Molecular dynamics or light scattering properties of the purified
cytoplasmic domain of the protein were carried out using a DynaPro-801
68
light scattering spectrometer following manufacturer's instructions. The
protein was used at a concentration of 0.5 mg/ml or 1 mg/ml in 20 mM
Tris.HCl pH 7.2, 100 mM NaCl, ImM NTA.NaOH pH 7.2. Additions of
CaCl2 were made to the protein solution so that free Ca2+ concentrations
of 1, 5, 10, 20, 30, 50, 100 and 200 jiM were obtained. After each addition a
200 pi sample of the protein was injected into the machine through a 0.02
pm nylon filter and the molecular dynamics parameters were measured.
The machine was flushed with distilled water after each measurement to
prevent residue build-up which distorted the measurement. A similar
titration with CaCl2 was also performed using a solution containing
equimolar concentrations of synaptotagmin and calmodulin.
2.27 Digestion with trypsin
Analytical digestion of purified synaptotagmin with trypsin was performed
in 200 pi reaction volumes in 50 mM Hepes.NaOH pH 7.2, 100 mM NaCl
containing 0.2 mg/ml of the protein and 100 pg/ml of phospholipid vesicles
(40% (w/v) each of PS and PC, 20% (w/v) cholesterol) and either 100 pM
CaCl2 or 1 mM EGTA. NaOH pH 7.2. Trypsin was added in the
concentrations 0, 6.25, 12.5, 25, 50 and 100 pg/ml and the reactions
incubated at 37°C for 45 min. The reaction was terminated by adding hot
SDS-PAGE sample buffer and heating the samples further at 95°C for 10
min. The digestion was analysed by electrophoretic separation and
Western blotting.
2.28 Digestion with thrombin
2.28a Digestion in solution
The soluble fraction prepared from a bacterial culture expressing protein
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A-SytC fusion protein was digested using purified thrombin obtained
commercially. Thrombin was added to the protein, prepared in 50 mM
Tris.HCl pH 7.8, 150 mM NaCl, 2.5 mM CaCl2, in an enzyme:substrate
protein ratio of 1:500 (w/w) and then incubated at 37°C for 1 h. The
reaction was stopped by adding SDS-PAGE sample buffer and the digest
analysed by gel electrophoresis.
2.28b Digestion of immobilised protein
Thrombin was also used to digest the fusion protein after it had been bound
to IgG-Sepharose and the Sepharose washed with TST and ammonium
acetate pH 5.0. The Sepharose (2 ml) was then washed 3 times in 20 ml of
50 mM Tris.HCl pH 7.8, 150 mM NaCl, 2.5 mM CaCl2 and finally
resuspended in 2 ml of the same buffer. Two units of thrombin
(corresponding to a thrombimrecombinant protein weight ratio of 1:40000)
were then added and the Sepharose incubated at 37°C for 9-13 h. The
buffer was removed from the top of the Sepharose and retained. Two
further washes of 2 ml wash buffer (50 mM Tris.HCl pH 7.8, 400 mM
NaCl, 4 mM EGTA, 10% (w/v) glycerol) were collected and retained and
the IgG-Sepharose was then treated with acetic acid pH 3.4 and
reequilibrated as previously described. Samples of 30 pi of the thrombin
digest buffer and subsequent wash buffers were taken, 10 pi SDS-PAGE
sample buffer added and the protein content analysed by gel
electrophoresis. All the washes and the Sepharose were treated with 0.1
mM PMSF after the digestion to ensure the thrombin activity was
inhibited.
2.29 Blue native gels
Blue native gel electrophoresis was performed using the method of
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Schagger & von Jagow (1994). Solutions used for blue native












15 mM bis Tris
0.02% (w/v) Serva Blue G
50 mM bis Tris.HCl pH 7.0
150 mM bis tris.HClpH7.0
1.5 M aminocaproic acid
48% (w/v) acrylamide
1.5% (w/v) bisacrylamide
1.5 M aminocaproic acid
0.1 M bis Tris.HCl pH 7.0
5% (w/v) Serva Blue G





lOx anode buffer 1 M Tris.HCl pH 8.9
3x gel buffer 3 M Tris.HCl pH 8.45
0.3% (w/v) SDS
Stain solution 0.025% (w/v) Serva Blue G
10% (v/v) acetic acid
Destain 10% (v/v) acetic acid
Gel mixtures were made up as outlined in tables 1 and 2.
Standard Hoefer Tall-Mighty-Small units were used for first dimension
gels. The first dimension gel was prepared with 1.5 mm spacers using a
peristaltic pump to create an exponential acrylamide gradient from 12% at
the bottom of the gel to 4.8% at the top of the separating gel with a 4%
stacking gel on the top.
Samples of chromaffin granule membranes were prepared by centrifuging
membranes containing 600 jig total protein at 100,000 rpm in a Beckman
TL100.2 rotor for 10 min. The pellet was resuspended in 80 |il of distilled
water and 80 pi of 2x sample buffer added.
30 pi 10% (w/v) dodecylmaltoside was then added and the sample
centrifuged again as before. The supernatant was removed and 15 pi 5%
(w/v) Serva Blue G added. 80pl of this prepared sample was loaded per lane
of the gel.
Bovine heart mitochondria were prepared as standard markers for the first
72
dimension gel. Mitochondria containing 800 jig protein were diluted with 60
pi water, 80 pi 2x sample buffer and 40 pi of the same detergent was added.
Finally, 20 pi of blue dye was added and 60 pi of this sample was loaded.
Table 2.1 Blue native gel first dimension solutions
volume of solution (ml)
Stack Top Bottom
4% 4.8% 12%
Acrylamide 0.5 0.6 1.5
3X gel buffer 2.0 2.0 2.0
Glycerol - - 1.2 g
Water 3.45 3.35 1.48
TEMED 0.005 0.003 0.002
10% (w/v)
ammonium 0.05 0.03 0.02
persulphate
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Table 2.2 Blue native gel second dimension solutions












The gel was subjected to electrophoresis at 100 V constant voltage for 1 h,
200 V for a further 2 h and then 300 V until the dye had reached the
bottom. If the first dimension was to be electroblotted to nitrocellulose, the
cathode buffer was replaced after 1 h with cathode buffer containing
0.002% (w/v) Serva Blue G. First dimension Western blotting was carried
out as the standard protocol with the addition of a destaining step for the
nitrocellulose with several changes of 50% (v/v) methanol immediately















For the second dimension, individual gel strips corresponding to single lanes
of ID gel were soaked twice for half an hour in 200 pi of 1% (w/v) SDS,
0.1 M DTT. The strips were then placed near the top of a notched 15 cm x
15 cm glass plate; 3 mm spacers and a straight glass plate were then
placed on the top. Holding the assembly together with bulldog clips, the
plates were carefully sealed on all straight sides using 1.5% (w/v) agar. The
separating gel was poured into the cassette to 1 cm below the gel strip; the
stacking gel was poured to 2 mm below the gel strip and overlay gel was
used to fill the remainder of the space including a few millimetres above the
gel strip. The gel was then run at 50 mV constant voltage for 1 h and then
switched to 30 mA constant current for a further 8 h until the blue dye was
just starting to come off the bottom. The gel was fixed in 10% (v/v) acetic
acid, 50% (v/v) methanol for several hours and stained in 5% (v/v) acetic
acid containing 0.025% (w/v) Serva Blue G for 2 h. Destaining was carried
out with 5% (v/v) acetic acid over night. Second dimension gels for
electroblotting were treated as normal SDS-PAGE gels.
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Chapter 3
Production and purification of a
synaptotagmin-ProteinA fusion protein and a
synaptotagmin-HislO fusion protein
3.1 Introduction
Many proteins thought to be involved in exocytosis have been identified
and the study of these proteins may help to elucidate the mechanisms
involved in this biological process. Such investigations are often hampered
by the relatively low abundance of these proteins which makes it difficult
to accumulate enough protein for biochemical study. Molecular cloning
technology circumvents this problem by allowing the cloning and bacterial
expression of eukaryotic genes encoding secretory proteins in large
amounts. In addition, it is possible to add DNA sequences to the gene of
interest to create convenient 'tags' on the protein product for ease of
identification, purification and experimental manipulation.
One such protein is synaptotagmin which, apart from being positioned in
the secretory vesicle membrane of cells which exhibit regulated exocytosis,
is further implicated as having a role in regulated secretion by the
existence of two putative Ca2+ binding sites in its sequence. Most of the
sequence of synaptotagmin is cytoplasmic. It is therefore assumed that
any interaction with other vesicle, cytoplasmic and plasma membrane
proteins must occur in this portion of the molecule (referred to as SytC).
For this project, a molecular cloning approach was adopted to study bovine
synaptotagmin I. The DNA encoding the cytoplasmic domain of the
protein (sytc) was cloned into two different vectors creating gene fusions
with either DNA encoding a ten-histidine peptide or DNA encoding part of
Protein A (pra). Both strategies gave a fusion protein which was easy to
purify by affinity chromatography either with Ni-NTA agarose (affinity to
histidine) or IgG-Sepharose (affinity to Protein A). Creating two fusions
would then enable a comparative evaluation of gene expression efficiency,
ease of purification and final protein yield.
3.2 Construction of a gene encoding pra-tagged synaptotagmin
Nucleotide primers delineating the sequence encoding the cytoplasmic
domain of synaptotagmin (approximately 1 kb) were designed and used in
PCR to amplify the portion of the gene from a bovine adrenal library using
Taq polymerase (see Appendix 2, table A2b). This polymerase adds
adenosine extensions to the 3' ends of the amplified product. This was
utilised in the initial cloning into a pGEM-T vector. The vector pGEM-
5Zf(+) has been linearised with EcoRV and modified with T extensions at
the 3' ends which will efficiently anneal to the 3' A extensions of the PCR
product.
The pAXll plasmid contains a sequence encoding a Pra-lacZ fusion protein
of 26 kDa containing the N-terminal portion of Protein A (two and a half
IgG-binding domains of approximately 16.9 kDa). The multiple cloning
region of the plasmid is situated in between the pra and lacZ DNA so that
insertion of sytc into it will form an in-frame fusion ofpra and sytc and
disrupt transcription of the lacZ giving blue/white selection of recombinant
plasmids in an E.coli strain containing ZAM15.
Once the sytc sequence had been cloned into the pGEM-T plasmid, it was
excised using EcoRI and Sail DNA restriction enzymes (the recognition
sequences for these enzymes had been included in the primer sequences
flanking the coding DNA) and ligated to pAXll plasmid DNA which had
been similarly digested. The resultant recombinant plasmid was labelled
pLClOO. The sequence of the gene junction and the sytc portion of the
construct was verified experimentally and found to be as expected. The
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gene junction is shown in figure 3.i below.
Figure 3.i DNA and protein sequence of the junction between pra
and sytc in the fusion construct
pra .EcoRI sytc
GAA TTG GCC AAT TCC CGG GGT ACC GAA TTC GGC CCG CGC GGA GGG




The full sequence of the Synaptotagmin I gene is shown in Appendix 3
giving the DNA sequence relevant to the cloning and the aminoacid residue
numbers as shown on the previous diagram. It was then possible to
express this construct in bacterial cells under lac promoter control
producing a fusion protein, Protein A-SytC with Protein A (PrA) at the N-
terminus. The primer encoding the N terminus of SytC was also designed
to contain the DNA encoding the three-ammo acid recognition site for the
protease thrombin. Thrombin could therefore be used to cleave Protein A
from SytC enabling purification of the cytoplasmic domain alone.
3.3 Induction of fusion gene expression
The cloned portion of the synaptotagmin gene had been placed under lac
promoter control in the pAXll plasmid. Expression of the chimaeric gene
should therefore be induced by the addition of IPTG to a growing culture of
transformed bacterial cells giving rise to the production of fusion protein.
Conversely, addition of glucose to a culture should ensure that no protein
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appears in the cells and is a useful way of controlling the onset of protein
production. Figure 3.1 shows that IPTG induced the production of a protein
which was recognised by the synaptotagmin-specific monoclonal antibody
cgm67 and was of the size expected (approximately 50 kDa) for the
expected fusion protein.
Levels of the fusion protein were found to increase over time reaching high
levels after 3 h of growth after induction with IPTG (figure 3.2). This
information was useful to set the initial growth conditions for a good yield of
the recombinant protein.
3.4 Fractionation studies showing intracellular distribution of the
fusion protein
Recombinant proteins produced in E.coli can often be made in such large
quantities that they aggregate and form insoluble inclusion bodies. These
can be isolated by differential centrifugation but the protein is not suitable
for functional studies due to its assuming a misfolded or unfolded
conformation which presumably causes the aggregation. Before
purification of the protein can be attempted therefore, it is important to
ascertain its location within the cell; if it is soluble, this will be an
indication that the protein is in a correctly folded conformation and will be
amenable to affinity chromatography. Figure 3.3 shows the P20, S20 and
P3 fractions from a bacterial culture containing the recombinant plasmid
after 3 h induction at 37°C. Since the P20 and P3 fractions have a much
smaller volume than S20, the material from them was resuspended in the
same total volume as S20 and equal volumes of each were analysed by
SDS-PAGE. Analysing equivalent volumes in this way gives a true
representation of the total amount of fusion protein present in each
fraction. The P20 fraction (inclusion bodies) and the P3 fraction (whole
cells and nuclear debris) contain substantial amounts of the fusion protein
but the soluble S20 fraction contains more. The culture conditions are
therefore suitable for producing large amounts of soluble fusion protein for
purification.
3.5 Digestion with thrombin
The fusion protein was designed with a cleavage site for the protease
thrombin. Initially, the accessibility of this site was tested with the
unpurified protein in the soluble S20 fraction. A time course of digestion
(figure 3.4) showed the main protein band in the extract was one of the
correct size for the Protein A-SytC fusion (57 kDa) and this disappeared
over a period of digestion with thrombin and was accompanied by the
appearance of a band of the correct position to be the SytC portion of the
protein (36 kDA). The synaptotagmin-specific antibody recognises both
the disappearing upper band and the appearing lower band (figure 3.5)
confirming that the lower band is the SytC product.
A titration with successively smaller amounts of thrombin (figure 3.6)
showed that a ratio of thrombin to total protein of 1:10000 was sufficient
to give substantial digestion of the fusion protein over short periods. This
was encouraging as it suggested that thrombin could be used in the
purification without it becoming a major protein contaminant. Figure 3.7
illustrates the appearance of Protein A during thrombin digestion. Any
non-specific IgG can be used to detect the fusion protein or Protein A alone
due to the affinity between Protein A and IgG but SytC will not be
detected. The large Protein A - containing band is shown to disappear and
a much smaller band the size of the Protein A domain alone appears upon
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digestion with thrombin giving farther evidence that the fusion protein is
indeed being cleaved into SytC and PrA. The purification strategy planned
would require the thrombin digestion to act on fusion protein immobilised
on IgG-Sepharose. A small-scale pilot study was therefore conducted to
establish whether this was feasible. Figure 3.8 shows that the fusion
protein binds to IgG-Sepharose although the amount applied probably
exceeds the capacity of the Sepharose used because there was still soluble
protein left in the S20 after binding. Buffer removed from the protein-
bound Sepharose after 4 h digestion with thrombin was found to contain
the 36 kDa protein recognised by the monoclonal antibody cgm67
suggesting that the thrombin site is accessible to the enzyme even in the
immobilised protein and that digestion in this way would be a convenient
method to purify SytC in one step, without the need for separation of PrA
and SytC after digestion as would be necessary if the cleavage was carried
out on soluble fusion protein. More of the SytC was recovered in the wash
steps and the final elution contains mainly the PrA portion of the construct
(data not shown) Some of the Pra portion of the fusion protein appeared to
leach off the Sepharose with SytC straight after the thrombin digestion.
This was not a large amount but was amplified by the sensitivity of the
detection method. Furthermore, the leaching was not seen in subsequent
purifications (eg figure 3.9) and so was probably an effect of a pH
inaccuracy in this experiment alone.
3.6 Affinity purification of the PrA-SytC fusion using IgG
Sepharose
A scaled-up version of the thrombin digestion of the fusion protein
immobilised on IgG-Sepharose was attempted in order to purify a larger
amount of SytC. The basic procedure for binding Protein A fusion proteins
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to IgG-Sepharose was followed and after extensive washing of the
Sepharose to remove residual contaminating proteins, thrombin was added
in the lowest dilution previously found to be effective and incubated
overnight at 37°C. Figure 3.9 shows that not all of the fusion protein is
removed from the bacterial lysate, presumably because the quantity
present exceeds the capacity of the Sepharose used, but the digestion with
thrombin released essentially pure SytC with a yield of 15-20 mg per litre
of bacterial culture. The main problem to be solved with this step was that
an equal amount of SytC remains bound to the IgG-Sepharose and is only
recovered in the low pH eluate when the resin is recycled. The Pra portion
of the chimaeric protein was not seen in the glycine eluate. It is possible
that the pH of the Sepharose was not lowered sufficiently for successful
elution of Pra. Alternatively, it is possible that the Pra has not stained well
on figure 3.9 since the Pra eluted well in subsequent purifications but
showed variability of staining on gels.
The nature of the interaction which was keeping SytC bound to the
Sepharose was not known so various wash conditions were tried after
thrombin digestion. Figures 3.10a and 3.10b show that no SytC is left
bound to the Sepharose in the presence of RIPA detergents and very little
is left bound with EGTA. It was therefore decided to include EGTA washes
in the purification when recovering the SytC protein rather than
introducing detergents into the preparation which may be difficult to
remove completely and may adversely affect the conformation of the
protein.
3.7 Further purification by exclusion chromatography
Figure 3.11 shows the protein purity (estimated by densitometry as 80%)
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after initial affinity purification and concentration by precipitation with
ammonium sulphate. The main contaminants are high-molecular weight
proteins, which are probably derived from the IgG heavy chain or E.coli
chaperone proteins such as hsp70 which may be complexed with the fusion
protein. A wash step with buffer containing 10 mM MgATP was
attempted before the thrombin digest because ATP is required for the
binding/release cycle of chaperones. Some high molecular weight
contaminants were released from the Sepharose but approximately half of
the bound fusion protein was also removed from the resin (data not shown)
giving a much lower final yield of SytC. Gel exclusion chromatography was
therefore selected as the method for further purification. The elution
profile and calibration curve for the column using marker proteins are
shown in figures 3.12a and 3.12b respectively and the elution profile for the
SytC preparation is shown in figure 3.13a. The composition of the main
peak fractions was analysed by gel electrophoresis and is shown in figure
3.13b. Fractions 24-29 all contain protein which was 90% pure (estimated
by densitometry). The purest fractions are 95-98% SytC and had a
protein concentration of 1.5-2.0 mg/ml.
3.8 N terminal peptide sequencing
The purified SytC protein was sequenced at the N terminus by automated
peptide sequencing of the protein bound to PVDF membrane. The N
terminus was found to be N A I N M. The original construct was designed
to have the sequence GGKNAINMat the N terminus of the protein.
The missing three amino acids are likely to be the result of other protease
activity in the thrombin used or residual protease activity from the E.coli
lysate although this is treated with a mixture of protease inhibitors during
the preparation of the lysate and also during binding to IgG-Sepharose. It
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is also possible that the G G K sequence is acting as a 'pseudo-recognition'
sequence for thrombin mimicking G P R (the accepted thrombin
recognition sequence)
3.9 Construction of a gene encoding HislO N-terminally tagged
synaptotagmin
The sytc gene was amplified by PCR and initially cloned into pGEM-T as
previously described. The primers contain DNA recognition sequences for
the restriction enzymes Ndel and BamHl so that sytc can be excised from
pGEM-T and ligated to the vector pET16b similarly digested with these
enzymes. pET16b is designed to create an in-frame fusion to the gene
inserted at this cloning site consisting of a sequence encoding a 10-histidine
peptide separated from the cloned gene by a sequence encoding the Factor
Xa protease site. The resulting fusion protein has therefore a cleavable N-
terminal oligohistidine tag referred to as HislO. The DNA and protein
sequence of the junction between the HislO and SytC portions of the
construct are shown in figure 3.ii below.
Figure 3.ii DNA and protein sequence of the junction between
his10 and sytc in the fusion construct
oligo his Ndel sytc
CAT CAT CAT AGC AGC GGC CAT ATC GAA GGT CGT CAT ATG GGA GGG




The junction sequence and the sytc portion were verified experimentally by
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DNA sequencing.
3.10 Synthesis of the HislO-SytC protein
The gene cloned in pET16b is under T7 promoter control so it must be
expressed in a strain which has an inducible T7 polymerase to transcribe
the gene. The E.coli strain BL21(DE3) was used which carries a T7
polymerase gene under lac promoter control. This enables the induction of
gene expression, again by the addition of IPTG and its repression with
glucose. Figure 3.14 shows induction of a protein, upon addition of IPTG,
recognised by cgm67 in cultures of cells transformed with different
recombinant plasmids. There is good repression of expression in the
presence of glucose and moderate induction with IPTG and there appear to
be three forms of the protein recognised by the monoclonal antibody.
Analysis of the construct sequence reveals the presence of three potential
methionine 'start' codons so alternative initiation events could be
responsible for the appearance of smaller cgm67 - reactive proteins
(Appendix 4). In this case, it may be predicted that only the largest
product will have a his-tag and therefore will be the only form purified on
Ni-NTA agarose.
The levels of expression of the HislO-fusion protein were not very high
even after 4 h growth following induction (cell death occurs if cells are
grown for longer than this). In an attempt to increase levels of the protein,
alternative E.coli DE3 strains were used which contain a plasmid encoding
T7 lysozyme (pLysS). This is a natural inhibitor of T7 RNA polymerase
and should prevent 'leaky' expression by low background levels of T7
polymerase. When IPTG is added this inhibition should be overcome by the
transcription of large amounts of the polymerase from the stronger lac
86
promoter. The strain containing pLysE gives even tighter control of
expression of the cloned gene. Figure 3.15 shows the distribution of fusion
protein in the S20, P20 and P3 fractions in three DE3 strains. Although
the LysE strain gives less of the smaller products, neither of the two
alternative strains gave an increase in protein levels. A HislO chimaeric
protein (of the 39 kDa subunit of the V ATPase) had previously been
purified in large quantities which suggests that this strategy is variable
with different proteins.
3.11 Affinity-purification of HislO-SytC with Ni-NTA agarose
The fusion protein produced can be purified by affinity chromatography on
Ni- agarose. Figures 3.16a and 3.16b show the purification of the fusion
protein with a step-wise gradient of imidazole which first elutes non-
specifically bound proteins at 50-100mM imidazole and then elutes the
specifically bound HislO-tagged protein at 150-200mM imidazole. As
predicted by the sequence analysis, only the largest product produced by
the cells is purified on Ni-NTA agarose suggesting it is indeed the only
product carrying the oligohistidine tag. This is shown in figure 3.17. It was
decided to leave the his-tag on the protein since it is only small and unlikely
to interfere structurally with the protein.
3.12 Conclusion
The construction of two gene fusions encoding affinity-tagged versions of
SytC has been described along with the identification and purification of
the protein products.
Both constructs encode soluble fusion proteins which are accessible to
affinity chromatography although the Protein A chimaera is produced in
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much larger quantities than the HislO chimaera. Conversely, the Ni-NTA
agarose purification procedure is more straightforward and gives a purer
product in one step. In addition, no other proteins are introduced during Ni-
NTA agarose purification whereas the IgG-Sepharose procedure involves
both IgG, probably responsible for the high molecular weight
contamination, and also thrombin. It was therefore difficult to decide at
this stage whether to work with one particular construct or to carry out
experiments using both. Anomalous behaviour of the his-tagged protein,
discovered later, along with structural studies eventually led to the use of
the Protein A fusion as the source of SytC for this study.
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Figure 3.1 Induction ofpra-sytc expression
Two flasks containing 50 ml medium (L-broth) with 50 pg/ml kanamycin
were inoculated with one fiftieth the volume of an overnight culture of
E.coli NM522(pLC100) grown in medium containing 0.4% (w/v) glucose.
One 50 ml culture still contained the same amount of glucose. The two
cultures were incubated at 37 °C for 0.5 h (to an O.Dgoo of 0-2) before the
addition of 0.1 mM IPTG to the culture not containing glucose. After 2 h
further incubation, 1 ml of each culture was centrifuged for 1 min at 13000
rpm in a MSE MicroCentaur and the pellet resuspended in 100 pi SDS-
PAGE sample buffer. These were analysed by gel electrophoresis (10 pi
loaded) and Western blotting using a synaptotagmin-specific monoclonal
antibody (cgm67) at a dilution of 1:5.
Lane 1 Culture induced with IPTG




Figure 3.2 Time course of PrA-SytC fusion protein production
Medium containing 50 pg/ml kanamycin (100 ml) was inoculated with one
fiftieth the volume of an overnight culture ofE.coli NM522(pLC100).
After growing to an ODeoo of 0.4 (45 min at 37°C), 0.1 mM IPTG was added
and 1 ml samples withdrawn from the culture after 0.5, 1, 2, 3 h growth.
The 1 ml samples were centrifuged for 1 min at 13000 rpm in a MSE
MicroCentaur and the pellet resuspended in 100 pi of SDS-PAGE sample
buffer. 15 pi of the first sample was loaded and the volumes loaded of the
other samples were adjusted according to the cell mass present in each
sample (estimated from the culture A^oo when the sample was taken). Gel
electrophoresis and Western blotting were carried out using cgm67 at a
dilution of 1:5 for detection of the protein.
Lane 1 0.5 h growth after induction
Lane 2 1.0 h growth after induction
Lane 3 2.0 h growth after induction




Figure 3.3 Fractionation of a bacterial culture expressing the
pra-syt gene
Fractionation was carried out with all culture ofE.coli NM522(pLC100)
as already outlined in Materials and Methods. All the fractions were made
up to a volume of 10 ml and samples of 10 pi were analysed by SDS-PAGE
followed by Western blotting using cgm 67 at a 1:5 dilution for detection.
Lane 1 P20 pellet (inclusion bodies)
Lane 2 S20 soluble fraction (cytosol)




Figure 3.4 SDS-PAGE gel showing the time course of thrombin
digestion of the PrA-SytC protein
The S20 fraction was prepared from a 100 ml culture ofE.coli
NM522(pLC100) . A 100 pi digest was carried out as described in
Materials and Methods using a thrombindotal protein weight ratio of
1:2000. Samples of 10 pi were removed from the digest at intervals of 0,
15, 30, 45, 60, 90, 120 and 150 min after the start of incubation and 3 pi
SDS-PAGE sample buffer added. 5 pi of each sample was analysed by gel
electrophoresis and Coomassie staining
Lane 1 Molecular weight standards
Lane 2 S20 incubated for 150 min at 37 °C without thrombin
Lane 3 0 min sample
Lane 4 15 min sample
Lane 5 30 min sample
Lane 6 45 min sample
Lane 7 60 min sample
Lane 8 90 min sample
Lane 9 120 min sample
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Figure 3.5 Western blot showing time course of digestion with
thrombin of Pra-SytC protein
A 200 pi thrombin digest was performed with the S20 fraction from a 100
ml culture of NM522(pLC100) using a thrombin:total protein weight ratio
of 1:2000 and 10 pi samples withdrawn after 0, 5, 10, 15, 20, 25, 30, 45, 60,
90, 120 and 150 min after the start of incubation. SDS-PAGE sample
buffer was added (3 pi) to each sample and 2 pi analysed by gel
electrophoresis followed by Western blotting using the monoclonal antibody
cgm67 at a dilution of 1:5.
Lane 1 0 min sample
Lane 2 5 min sample
Lane 3 10 min sample
Lane 4 15 min sample
Lane 5 20 min sample
Lane 6 25 min sample
Lane 7 30 min sample
Lane 8 45 min sample
Lane 9 60 min sample
Lane 10 90 min sample
Lane 11 120 min sample
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Figure 3.6 Gel showing titration of Pra-SytC protein with
thrombin
Protein from the S20 fraction of a 100 ml culture ofE.coli
NM522(pLC100) was used to set up 20 pi thrombin digests incubated at
37 °C for 4 h following the basic procedure already outlined but with
different weight ratios of thrombimtotal protein. The reaction was
terminated by adding 7 pi SDS-PAGE sample buffer and 5 pi analysed by
gel electrophoresis and Coomassie blue staining.
Lane 1 Thrombimtotal protein weight ratio of 1:1000000
Lane 2 Thrombimtotal protein weight ratio of 1:100000
Lane 3 Thrombimtotal protein weight ratio of 1:10000
Lane 4 Thrombimtotal protein weight ratio of 1:5000
Lane 5 Thrombimtotal protein weight ratio of 1:2000
Lane 6 Thrombimtotal protein weight ratio of 1:1000
Lane 7 S20 incubated at 37 °C for 1.5 h without thrombin









Figure 3.7 Western blot showing titration of Pra-SytC protein
with thrombin
Thrombin digests of of 20 pi using S20 protein were incubated at 37 °C for
1.5 h with larger amounts amounts of thrombin than previously used to
ensure complete digestion in a short time. Reactions were terminated by
the addition of 7 (il SDS-PAGE sample buffer and 2 pi of the samples
analysed by gel electrophoresis and Western blotting using anti-bovine
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Figure 3.8 Thrombin digestion of Pra-SytC immobilised on IgG
Sepharose
3 ml of S20 (containing approximately 10 mg recombinant protein),
prepared from a culture of E.coli NM522(pLC100), was mixed with 400 pi
IgG-Sepharose, incubated overnight and washed as described in Materials
and Methods. The Sepharose was then equilibrated in thrombin digest
buffer (50 mM Tris.HCl pH 7.8, 2.5 mM CaCl2, 100 mM NaCl) and 100 pi
of the buffer added along with 10 units of thrombin, corresponding to a
PraSytC:thrombin weight ratio of 4000:1. After incubation at 37°C for 4
h, the buffer was removed and the IgG-Sepharose washed twice with 100
pi of digest buffer. Finally, 100 pi of 0.2 M glycine pH 2.8 was used to elute
any protein left bound to the column. 20 pi samples were taken from the
initial digest buffer and the washes. SDS-PAGE sample buffer was added
and 5 pi of each sample was loaded on a gel and subjected to
electrophoresis followed by Western blotting using the monoclonal antibody
cgm67 for detection at a dilution of 1:5 together with anti-bovine IgG-HRP
at a dilution of 1:10000 for detection of Pra.
Lane 1 S20 before binding to IgG-Sepharose
Lane 2 Blank
Lane 3 S20 after binding IgG-Sepharose
Lane 4 Digest buffer after incubation at 37 °C with thrombin
Lane 5 First wash after digestion
Lane 6 Second wash after digestion










Figure 3.9 Large-scale preparation of SytC
Large scale purification was carried out with the S20 fraction from all
culture of NM522(pLC100) by first binding the fusion protein to the resin
and then carrying out a thrombin digest on the immobilised protein as
described in Materials and Methods except the Sepharose was washed
after thrombin digestion with two further washes of thrombin digest buffer
without EGTA. Samples of the S20 fraction, the digest fraction and the
washes were taken and 2 pi analysed by gel electrophoresis and silver
staining.
Lane 1 Molecular weight standards
Lane 2 S20 before binding to IgG-Sepharose
Lane 3 S20 after binding to IgG-Sepharose
Lane 4 Thrombin digest buffer
Lane 5 First wash
Lane 6 Second wash
Lane 7 elution with glycine
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Figure 3.10 Recovering IgG-Sepharose - bound SytC protein
using different wash conditions
Six identical tubes were set up with 1 ml of the S20 fraction from all bacterial culture
and 200 pi of IgG-Sepharose and incubated overnight to bind the fusion protein to the
resin. Thrombin digestion was then carried out on the immobilised fusion protein using
0.5 ml thrombin digestion buffer and 0.5 units of thrombin with overnight incubation at
37°C. After removal of the initial digestion buffer, the six tubes were washed twice
with different washing buffers in each tube and then a final elution with 0.2 M glycine
pH 2.8 was carried out. The washing conditions used were: condition 1- thrombin
digestion buffer; condition 2- digestion buffer with 50% (v/v) ethylene glycol; condition 3 -
digestion buffer with NaCl reduced to 25 mM; condition 4 - digestion buffer with NaCl
increased to 400 mM; condition 5 - digestion buffer with RIPA detergents (1% (w/v) Np-
40, 0.5% (w/v) deoxycholate, 0.1% (w/v) SDS); condition 6 - digestion buffer with 2 mM
EGTA instead of CaCl2-
Figure 3.10a Figure 3.10b
Lane
1 Molecular weight standards Molecular weight standards
2 S20 before binding to IgG-Sepharose Blank
3 S20 after binding to IgG-Sepharose Second wash with buffer condition 1
4 Initial digest buffer Second wash with buffer condition 2
5 Initial digest buffer Second wash with buffer condition 3
6 Initial digest buffer Second wash with buffer condition 4
7 Initial digest buffer Second wash with buffer condition 5
8 Initial digest buffer Second wash with buffer condition 6
9 Initial digest buffer Blank
10 First wash with buffer condition 1 Elution with glycine for condition 1
11 First wash with buffer condition 2 Elution with glycine for condition 2
12 First wash with buffer condition 3 Elution with glycine for condition 3
13 First wash with buffer condition 4 Elution with glycine for condition 4
14 First wash with buffer condition 5 Elution with glycine for condition 5
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Figure 3.11 Ammonium sulphate-precipitated SytC protein after
affinity purification on IgG-Sepharose
The pooled washes from the thrombin digestion of immobilised PrA-SytC
were precipitated using (NH^SC^ to 80% saturation. 2 pi of the protein
was analysed by gel electrophoresis and Coomassie staining.
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Figure 3.12a Elution profile of molecular weight standard
proteins in gel exclusion chromatography
The A28O of the first eighty fractions was measured and the value obtained
was plotted against the elution volume.
Peak 1 670 kDa thyroglobulin
158 kDa y globulin
Peak 2 44 kDa ovalbumin
Peak 3 17 kDa myoglobin
Peak 4 1.35 kDa vitamin B12
void volume = 10 ml
total volume = 42 ml
Figure 3.12b Calibration curve for the gel exclusion column
Ve was calculated from the peak fraction number for each protein given
that the volume of each fraction is 0.5 ml. The curve was drawn assuming














Figure 3.13a Elution profile for the SytC protein in the gel
exclusion column.
The A280 of each fraction was measured and the value obtained for the first
eighty fractions was plotted against the fraction number.
Figure 3.13b Protein composition of the elution peak fractions
in gel exclusion chromatography
A 5 jil sample of each fraction from the main peak of absorbance was
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Figure 3.14 Production of HislO-SytC
Seven 10 ml cultures containing 0.4% (w/v) glucose and 100 pg/ml
ampicillin were inoculated from E.coli BL21 DE3 colonies transformed with
different hisio-sytc recombinant plasmids. These were grown overnight and
1 ml of each was used to inoculate 50 ml cultures all containing ampicillin.
One culture of each transformant contained 0.4% (w/v) glucose. The
cultures were grown at 37°C for 1 h and then 0.1 mM IPTG was added to
each culture not containing glucose. All the cultures were grown for a
further 2 h and the S20 fraction prepared from each culture. A 20 pi
sample was taken of all the S20 fractions, 7 pi SDS-PAGE sample buffer
added and 10 pi analysed by gel electrophoresis and Western blotting using
cgm 67 for detection at a 1:5 dilution.
Lane 1 Transformant 1 grown in glucose
Lane 2 Transformant 1 grown with IPTG
Lane 3 Transformant 2 grown in glucose
Lane 4 Transformant 2 grown with IPTG
Lane 5 Transformant 3 grown in glucose
Lane 6 Transformant 3 grown with IPTG
Lane 7 Transformant 4 grown in glucose
Lane 8 Transformant 4 grown with IPTG
Lane 9 Transformant 5 grown in glucose
Lane 10 Transformant 5 grown with IPTG
Lane 11 Transformant 6 grown in glucose
























Figure 3.15 Fractionation of three bacterial strains producing
HislO-SytC protein
100 ml cultures of three E.coli strains were set up; BL21 DE3(pLC600),
BL21 DE3 pLysS(pLC600) and BL21 DE3 pLysE(pLC600). All the
cultures contained 100 pg/ml ampicillin and were grown at 37°C for 2 h for
a further 4 h after induction with IPTG (0.1 mM); the cultures all reached
the same Agoo in this time. P3, P20 and S20 fractions were prepared from
each culture and 20 pi samples taken. SDS-PAGE sample buffer was
added (7 pi) and 5 pi of each sample was analysed by gel electrophoresis
and Western blotting using cgm67 at a dilution of 1:5.
Lane 1 BL21 S20 fraction
Lane 2 BL21 P20 fraction
Lane 3 BL21 P3 fraction
Lane 4 pLysS S20 fraction
Lane 5 pLysS P20 fraction
Lane 6 pLysS P3 fraction
Lane 7 pLysE S20 fraction
Lane 8 pLysE P20 fraction







Figure 3.16 Purification of HislO-SytC on Ni-Agarose
The S20 fraction was prepared from a 2 1 culture of E.coli BL21 DE3(pLC600) and
bound to Ni-NTA agarose overnight as already detailed in Materials and Methods and
the agarose subsequently washed many times. Initially, to ascertain the imidazole
concentration necessary for the elution of the fusion protein, a step-wise gradient of
imidazole was applied by washing the agarose twice with 2 ml of each imidazole
concentration from 50 mM to 500 mM in the pH 6 wash buffer. A sample of 20 pi was
taken from all the washes, SDS-PAGE buffer added and 10 pi analysed by gel
electrophoresis and Coomassie staining.
Figure 3.16a
Lane
1 Molecular weight standards
2 S20 before binding to Ni-agarose
Figure 3.16b
10 Second 100 mM imidazole wash
11 First 150 mM imidazole wash
12 Second 150 mM imidazole wash
13 First 200 mM imidazole wash
14 Second 200 mM imidazole wash
3 S20 after binding to Ni-agarose
4 First wash with pH 8.0 buffer
5 Last wash with pH 8.0 buffer
6 Last wash with pH 6.0 buffer
7 First 50 mM imidazole wash
8 Second 50 mM imidazole wash
9 First 100 mM imidazole wash
Molecular weight standards
First 250 mM imidazole wash
Second 250 mM imidazole wash
First 300 mM imidazole wash
Second 300 mM imidazole wash
First 350 mM imidazole wash
Second 350 mM imidazole wash
First 400 mM imidazole wash
Second 400 mM imidazole wash
First 450 mM imidazole wash
Second 450 mM imidazole wash
First 500 mM imidazole wash
Second 500 mM imidazole wash
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Figure 3.17 Western blot showing final purification of HislO-SytC
protein
After the initial determination of elution conditions for the protein (Fig
3.17), purification was carried out as already outlined in Materials and
Methods. Samples were taken of the starting protein and all the washes
(20 pi), SDS-PAGE sample buffer added and 10 pi analysed by gel
electrophoresis and Western blotting using cgm67 at a dilution of 1:5 for
detection of the protein.
Lane 1 P20 fraction
Lane 2 S20 fraction before binding to Ni-NTA agarose
Lane 3 S20 fraction after binding to Ni-NTA agarose
Lane 4 First wash with buffer pH 8.0
Lane 5 First wash with buffer pH 6.0
Lane 6 Last wash with buffer pH 6.0
Lane 7 First 50 mM imidazole wash
Lane 8 Last 50 mM imidazole wash
Lane 9 First 200 mM imidazole elution
Lane 10 Second 200 mM imidazole elution
Lane 11 Third 200 mM imidazole elution
Lane 12 Fourth 200 mM imidazole elution
Lane 13 Fifth 200 mM imidazole elution
Lane 14 Sixth 200 mM imidazole elution
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Appendix to Chapter 3
Production of affinity purified polyclonal antibodies
Appendix to chapter 3
3.A.1 Production of affinity purified polyclonal antibody to SytC
During this study, a polyclonal antibody was raised against PrA-SytC. A
fusion between the gene encoding Protein A from S. aureus and the sytc gene
was made in the plasmid pLClOO and expressed in bacteria. The fusion
protein produced was purified by affinity chromatography on IgG-
Sepharose and used to immunise rabbits. Protein A fusions have been
reported to give good immune responses (Lowenadler et al 1986) possibly
due to the repetitive globular units of the Protein A moiety.
Affinity purification of the specific SytC antibodies was carried out as
described in Materials and Methods using an analogous fusion between
oligohistidine and SytC. The affinity-purified antibody was shown to
recognise protein of the correct molecular size of 67 kDa in chromaffin
granule membranes and synaptosomes as well as the HislO-SytC fusion
protein. It does not however detect the purified SytC protein very well
even though this was part of the protein used to immunise the rabbits.
Figures 3Ala and 3Alb show a comparison of the specificities of the
affinity purified polyclonal antibody for SytC and the monoclonal anti-
synaptotagmin cgm67.
It is difficult to explain this phenomenon. It may be possible that some
structural property of SytC is absent in Western blots but this would
certainly not explain why the antibody recognises other synaptotagmins
and even SytC in another fusion protein. The antibody does of course
recognise the PrA-SytC fusion protein but any IgG would also do the same.
The only explanation in line with the facts, albeit the result of an
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unfortunate coincidence, is that the polyclonal antibody has one main
epitope on SytC at the junction region where thrombin cleaves the protein.
As has been discovered, the thrombin recognition sequence and three extra
amino acids are removed by the thrombin digestion process. It is likely
that the sequence G P A G G K would be exposed at the junction between
two globular domains of the fusion since it is relatively charged and
therefore might be a potential target for the immune system.
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Figure 3 A 1 Specificities of polyclonal and monoclonal
antibodies against synaptotagmin
Samples of CGM (15 pg total protein), rat brain synaptosomes (10 pg
protein), SytC (10 pg) and HislO-SytC (10 pg) was subjected to gel
electrophoresis and Western blotting. Polyclonal antibody raised against
Pra-SytC and affinity purified using HislO-SytC was used for detection at
a dilution of 1:100 for 3Ala and monoclonal antibody cgm67 at a dilution of
1:4 was used for 3Alb.







SytC purified from Pra-SytC fusion
HislO-SytC
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Chapter 4
Biochemical analysis of Ca2+-dependent
conformational change, interaction with calmodulin
and phospholipids of recombinant SytC
4.1 Introduction
The recombinant cytoplasmic portion of synaptotagmin I (SytC) was
purified using a combination of affinity chromatography and gel exclusion
chromatography (see Chapter 3). It was then characterised using a
variety of biochemical techniques.
4.2 Digestion of SytC with trypsin
SytC contains two regions with sequence homology to the regulatory
domain of protein kinase C, which is responsible for Ca2+ and phospholipid
binding in that protein and it has therefore been suggested that
synaptotagmin also may have Ca2+ and phospholipid-binding properties.
The binding of an ion such as Ca2+ to a protein may cause changes in its
structure which can be detected by examining the structure of the protein.
A simple and powerful technique for investigating conformational change in
a protein is to examine its protease sensitivity in the presence and absence
of the effector molecule.
Digestion of SytC with trypsin was performed at various trypsin
concentrations for a fixed time period in the presence and absence of
different divalent and trivalent metal cations. Figure 4.1 shows a
comparison of the protease sensitivity of SytC in the presence of
Ca2+EGTA or with EGTA only. As can be seen in lane 4, the protein was
completely digested with trypsin at 25 pg/ml in the absence of Ca2+
whereas it was resistant to even the highest trypsin concentration used
(100 pg/ml) when Ca2+ was included (lane 12). One or both termini of the
protein seem to be accessible to the protease as indicated by the
appearance of a ladder of tryptic products, differing in size by only 2 kDa.
This suggests that Ca2+ binds to SytC and causes the core of the protein to
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fold up more tightly masking potentially trypsin-sensitive sites and leaving
only the ends of the peptide chain available for proteolytic degradation.
The same experiment was repeated substituting Ba2+, Tb3+ or Mg2+ for
Ca2+. Ba2+ is reported to mimic Ca2+ in exocytosis whereas Mg2+ does not
and Tb3+ has affinity for divalent cation binding sites (Hadad et al 1994,
Zhang et al 1993). Figure 4.2a shows that Ba2+ also gave an increased
resistance to trypsin digestion as did Tb3+ (figure 4.2b) whereas Mg2+ did
not (figure 4.2c). These data suggest that Ba2+ and Tb3+ probably bind to
the protein at the Ca2+ binding sites producing the same effect as Ca2+.
The efficiency of trypsin digestion with a control protein, lactate
dehydrogenase, in the presence of each of these ions and EGTA alone was
found to be unaffected (data not shown).
4.3 Probing Ca2+-binding sites with Tb3+
Tb3+ has been used to probe the divalent cation-binding sites of proteins
(Hadad et al 1994, Zhang et al 1993) and has also been found to bind
chromaffin granule membranes with affinity parameters suggesting
protein involvement (Morris & Schober 1977). The ion has affinity for
divalent cation binding sites in proteins and its fluorescence is greatly
enhanced on binding to a protein. The fluorescence enhancement is then
competitively inhibited by divalent cations with affinity for the protein.
For this reason, Tb3+ was chosen as a convenient tool to probe the Ca2+-
binding sites of SytC.
Figure 4.3a shows the fluorescence enhancement of Tb3+ when added to a
solution of SytC with the protein in excess. Under these conditions
essentially all Tb3+ is bound at the start of the titration, allowing
determination of the 'endpoint' when all the binding sites are filled. The
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initial slope of the curve gave a specific change in fluorescence (AF) of 11
fiM-i and maximal binding of 24 pM Tb3+ overall as calculated from the
fluorescence difference between the sample with protein and the
background fluorescence due to Tb3+ alone at the maximum Tb3+
concentration used. Since the protein concentration used in this titration
was 40 pM, the [Tb3+] at the equivalence point would be expected to be at
least 40 pM, or more if the protein has more than one binding site for the
ion. It is however only just over half the expected value which suggests
that not all the protein molecules are binding the cation. This is possibly
due to overestimation of the concentration of SytC. However the the
assumption that all the protein is functional may be incorrect or
aggregation of the protein molecules may occur so that some of the cation-
binding sites are inaccessible - certainly the protein is more prone to
aggregation in a more concentrated solution. When titrations were
performed with low concentrations of SytC, fluorescence enhancement
showed typical hyperbolic characteristics (figure 4.3b). The curves
appeared to approach saturation by 10-20 pM Tb3+ but there was a
continued drift to higher fluorescence at the higher Tb3+ concentrations,
even though the data was corrected for background Tb3+ fluorescence,
suggesting that there was background light scattering due to protein
aggregation which was distorting the result. In a third type of titration,
successive quantities of SytC were added to solutions of fixed Tb3+
concentration; as expected, the fluorescence/protein concentration
relationship was linear giving a series of almost parallel lines on a plot of
fluorescence versus protein concentration (figure 4.4a). The slope of the
lines for 10-50 pM Tb3+ is almost constant and gives a specific AF for Tb3+
binding of 0.19 nM-i SytC when a plot of slope against [Tb3+] was
extrapolated to zero (figure 4.4b). To convert this to a specific fluorescence
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as in figure 4.3a, it would be necessary to know how much protein in the
titration is actually functional in the binding and also how many Tb3+
binding sites are on the protein. Although the number of binding sites could
theoretically be estimated by Scatchard analysis, the amount of functional
protein is impossible to measure without an assay for the protein's
function. The fact that the gradient of the fluorescence enhancement
changes dramatically at 100 pM Tb3+ is also an indication that the protein
is being affected by the higher ion concentration. Indeed, aggregation
became visible in the solution at 400 pM Tb3+ which called into question
the specificity of the observed fluorescence increase.
Using the data obtained (figure 4.3b), a Hanes plot (figure 4.5a) was used
to calculate Kd for Tb3+ from SytC. The value of Kd should be independent
of the concentration of SytC and it was, in fact, fairly consistent in all the
data sets at around 10 pM (table 4.1). The highest and lowest
concentrations of SytC gave a value for Kd closer to 20 pM but this is still
of the same order of magnitude as the other data sets. The Hill coefficient
is close to 1 for all the measurements taken indicating that there is no
cooperativity of binding.
The data were also analysed by a Scatchard plot using the specific
fluorescence calculated in fig 4.3a (11 pM-1) and this plot is shown in figure
4.6. Unfortunately, the specific fluorescence did not seem to be a reliable
conversion factor since it gave values of bound Tb3+ greater than the total
Tb3+ present for many data points which consequently had to be ignored
when plotting the data if a straight line was to be obtained.1 It is difficult
to be confident of the accuracy of the specific fluorescence measurement
1 The points that can be plotted will still represent an overestimate of Tb3+ bound since
the specific fluorescence is erroneous.
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since the sensitivity settings for the fluorescence spectrometer were
different for separate experiments. The value of 11 jiM-1 is however very
close to the initial slope of the curve for the highest protein concentration
in figure 4.3b and so could be considered a reasonable estimate. An
alternative possibility is that the functional protein present in the
determination of specific fluorescence is much lower than the apparent
protein concentration giving rise to inaccurate parameters. The values of
Kd obtained were fairly consistent in the region of 2-3 llM which although
smaller are of the same order of magnitude than those obtained by the
Hanes analysis. Scatchard analysis was attempted because it should give
an indication of number of binding sites for Tb3+ on SytC which may be
related to the number of Ca2+ binding sites if the two ions compete for the
same sites. The values obtained ranged from 8 to 14 binding sites per
SytC molecule. This is rather high given that the number of Ca2+ binding
sites on the protein, assumed from structural analysis, is 4. The number
of binding sites will be an overestimate because of the specific fluorescence
used as a conversion factor but taken at face value this suggests that Tb3+
may not binding in the same way as Ca2+ to the protein. This conclusion
was further supported when titrations were carried out using the two ions
in a competitive binding assay discussed below.
Further titrations were carried out in the presence ofvarious
concentrations of Ca2+ in order to determine whether competition for
binding to SytC was occurring between Ca2+ and Tb3+. It was expected
that Ca2+ would compete for binding sites on SytC and would therefore
reduce the fluorescence enhancement seen when Tb3+ was added to a
protein solution. This method would then be a convenient way of analysing
Ca2+ binding fluorimetrically. As can be seen from figure 4.5b, Ca2+ did not
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give parameters consistent with this hypothesis (except for the 15 pM
Ca2+ condition). In addition to this, it was impossible to reduce
fluorescence (displace Tb3+ from SytC) by the addition of Ca2+ after the
Tb3+ had been added suggesting either that the Tb3+ was binding
irreversibly to SytC or that it was binding to sites other than the Ca2+
binding site.
It is possible that Ca2+ is not binding optimally to SytC because the Ca2+-
binding properties of the protein are highly phospholipid dependent.
Including phospholipid vesicles in this assay was not feasible because they
interfered with the fluorescence measurements by scattering light and
they also aggregated upon addition of Ca2+ further distorting the data. The
methodology was tested using calmodulin as a model Ca2+ binding protein
and was found to be satisfactory but of course, this is a protein with a very
high affinity for Ca2+ and a much lower affinity for Tb3+ (table 4.1). The
parameters calculated with the data obtained are summarised in table 4.1
but the fluorescence data for competition between Ca2+ and Tb3+ were
considered too unreliable to interpret and it was decided to proceed no
further with this analysis.
4.4 Binding of SytC to phospholipid vesicles
The phospholipid-binding properties of SytC were investigated by studying
the binding of the protein to phospholipid vesicles ofvarious compositions
in the presence and absence of Ca2+. SytC was mixed with phospholipid
vesicles and incubated at room temperature for 15 minutes. The vesicles
were then pelleted by centrifugation at 100,000g for 30 min. Figure 4.7a
shows that the protein found bound to phospholipid vesicles after
incubation at room temperature and separation of the vesicles from
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solution by centrifugation. Figure 4.7b shows the corresponding protein
left in the supernatant after the centrifugation to remove the vesicles. In
the presence of EGTA (no Ca2+) there was a low level of binding of SytC to
the phospholipid vesicles, which did not appear to be dependent on the
composition of the vesicles or even on the presence of vesicles at all, since
the sample with no phospholipid also contains a small amount of protein in
the pellet. This would suggest that there was a low level of aggregation of
the protein even under these conditions. The amount of the protein in the
pellets was very low and was probably over-represented because the
immunological detection technique is very sensitive. The supernatants
from this incubation still contained most of the protein. The background
levels of protein in the lipid pellet completely disappeared in the presence of
Ca2+ suggesting that the ion had had some effect on the solubility of the
protein (lane 6). In these conditions, specific binding was seen with vesicles
containing PS, PI and PC. The protein had bound in the largest quantities
to Pi-containing vesicles and this was supported by the fact that the PI
supernatant was the only one to be depleted of SytC. An attempt was
made to quantitate the binding of SytC using densitometric scanning but
proved difficult because the Western blotting detection signal is very
sensitive and easily saturated by even small amounts of protein. A
calibration blot containing different amounts of protein did not give
sufficiently linear measurements to use as a basis for quantitation.
A similar experiment was carried out using phospholipid vesicles of more
complex lipid composition. In the presence of EGTA (figure 4.8a), most of
the protein remained in solution although some specific binding was
observed to PS/PI and PS/PE vesicles. Traces of protein could be seen
bound to PS/PC and PI/PE vesicles but these amounts were negligible
given the sensitivity of the detection method. None of the vesicles caused
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enough protein to bind to reveal depletion of protein from the supernatant
(figure 4.8b). In the presence of Ca2+, substantial binding occurred
particularly to PS/PE, PC/PI, PI/PE and PS/PC/PI vesicles since these
conditions also showed protein depletion in the supernatant (figure 4.8c and
d). Some protein also bound to PS/PI vesicles but although such binding
was detectable in the pellets it was not accompanied by substantial
depletion of the supernatant.
4.5 Interaction of SytC with immobilised calmodulin
Synaptotagmin from chromaffin granule membranes has been reported to
bind calmodulin in a Ca2+ - dependent manner (Hikita et al 1984) and the
cytoplasmic domain purified from a trypsin digestion of chromaffin
granules was shown to contain the calmodulin binding site (H.B.Tugal, PhD
thesis 1991). The Ca2+-dependent calmodulin binding properties of SytC
were therefore investigated by mixing purified recombinant protein with
immobilised calmodulin in the presence or absence of Ca2+ using native
synaptotagmin from the glycoprotein - rich fraction of CGM as a control
for the experiment. Figure 4.9a shows that a large proportion of SytC
bound to immobilised calmodulin in the presence of Ca2+ and was
subsequently eluted by the addition of EGTA. All the native
synaptotagmin also bound to the immobilised calmodulin in the presence of
Ca2+; although this suggests that binding of full-length synaptotagmin is
more efficient, it was present at a much lower concentration (not
determined) than the recombinant protein. The amount of recombinant
protein used exceeded the binding capacity of the immobilised calmodulin
used by a factor of 2. It has already been shown that Ba2+ mimics the
effect of Ca2+ on SytC, as determined by proteolytic cleavage (section 4.2).
Since Ca2+ binds both calmodulin and SytC whereas it is known that Ba2+
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does not bind calmodulin (Klee 1988), this experiment was repeated in the
presence of Ca2+ or Ba2+ to determine which protein stimulated the
binding. It can be seen from figure 4.9b that only Ca2+ caused significant
depletion of protein from the supernatant with an equal quantity of protein
in the eluate arid still bound to the calmodulin agarose. No protein could be
seen in the eluate when Ba2+ was used. This suggests that the binding
between calmodulin and SytC is primarily stimulated by interaction
between Ca2+ and calmodulin rather than between Ca2+ and SytC
because Ba2+ would be expected to reproduce the protein interaction if it
were dependent on SytC.
4.6 Fluorimetric analysis of interaction between calmodulin and
SytC
The dansyl molecule gives a characteristic fluorescence and can be
chemically attached to proteins.. The fluorescence may change if the
protein interacts closely with another molecule. This was used as the
basis of a fluorimetric assay for the Ca2+-dependent interaction of
calmodulin and SytC. Calmodulin was modified by the addition of a dansyl
moiety in a 1:1 molar ratio.Figure 4.10 shows the typical spectrum
obtained from a solution of dansyl-calmodulin. The fluorescence showed a
large decrease of maximum fluorescence when 1 uM free Ca2+ was added
(figure 4.11a) and smaller decreases up to 50 pM free Ca2+. At higher Ca2+
concentrations, the fluorescence increased again and at any point in the
titration, the starting fluorescence could be restored by the addition of
enough EGTA to chelate virtually all of the Ca2+ added. It was also
possible to increase the fluorescence by the addition of SytC in
calmodulin:SytC molar ratios of 2:1. 1:1 and l:2(data not shown). This
could be due to an interaction between the two proteins or simply because
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some of the Ca2+ is being removed from solution by binding to SytC
(although this should be negligible in a Ca2+ buffered solution) but it is most
likely to be due to a Ca2+-independent protein interaction, which SytC
caused even when added to dansyl calmodulin at zero Ca2+ (figure 4.11b).
The intensity across the whole spectrum of dansyl fluorescence appeared
to increase upon addition of SytC in the absence of Ca2+ and the peak of
the spectrum shifted slightly to a lower wavelength as the SytC
component was increased. This effect could not be accounted for by a
change in fluorescence when SytC was added to a buffer solution with or
without Ca2+ since the change was minimal. It was therefore decided to
begin with a Ca2+-buffered solution of dansyl calmodulin and SytC in a 1:1
molar ratio and add increments of Ca2+ to it since the starting spectrum
would then already take into account the increase in fluorescence produced
by mixing the two proteins and any further changes should be due to the
Ca2+ additions alone. Figure 4.12a shows the change in fluorescence of
dansyl calmodulin alone and of a protein mixture over a wide range of Ca2+
concentrations. The values are corrected for the difference in starting
fluorescence due to the SytC component. Since no change occurred in the
fluorescence of SytC alone in similar conditions, the difference indicates a
Ca2+-dependent interaction between the two proteins. Similar titrations
with Ba2+ and Mg2+ caused no difference in the fluorescence response of the
dansyl calmodulin alone compared to a protein mixture confirming that the
interaction is due to the effect of Ca2+ on calmodulin rather than SytC.
The main difference occurred within 5-20 pM Ca2+. Figure 4.12b shows a
titration in the 10 pM range with smaller increments of Ca2+ showing a
steady fall in fluorescence in dansyl calmodulin whereas a mixture of the
two proteins showed a fall in fluorescence followed by a reversal at 3 pM
Ca2+ where the fluorescence began to increase.
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4.7 Conclusions
Five biochemical approaches have been described which have allowed
some assessment of the binding properties of SytC with other molecules.
It has been shown that Ca2+, and also other metal ions which have affinity
for Ca2+ binding sites, bind to SytC causing it to alter conformation to the
extent that it becomes resistant to trypsin digestion. An attempt to
further study the Ca2+ binding properties of the protein using Tb3+ as a
fluorescent probe and competitive substrate for Ca2+ binding sites was
unsuccessful because the Tb3+ appeared to bind irreversibly to the protein,
probably due to some adverse effect the ion had on the tertiary structure
and solubility of the protein. SytC also demonstrates Ca2+-stimulated
phospholipid binding properties as would be predicted from the presence of
regions homologous to the regulatory domain of protein kinase C. SytC
shows particular affinity for phosphatidyl inositol and for combinations of
lipids which are charged. The binding of SytC to calmodulin has been
illustrated by the interaction with immobilised calmodulin and also by a
change in fluorescence of a reporter molecule attached to the calmodulin
when the two proteins were mixed. Both of these techniques show that the
interaction is stimulated by the effect of Ca2+ on calmodulin rather than
on SytC.
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Figure 4.1 Trypsin digestion of SytC with Ca2+
Digestions of SytC with varying trypsin concentrations were performed in the
presence of 100 pg/ml phospholipid vesicles (40% (w/v) each of PS and PC, 20%
(w/v) cholesterol) and in the presence or absence of 100 pM Ca2+ in 200 pi digest
volumes as described in Materials and Methods. 5 pi of each reaction was
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Figure 4.2 Trypsin digestion of SytC with Ba2+ Tb3+ and Mg2+
Digestions were performed as described in Materials and Methods substituting
100 |LM Ba2+, Tb3+ or Mg2+ for Ca2+. 5 pi of each reaction was analysed by SDS-
PAGE and Western blotting using cgm67 at a dilution of 1:5 for
immunodetection.
Figure 4.2a Lanes 1-6 Digestions performed with Ba2+
Figure 4.2b Lanes 1-6 Digestions performed with Tb3+
Figure 4.2c Lanes 1-6 Digestions performed with Mg2+
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Figure 4.3 Titration of SytC with Tb3+
Fluorimetric titrations were performed as outlined in Materials and Methods. A
10 mM TbCl3 solution was used to make additions to a 40 pM solution of SytC
in Hepes.NaOH pH 7.4 to give Tb3+ concentrations of up to 120 |iM. The
emission was recorded at 580nm. All figures were corrected for dilution effects
which were no greater than 5%.
Figure 4.3a Fluorescence enhancement versus Tb3+ added in
a 40 pM protein solution
Figure 4.3b Fluorescence enhancement versus Tb3+ added in
solutions of 1 - 4 pM protein concentration.
Figures are corrected for background
fluorescence due to Tb3+ alone which is also
shown as a separate line 'no SytC'.
Note that the fluorimeter sensitivity is set
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Figure 4.4 Titration of Tb3+ with SytC
Additions of SytC protein were made to TbCl3 solutions in Hepes.NaOH
PH 7.4 to give protein concentrations of up to 400 nM (4.4a). The slope of
the line for the concentrations between 10-50 |iM Tb3+ in figure 4.4a were
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Figure 4.5a Hanes plot of binding of Tb3+ to SytC
Fluorescence emissions were recorded in protein solutions of 0.4 - 3.7 pM
with additions of TbCl3 up to 120 pM (see figure 4.3b). The data were
plotted in a Hanes transformation and the for Tb3+ found from the
graph. Regression fines were fitted using a computer program.
Figure 4.5b Inhibition of Tb3+ fluorescence enhancement by
Ca2+
Titrations of up to 80 pM Tb3+ were made to a 0.5 pM SytC solution
including Ca2+ in varying concentrations. Figures are corrected for
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Table 4.1 Parameters for interaction of SytC and Tb3+
The table shows for Tb3+ calculated from Hanes plots of the
fluorescence data obtained and the Hill coefficient for the data. The Hill
coefficient was calculated from the gradient of a plot of logio [AF / AFmax -
AF] versus logio Tb3+- AFmax was calculated from the gradient of the
Hanes transformations of the data. Parameters are shown for SytC and














Figure 4.6 Scatchard analysis of Tb^+ binding
Using the specific fluorescence value determined from figure 4.3a to
calculate the concentration of bound and free Tb3+, the data from figure
4.3b were transformed and plotted according to Scatchard and used to
























y = 8.4163 - 0.27480X RA2 = 0.983
Bound Tb3+ (jiM)
Parameters obtained by Scatchard analysis
SytC Kd Bmax binding sites for
(pM) (pM) (pM) Tb3+
0.4 1.67 5.8 14
2.3 2.77 27.5 12
3.7 3.70 30.6 8
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Figure 4.7 Binding of SytC to phospholipid vesicles of
simple composition
Binding of SytC to phospholipid vesicles was carried out as described in
Materials and Methods using vesicles composed of 20% (w/v) cholesterol
and 80% (w/v) PS, PI, PC or PE. 5 (il samples of the lipid pellets and the
TCA precipitated supernatants were analysed by SDS-PAGE and
Western blotting using cgm67 at a dilution of 1:5 for detection.
Figure 4.7a
Lane 1 Molecular weight standards
Lane 2 Blank
Lane 3 Protein pellet with no lipid+EGTA
Lane 4 Protein pellet with PS+EGTA
Lane 5 Protein pellet with PI+EGTA
Lane 6 Protein pellet with PC+EGTA
Lane 7 Protein pellet with PE+EGTA
Lane 8 Blank
Lane 9 Protein pellet with no lipid+Ca2+
Lane 10 Protein pellet with PS+Ca2+
Lane 11 Protein pellet with PI+Ca2+
Lane 12 Protein pellet with PC+Ca2+
Lane 13 Protein pellet with PE+Ca2+
Figure 4.7b
Lane 1 Molecular weight standards
Lane 2 Blank
Lane 3 Supernatant with no lipid+EGTA
Lane 4 Supernatant with PS+EGTA
Lane 5 Supernatant with PE+EGTA
Lane 6 Supernatant with PC+EGTA
Lane 7 Supernatant with PI+EGTA
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Lane 8 Blank
Lane 9 Supernatant with no lipid+Ca2+
Lane 10 Supernatant with PS+Ca2+
Lane 11 Supernatant with PE+Ca2+
Lane 12 Supernatant with PC+Ca2+
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Figure 4.8 Binding of SytC to phospholipid vesicles of
complex composition
Phospholipid vesicle binding assays were carried out as already outlined
using vesicles of 20% (w/v) cholesterol and 40% (w/v) each of two
phospholipids. All possible combinations of four lipids were used: PS/PC,
PS/PI, PS/PE, PC/PI, PC/PE and PI/PE and lipid vesicles of a mixed
composition more typical of biological membranes were also used (25%
(w/v) cholesterol, 5% (w/v) PI, 60% (w/v) PC and 10% (w/v) PS. 5 jil of each
lipid pellet and the corresponding TCA precipitated supernatant were
analysed by SDS-PAGE and Western blotting using cgm67 at a dilution of
1:5 for detection.
All gels were loaded similarly as outlined below
Figure 4.8a Lipid pellets with EGTA
Figure 4.8b Supernatants with EGTA
Figure 4.8c Lipid pellets with Ca2+
Figure 4.8d Supernatants with Ca2+
Lane 1 No lipid added
Lane 2 PS/PC vesicles
Lane 3 PS/PI vesicles
Lane 4 PS/PE vesicles
Lane 5 PC/PI vesicles
Lane 6 PC/PE vesicles
Lane 7 PI/PE vesicles
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Figure 4.9 Binding of SytC to immobilised calmodulin
Binding of SytC to immobilised calmodulin was carried out as described in
Materials and Methods. The TCA precipitated eluates were resuspended in
50 pi SDS-PAGE sample buffer and neutralised with 2 pi 2 M Tris. 30 pi
samples of the starting protein and the protein after binding to the
immobilised calmodulin were taken and 10 pi 4x SDS-PAGE sample buffer
added. 5 pi of these samples and 10 pi of the eluates were analysed with




1 Starting SytC sample
2 Native synaptotagmin starting sample
3 Supernatant after binding in EGTA
4 Supernatant after binding in Ca2+
5 Eluate from Ca2+ binding
6 Eluate from EGTA binding
7 Blank
8 Blank
9 Native synaptotagmin after binding in C
10 Eluate of native synaptotagmin in Ca2+
figure 4.9b
Starting SytC sample
Supernatant after binding in EGTA
Supernatant after binding in Ca2+
Supernatant after binding in Ba2+
Eluate from EGTA binding
Calmodulin agarose from EGTA binding
Eluate from Ba2+ binding
Calmodulin agarose from Ba2+ binding
+ Eluate from Ca2+ binding











Figure 4.10 Emission spectrum of dansyl calmodulin
A 150 nM solution of dansyl calmodulin was excited at 340 nm and




















Figure 4.11a Titration of dansyl calmodulin with Ca2+
A titration with Ca2+ was performed as outlined in Materials and Methods
using a 150 nM solution of dansyl calmodulin in 50 mM Hepes.NaOH pH
7.4, 1 mM NTA.NaOH pH 7.4. Additions of 100 mM CaCl2 were made so
that the free Ca2+ concentration would range from 1 - 200 pM.
Line 1 zero Ca2+
Line 2 100 pM Ca2+
Line 3 1 pM Ca2+
Line 4 50 pM Ca2+
Line 5 20 pM Ca2+
Line 6 5 pM Ca2+
Line 7 10 pM Ca2+
Figure 4.11b Titration of dansyl calmodulin with SytC
SytC was added to a 150 nM solution of dansyl calmodulin in 50 mM
Hepes.NaOH pH 7.4, 1 mM NTA.NaOH pH 7,4 to give SytC calmodulin
ratios of 1:2, 1:1 and 2:1. The solution was excited at 340 nm and the
emission spectrum recorded between 400 and 550 nm.
Line 1 SytC:calmodulin 2:1
Line 2 SytC:calmodulin 1:1
Line 3 SytC:calmodulin 1:2




Figure 4.12 Fluorescence change on addition of Ca2+
A titration with Ca2+ was performed as outlined in Materials and Methods
using a 150 nM solution of dansyl calmodulin in 50 mM Hepes.NaOH pH
7.4, 1 mM NTA.NaOH pH 7.4. Additions of 100 mM CaCl2 were made so
that the free Ca2+ concentration would range from 1 - 200 pM. A similar
titration was also carried out using a 300 nM protein solution containing a
1:1 molar ratio of SytC and dansyl calmodulin. Excitation was carried out
at 340nm and emissions were recorded at 490 nm after each addition of
Ca2+. The fluorescence measurements were then plotted as a function of
the free Ca2+ concentration in the assay after the figures had been
corrected for the difference in starting fluorescence.
Figure 4.12a Fluorescence changes over a wide Ca2+
concentration range
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Analysis of quaternary structure of recombinant SytC
and biophysical analysis of Ca2+-dependent
conformational change
5.1 Introduction
Data presented in the previous chapter have suggested that SytC has
phospholipid and Ca2+-binding properties as well as interacting with
calmodulin. Protection from protease digestion in the presence of Ca2+
implies that a Ca2+-dependent conformational change occurs in the protein
and this would be one of the likely mechanisms whereby the protein exerts
its effect in regulated exocytosis. In addition to this, Tb3+ titrations and the
study of binding to phospholipid vesicles have shown the protein to be in a
state of easily-induceable aggregation which is apparently reversible by
the addition of Ca2+.
It was therefore considered important to make a study of the structural
properties of the protein and this was done using both gel exclusion
chromatography and native gel electrophoresis to look at the quaternary
structure of SytC and native bovine synaptotagmin respectively. The
biophysical techniques of molecular dynamics and circular dichroism were
also used to examine changes in quaternary and secondary structure under
different conditions.
5.2 Analysis of the quaternary structure of SytC by gel exclusion
chromatography
A Biogel P100 gel exclusion column was used (as in the purification of
SytC) to measure the apparent size of SytC when run in buffer containing
EGTA or Ca2+. Figure 5.1 shows elution profiles of the protein run under
both conditions. As can be seen the major absorbance peak was very
similar in both cases giving an apparent size of 50 000 Da in EGTA and
44 000 Da in Ca2+ which cannot be classed as a significant difference
between the two conditions given the accuracy limits of this technique.
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The column had previously been calibrated with standard proteins
(chapter 3). This does not rule out the possibility that there are very large
aggregates which never enter the column gel but get trapped at the top, so
that differences in the solubility in the two conditions are not apparent by
this method, or that dissociation of a multimer occurs during filtration, ie
that aggregation is a reversible association. It may be significant that in
the presence of Ca2+» the protein is more resolved from minor
contaminants (peak at fraction 23) and gives a sharper maximum peak at
fraction 28 suggesting that the structure is more uniform in Ca2+ than in
EGTA, where the protein may be more polydisperse. If SytC molecules
aggregate or in some way interact with each other then there would
probably also be an interaction between SytC and PraSytC (the fusion
protein of protein A and SytC). It had previously been noticed during
purification by gel exclusion chromatography that a fraction of SytC
emerges at a much larger apparent size, approaching the exclusion limit of
100 000 Da, along with traces of PraSytC and other contaminating
proteins (fig 5.2a). This was unexpected because purified samples of both
SytC and PraSytC alone are resolved well within the elution volume of the
column (PraSytC has an apparent size of 68 kDa). It is possible that in
the purification mixture, the mixture of contaminating proteins crosslinks
a fraction of the SytC by specific or non-specific interactions; the very
reason they have remained in the mixture as contaminants. However, the
increased elution volume of both SytC and PraSytC and their co-elution
can also be detected if the fully-purified proteins are mixed and again
separated on the same column. Figure 5.2b shows elution profiles of a
mixture of PraSytC and SytC run in the presence of Ca2+ and EGTA .
Figure 5.2c shows the composition of fractions in the two main peaks of
the protein mixture in EGTA. Both conditions gave the same pattern of
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protein distribution; two peaks both containing SytC with PraSytC
additionally present in the first peak only. The second peak contained the
main proportion of total SytC in a purified form. The only difference
between the two conditions was that in the presence of Ca2+ the first peak
emerged just after the void volume and could therefore be estimated to
have a size very close to the exclusion limit of 100 kDa whereas the peak
in the presence of EGTA emerged exactly at the void volume and may
therefore be of any size above 100 kDa or even a large aggregate (markers
of both 158 kDa and 670 kDa both eluted in this volume during calibration
of the column). Given the narrow difference in elution volume between the
two conditions and the possibility that the gel exclusion limit may not be
precisely 100 kDa, these data do not constitute strong evidence of a Ca2+-
dependent effect on the quaternary structure of SytC but suggested that
further study might be valuable. A column with a larger exclusion limit
would allow more accurate sizing in this range but it was decided to proceed
no further with a column technique because if an equilibrium between
multimeric forms of SytC did exist, this technique did not reveal it in either
of the purified forms of the protein but only in the mixture, which makes it
a possibility that mixing the two forms is producing an artefact by
stabilising a transient association or causing an aggregation that would not
normally occur. Non invasive biophysical techniques were therefore
adopted to probe the quaternary structure in a more dynamic and
potentially less disruptive assay.
5.3 Light scattering properties of SytC
The quaternary structure of SytC was further studied by measuring the
light scattering properties of the protein molecules in solution and hence
estimating their molecular sizes. The Dyna Pro-801 light-scattering
172
spectrometer fits the data to a single Gaussian distribution measuring the
hydrodynamic radii of the molecules and calculating molecular weights
from them. If the sample is essentially monodisperse, this unimodal
analysis will yield low-error parameters as follows: polydispersity, the
standard deviation of the spread of particle sizes about the measured
average radius; base line, which represents the completeness and fit of the
regression applied during the analysis; and the sum of squares of the
deviations between the measured data and the theoretically-calculated
data, giving the closeness of fit between the experimental data and an
autocorrelation function generated from the analysis results. If the
polydispersity measurement is high, bimodal analysis is used to resolve the
size distribution more accurately and the same error parameters are
calculated for it. Table 5.1 shows examples of raw experimental data
illustrating the parameters measured by the light-scattering spectrometer
A titration with Ca2+ was carried out with a solution of SytC in 20 mM
Tris.HCl pH 7.4, 1 mM NTA. Figure 5.3a shows the amplitude of the
signal, representative of the proportion of molecules, from different
molecular species of various sizes which appear during the addition of Ca2+
to the protein solution. All measurements which gave low error readings
were included in both monomodal and bimodal analyses. The data show
that at zero [Ca2+] SytC exists as a species of between 100-200 Da with a
small amount of aggregated protein. Some of the measurements at this
stage had high error parameters associated with them indicating that the
solution was polydisperse. Both the aggregate and the 100 kDa form of the
protein appeared to undergo a transformation at 1 pM Ca2+ with the
appearance of 80-100 kDa and 200-400 kDa forms. It is possible that this
represents a transition through intermediates of disassociation, the
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original 100-200 kDa form being converted to a species of 80-100 kDa
while the original protein aggregate also disassociated but was observed at
an earlier stage of dissociation where a 200-400 kDa species was formed.
The error parameters for these size estimates were better than those from
the starting solution but still showed polydispersity indicating that the
statistical software was not able to resolve only two molecular species.
The major change occurred at 5 pM Ca2+ when all the forms so far detected
were completely converted to a 50-60 kDa species. Here the low error
parameters indicated the protein to be monodisperse. The protein
remained in this form throughout the subsequent titration except for the
appearance of the 200-400 kDa species at 100 pM Ca2+. This was
probably not significant since it did not persist at 200 (iM Ca2+ whereas
the 50-60 kDa form remained throughout. The molecular composition of
the protein returned to one similar to the starting point upon the addition of
EGTA, i.e. mainly the 100-200 kDa form and some aggregated protein.
These figures strongly suggest a Ca2+-dependent switch from a multimeric
complex or aggregate at low Ca2+ to a monomeric form at 1-5 pM Ca2+
which is maintained even at super-physiological Ca2+ concentrations.
From the estimates of molecular weight, the multimer could be a dimer,
trimer or tetramer but it was impossible to say exactly because the
estimates of the multimer at low [Ca2+] were more variable due to
polydispersity. Most of the measurements were in the region of 110 kDa
which would point to the existence of a dimer given the monomeric
measurement of 55 kDa. No similar changes in the light scattering
properties were detected when the titration was performed with Ba2+ or
Mg2+ (data not shown).
The same light scattering experiment was repeated with a 1:1 molecular
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mixture of calmodulin and SytC(15pM each protein). The molecular
species seen in this mixture are summarised in figure 5.3b. Calmodulin
itself is at the limits of detection by this method and when measured alone
gave an apparent size of 28 kDa but often gave high error parameters.
When mixed with SytC, it was equally difficult to evaluate the data
because SytC began as a polydisperse solution and the addition of another
protein introduced more noise into the readings. Calmodulin seemed to
have a significant effect on the properties of SytC at zero Ca2+. The
solution at this point no longer contained large aggregates ofhigh
polydispersity but contained a 60-80 kDa species and a 10-20 kDa species
which were well resolved by bimodal analysis. Most likely this indicates
the existence of a complex between SytC and calmodulin and some free
calmodulin since monomeric SytC has an apparent mass of 55 kDa. If
calmodulin and SytC are in a 1:1 molecular ratio, there would also be some
free SytC if there is free calmodulin. The discrepancy in the result and the
logical argument is due to the fact that the analysis package cannot
calculate a light scattering distribution for more than two molecules. This
means that any mixture likely to be made of more than two molecular
species will not be measured accurately and interpreting such results
should be done with caution. At low Ca2+ concentrations, a 20-30 kDa
form appeared which could be calmodulin and the amount of 60-80 kDa
molecules is reduced to almost half the previous number suggesting that
an initial complex may be separating at lpM Ca2+. The larger molecule,
seen previously, of 100-200 kDa appeared at 5 pM Ca2+ but at this Ca2+
concentration, calmodulin was calculated to bind much of the Ca2+ because
its Kd for Ca2+ is lower than that of NTA and the concentration of
calmodulin in the experiment was high. The [Ca2+] not bound to calmodulin
or NTA was calculated to be 0.4 pM. The predominant forms of SytC are
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therefore not seen at low [Ca2+]. Presumably, whatever effect calmodulin
had on the structure of SytC at zero Ca2+ was reduced as soon as
calmodulin began to bind Ca2+. Beyond this point in the titration, from 10-
200 jiM Ca2+, the 20-30 kDa molecule, assumed to be calmodulin,
disappeared and the mass estimates varied from 80-50 kDa but the error
parameters indicated a monodisperse solution. The polydispersity
increased at 100 (iM Ca2+ but bimodal analysis resolved two components
quite well giving a new 10-20 kDa molecule which could be calmodulin.
In summary, these data suggest that a complex exists between SytC and
calmodulin at zero Ca2+ and at low Ca2+ concentrations but since the
proteins are necessarily used at high concentrations for light scattering
measurements, the calmodulin makes significant changes to the free Ca2+
concentrations and so exact changes are difficult to determine. It is clear
however that calmodulin does have an effect on the quaternary structure
of SytC even in the absence of Ca2+ but it is difficult to analyse the data at
higher Ca2+ concentrations since calmodulin itself is not resolved as a
separate species, the size of the molecular species is the same as in the
SytC solution alone and the error parameters do not show polydispersity to
indicate the presence of other molecular species in the mixture and so
there is nothing which suggests the existence of a complex between
calmodulin and SytC. On the whole, although this approach is useful for
the study of monomer-oligomer transitions and aggregation, it is very
difficult to interpret for heterologous interactions, as was required in this
study.
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5.4 Analysis of the quaternary structure of bovine adrenal
synaptotagmin I
The quaternary structure of native bovine synaptotagmin was analysed
using Blue Native PAGE, a technique which allows the separation of
native proteins according to their molecular size (Schagger, H. 1994). The
proteins are mixed with Coomassie blue G which gives the molecules
uniform negative charge but does not denature them or disrupt complexes.
The proteins solubilised with non ionic detergent if necessary can then be
separated on a polyacrylamide gel to visualise the main protein complexes
and then further resolved by second dimension electrophoresis in a SDS-
polyacrylamide gel, to separate the components of each complex.
Chromaffin granule membranes were solubilised with dodecyl maltoside at
high ionic strength and the proteins separated in this way. Figure 5.4a
shows a Western blot of a first dimension (non denaturing) gel probed with
a polyclonal anti-synaptotagmin serum along with the pre-immune serum
control. Beef heart mitochondrial respiratory complexes were used as
molecular mass markers. The Coomassie G -stained gels of chromaffin
granule membranes and beef heart mitochondria are shown in figure 5.4b.
The blot showed one main band very close to the 800 kDa marker
suggesting that synaptotagmin is part of a large complex. The monoclonal
antibody to synaptotagmin, cgm 67, did not recognise any band in a first
dimension blot. This is possibly because the epitope for the antibody is
masked in the complex. In order to determine whether the 800 kDa
species is made up of many proteins or only synaptotagmin, the bands on
the first dimension native gel were further separated on a second-
dimension SDS gel. Figures 5.5a and b show Western blots of the second
dimension with polyclonal and monoclonal antibodies to synaptotagmin
and figure 5.5c shows a Coomassie-stained version of the same gel. Both
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antibodies decorated a protein of 67 kDa (the expected size of
synaptotagmin) but in different places with respect to the first dimension.
The polyclonal gives bands at the position of the 800 kDa complex and a
wide band at 200-100 kDa whereas the monoclonal shows only a wide band
stretching from the position of dopamine [3 hydroxylase (296 kDa) to a
position corresponding to 150 kDa. The monoclonal is probably the more
reliable of the two blots since it is cleaner and does not have the curvature
which can be seen on the polyclonal blot. It is possible that there is
something at 800 kDa which cross-reacts with the polyclonal antibody,
possibly the V ATPase subunit A(72 kDA) since V ATPase subunits make
up the greatest proportion of proteins at this position (figure 5.5c). There
is some evidence of cross reactivity in chromaffin granule membranes on
blots of normal Laemmli gels but this has always been assumed to be
aggregation in samples. The result obtained with the monoclonal suggests
that native synaptotagmin is present in a variety of complexes or
multimeric forms and this is supported by the appearance of the wider
band on the polyclonal blot. From the stained gel it is difficult to see how
many proteins which could be part of a complex are in this region of the gel
because the protein concentration is not high enough for clear staining. It
may be possible to identify other proteins in a complex with
synaptotagmin by using this technique to perform Western blotting with
antibodies to other proteins. One experiment of this sort has already been
performed in this lab using antibodies to SV2, one of the many proteins
which may interact with synaptotagmin, but the two proteins did not
appear to comigrate on these gels (data not shown).
5.5 Circular dichroic properties of SytC
Circular dichroic spectroscopy was used to study the changes in the
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secondary structure of SytC as [Ca2+] was increased. Figure 5.6 shows
the CD spectra of SytC at zero Ca2+ and at 200 pM free Ca2+, the extreme
points of the Ca2+ titration performed. There was no change in the
spectrum of SytC at any free Ca2+ concentration between 0 and 200 pM
but when the measurements were repeated with protein together with
phospholipid vesicles (figure 5.7a) there were changes in the peptide
backbone mainly occurring at 50 uM free Ca2+. Figure 5.7b shows the 0,
50, and 200 pM Ca2+ titration points with the data smoothed. The main
changes were occurring in the 200-220 nm region. Unfortunately it was
impossible to measure below 200 nm due to noise in the signal. These data
suggest that there is a Ca2+ - dependent secondary structural change in
SytC but that this is also dependent on the presence of phospholipid
vesicles.
CD spectroscopy was also used to look for secondary structural changes
associated with the interaction between calmodulin and SytC. Mixing the
proteins did not produce a spectrum different from the algebraic addition of
the spectra of each component and the subsequent addition of Ca2+ caused
only the spectral change associated with the addition of Ca2+ to calmodulin
(data not shown).
Originally, SytC was produced also as a HislO-SytC fusion but this
construct proved difficult to use in many of the experiments described and
it was found to be highly aggregated in light-scattering measurements.
The protein also seemed to precipitate if the ionic strength was below 300
mM. The CD spectrum of SytC showed the protein to contain 25% a helix
and 65% (3 sheet whereas CD analysis of the HislO-SytC protein revealed
it to have a totally different structure to that of SytC appearing to be
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much more random (figure 5.8). It may well be that the protein
conformation is altered by the oligohistidine tag or that it makes the folded
conformation less stable.
5.6 Conclusion
Biochemical and biophysical techniques have been described which have
been used to investigate the secondary and quaternary structure of SytC.
Gel exclusion chromatography, used in the purification of the expressed
protein, had suggested that SytC molecules would form complexes or
aggregates and light scattering measurements showed that the protein
does indeed exist in multimeric and monomelic forms, the interconversions
of which are controlled by the Ca2+ concentration in the buffer. This
technique suggested that calmodulin affects the quaternary structure of
SytC in the absence of Ca2+ but the results proved too complicated to
analyse this and it is probably better to reserve this technique for the
study of polydispersity in a solution of a single protein.
Native bovine synaptotagmin also seems to be part of one or different
complexes in chromaffin granule membranes although it was impossible to
conclude whether the complex is made up of synaptotagmin alone or
contains other proteins. Differences in the result obtained with polyclonal
and monoclonal antibodies make the data confusing but the monoclonal
result seems convincing particularly as there is no other non-specific
binding associated with this antibody.
Circular dichroic spectroscopy has shown that SytC has a spectrum
consistent with that of a folded protein and calculations indicate a 25% a-
helix and 65% [3-sheet. The spectrum of HislO-SytC was typical of a
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protein in random coil. A previously published crystal structure of one C2
domain of synaptotagmin (Sutton et al 1995) , approximately half of SytC,
indicated a structure composed mainly of (3-sheet although no exact figures
were given. These data are consistent with the published structure and
suggests that the second C2 domain adopts a similar structure to the first
in terms of the amount of (3-sheet. Circular dichroism has also shown that
there is a Ca2+ - dependent conformational change at the secondary
structural level in SytC which is also dependent on the presence of
phospholipid vesicles although there are no conformational changes
associated with mixing SytC and calmodulin in the presence or absence of
Ca2+.
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Figure 5.1 Elution profile of SytC in buffer containing EGTA
or Ca2+
Purified SytC (15 jig) was loaded onto a Biogel P100 gel exclusion column
equilibrated with 20 mM Tris pH 7.4, lOOmM NaCl containing either 2 mM
EGTA or 1 mM CaCl2. The protein was loaded in 250 jil of this. Fractions
of 0.5 ml were collected. The apparent size of the protein was calculated
using the calibration curve for the column shown in chapter 3 taking the
elution volume corresponding to the fraction with the maximum A280-
Where more than one fraction gave a high A28O value, the elution volume
was taken to be the average of the two fractions taking into account the
relative A280 °f each.
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Figure 5.2 Elution of a mixture of SytC and PraSytC in
EGTA or Ca2+
Purified SytC and PraSytC were mixed in a molar ratio of 4:1 in a 200 jfi
volume of 20 mM Tris.HCl pH 7.4, 100 mM NaCl containing either 2 mM
EGTA or 1 mM CaCl2. The mixture was incubated at 20°C for 15 min and
then loaded onto a Biogel P100 gel exclusion column previously equilibrated
in the same buffer. Fractions of 0.5 ml were collected in and analysed by
measuring the A280 and by SDS-PAGE of selected fractions with the peak
A280 values. Figure 5.2b shows the A28O elution profile of the mixture in the
two conditions and figure 5.2c shows the composition of the fractions in the
two main peaks. Figure 5.2a shows the fractions from routine purification
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Figure 5.3 Light scattering measurements of SytC
Light scattering measurements were carried out as described in Materials
and Methods using SytC solutions of 0.5 mg/ml in 20 mM Tris.HCl pH 7.4.
The estimated weights of molecular species appearing during a Ca2+
titration are summarised in figure 5.3a. The light scattering amplitude is
proportional to the fractional mass of molecules in each category.
Measurements with with the lowest error parameters were selected.
Figure 5.3b illustrates a similar titration with a protein solution containing
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Figure 5.4 Western blot of a first dimension native blue gel
of chromaffin granule membranes.
Chromaffin granule membranes (20 ug of protein per lane of gel) were
separated by first dimension native gel electrophoresis and then subjected
to standard Western blotting using a polyclonal antibody to synaptotagmin
at a dilution of 1:1000 for detection. This is shown on the left (figure 5.4a).
A similar Western blot was probed with pre-immune rabbit serum and is
shown on the right (figure 5.4b). Figures 5.4c and d show stained native
first dimension blue gels of mitochondrial respiratory membranes, used as





complex I 880 kDa-
complex V 600 kDa-
complex III 485 kDa-
complex IV 200 kTla-
complex II 130 kDa-
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Figure 5.5 Second dimension blue native gel electrophoresis
of chromaffin granule membranes
Chromaffin granule membranes (20 jig of protein per lane of gel) were
subjected to first and second dimension blue native electrophoresis. The
resulting gel was then subjected to standard Western blotting procedures
using either a polyclonal antibody to synaptotagmin at a dilution of 1:1000
for detection (figure 5.5a) or the monoclonal cgm67 at a dilution of 1:5
(figure 5.5b). The second dimension gel was also stained with Coomassie








































Figure 5.6 Circular dichroic spectrum of SytC in two Ca2+
concentrations
A Ca2+ titration was performed and the circular dichroism spectrum
obtained for a 0.25 mg/ml solution of SytC as described in Materials and
Methods. The protein was diluted in 20 mM Tris.H2S04 pH 7.4,1 mM
NTA . Ca2+ additions made to give free Ca2+ concentrations of 1, 5, 10, 20,
30, 50, 100 and 200 pM and CD spectra measured after each addition. The






Figure 5.7 Circular dichroic spectra of SytC in different
Ca2+ concentrations in presence of phospholipid
vesicles
A Ca2+ titration was performed as described in the previous figure using a
0.2 mg/ml SytC solution containing 100 pg/ml phospholipid vesicles (20%
(w/v) cholesterol, 40% (w/v) PS, 40% (w/v) PC) and the circular dichroism
spectrum measured for each concentration. Figure 5.7a shows the data
from 200-260 nm for all the titration points. Figure 5.7b shows the three
titration points with the data smoothed.
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—0.25mg/mlSytCwithzeroCa^+andphospholipid 0.25mg/mlSytCwith10pMCa^+andhospholipid —0.25mg/mlSytCwith50pMCsfi+andhospholipid 0.25mg/mlSytCwith100pMCa^+andhospholipid 0.25mg/mlSytCwith200pMCa^+andphospholipid
0.25mg/mlSytCwithzeroCa +andnophospholipid
—0.25mg/mlSytCwith50jiMCa +andphospholipid —0.25mg/mlSytCwith200|iMCa +andphospholipid
Figure 5.8 Circular dichroism spectrum for SytC and
HislOSytC




Table 5.1 Raw data from light-scattering measurements of
SytC
The table shows some light-scattering parameters measured for SytC at
0, 1 and 5 uM Ca2+ concentrations giving error measurements for both
monomodal and, where applicable, bimodal analyses. Base-line readings of
1 or lower, SOS readings of 5 and lower and low polydispersity readings
(indicated by a dotted line) show the measurement is representative of a
large proportion of the molecules in the solution. If these error readings
were high, a bimodal analysis was performed to attempt to resolve signals
from the solution into two molecular species rather than one species which
is the default analysis performed by the spectrometer.
Data was selected for figure 5.3 if it fitted the base-line and SOS criteria
already stated. If the polydispersity was greater than 15% of the average
molecular radius measurement given the monomodal default analysis was
used. If bimodal analysis was necessary because of high polydispersity the
resulting measurements were used instead of the monomodal
measurements. If no analysis gave reasonably low error parameters, the










1 0.511 8.3 4.635 497 1.065 90.722
2 0.459 9.3 5.188 654 1.068 100.275
3 0.553 6.7 3.741 296 1.045 65.330
4 0.478 4.4 104 1.003 2.025
0.093 47.5 33763
1 0.582 4.2 2.096 97 1.023 10.562
2 0.586 4.0 1.574 84 1.017 3.707
3 0.583 4.9 2.717 136 1.060 15.261
4 0.494 3.5 65 1.012 1.501
0.099 7.4 374
1 0.688 3.5 1.215 62 1.002 2.497
2 0.668 3.2 51 1.000 3.003
3 0.673 3.5 1.304 60 0.999 4.119
4 0.078 1.3 5 1.001 2.159
0.595 3.8 72




6 Summary and Discussion
The cytoplasmic domain of synaptotagmin (SytC) was produced by
recombinant DNA technology and expression in a bacterial host. Two
different cloning and expression strategies were used giving proteins which
were tagged either with protein A or oligohistidine to facilitate purification.
Purification procedures were developed for both affinity-tagged proteins
but the SytC derived from the protein A construct was found to be the
more stable and consequently used for most further studies.
The main hypothesis which drove the work was that synaptotagmin
effects its function in regulated exocytosis by undergoing a conformational
change upon binding of Ca2+ which is the stimulus for regulated secretion
to occur. Initially, biochemical assays were used to explore the possibility
of Ca2+-dependent conformational change and also to look at the
interaction of other molecules with the protein with a view to later testing
their influence on the protein's conformation. Partial proteolysis of SytC
with trypsin in the presence and absence of Ca2+ indicated that Ca2+
induced a conformational change in the protein which rendered it resistant
to proteolytic degradation. Binding assays also showed that SytC
interacted with phospholipids in a Ca2+-dependent manner which was
subsequently supported by published evidence of these interactions
(Davletov and Siidhof 1993). Calmodulin was also found to bind the protein
in this way, as detected by binding of SytC to immobilised calmodulin and
also by fluorimetric analysis using calmodulin with a dansyl reporter group
attached. The interaction was shown to be greatest at Ca2+ levels
between 1-10 pM.
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Study of the Ca2+-dependence of SytC would be easier if a simple Ca2+-
binding assay was available. An attempt was made to develop a
fluorimetric assay for Ca2+ binding which would depend on the change in
fluorescence from Tb3+ used as a competitive probe for Ca2+-binding sites.
Unfortunately, Tb3+ appeared to cause aggregation of SytC and to bind
irreversibly so that Ca2+ did not displace it when included in the assay.
Direct Ca2+ binding measurements were therefore abandoned in favour of
techniques which measured the influence of Ca2+ on other characteristics
of the protein.
The effects of Ca2+ on the secondary and quaternary structure of SytC
were studied using circular dichroic spectroscopy, gel exclusion
chromatography and light scattering. These experiments revealed that
SytC may exist as both an oligomer (probably a dimer) and also a
monomer depending on the Ca2+ concentration in the solution dissociating
from a dimer at 1 pM to a monomer at 5 pM free Ca2+ and reassociating on
removal of the ion. In addition, this effect is not reproduced by Ba2+ or
Mg2+- The secondary structure, as determined by CD spectroscopy, was
primarily composed of [3 sheet and was not influenced by additions of Ca2+
unless phospholipid vesicles were also included, whereupon some shifts in
the peptide backbone occurred at a [Ca2+] of 50 pM. Finally, native gel
electrophoresis was used to examine the quaternary structure of native
synaptotagmin in chromaffin granule membranes. The results again
indicate that synaptotagmin exists as a dimer and is possibly a member of
a much larger complex of proteins.
The interaction between calmodulin and synaptotagmin was stimulated by
low [Ca2+] and the effect was not reproduced using Ba2+. Since calmodulin
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shows only a low affinity for Ba2+, this could indicate that the interaction is
a result of the binding of Ca2+ to calmodulin rather than to synaptotagmin
which, in addition to showing some Ba2+-dependent characteristics, has
also been shown previously to have a lower affinity for Ca2+ than does
calmodulin (see introduction). However, there are problems with the
interpretation of this experiment. Firstly there is also some evidence in the
same experiment of a Ca2+-independent interaction which was not seen
using a different technique ofbinding to immobilised calmodulin and so is
potentially an artefact of this technique. Secondly, Ba2+ does not seem to
mimic the effects of Ca2+ on synaptotagmin consistently between different
assay types in this thesis and also in the literature (Brose et al 1992 found
that Ba2+ didn't bind synaptotagmin whereas Davletov and Siidhof 1993b
found that Ba2+ had the same effect as Ca2+). It is therefore impossible to
be sure that the ineffectiveness of Ba2+ in this assay is due to the fact that
the interaction is stimulated by Ca2+/calmodulin as it is equally possible
that the ion is having no effect on synaptotagmin in this assay. On the
whole, more of the literature points to the affinity of synaptotagmin for
Ba2+ and so it can be tentatively suggested that an interaction exists
between calmodulin and synaptotagmin which relies on the effect of Ca2+
on calmodulin. The significance of this interaction is, of course, difficult to
discuss because of our incomplete understanding of the function of
calmodulin in exocytosis. Although it is possible that the interaction does
not occur in the cell, some evidence from the literature suggests that
calmodulin is involved in the fast step of exocytosis or in endocytosis
(Kibble and Burgoyne 1996) and it is possible that the close association of
calmodulin with exocytotic proteins is required as a Ca2+ buffer to stop
'overshoot' of the Ca2+ signal thus maintaining the fidelity of the response.
In endocytosis, calmodulin might be needed to remove all traces of Ca2+
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before synaptotagmin can be retrieved perhaps in an oligomeric form as
discussed below.
The other work presented in this thesis supports the hypothesis that
synaptotagmin undergoes a Ca2+-dependent conformational change both in
quaternary structure at lower [Ca2+] and secondary structure at higher
[Ca2+]. Trypsin digestion indicates quite clearly that there is a structural
change upon binding to Ca2+ which protects the protein from proteolysis
even at high trypsin concentrations and that this protection is also
produced by Ba2+ which is known to mimic the effects of Ca2+ in exocytosis
(Terbush and Holz 1992) and has also been found to mimic the effects of
Ca2+ on synaptotagmin (Davletov and Sudhof 1993b). Further work with
light scattering measurements corroborates this. Although it is probable
that the recombinant protein shows aggregation which is not a feature of
the native protein, the fact that Mg2+ does not produce the same effect
suggests that it is not simply a result of the increased ionic strength of the
solution. The lack of change with Ba2+ (which has been found to mimic
some effects of Ca2+ in this thesis) rules out the possibility that the binding
of an ion to the protein will produce the same effect by simple physical or
electrostatic disruption of an aggregate. In addition, the fact that the
structural change is reversible by removal of Ca2+ suggests that there is
potential for this change to occur in vivo where Ca2+ levels rise and fall in a
controlled fashion particularly in view of the fact that native
synaptotagmin also seems to be a dimer. The changes in secondary
structure seem to have the more stringent requirements of a higher [Ca2+]
and the presence of phospholipids. Since it was also found that
synaptotagmin binds phospholipids in a Ca2+-dependent manner, this
effect probably involves the binding of all three molecules which can be
easily envisaged given the context of the native protein in the membrane of
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secretory vesicles.
The mechanism by which Ca2+ induces conformational change is a matter
of speculation. However, some clues can be gained from accumulated
biochemical and structural information about other proteins which contain
a C2 domain such as protein kinase C and phospholipase CS. As already
discussed in the introduction, the C2 domain is thought to be responsible
for the Ca2+ - and phospholipid-binding properties of synaptotagmin as it is
in protein kinase C. NMR and crystallographic data have shown that
metal ion binding to phospholipase C5 produces a significant
conformational change in the C2 domain exposing three lysine residues on
the back face of the Ca2+ binding site (Grobler et al 1996, Essen et al 1996)
which could bind acidic lipids. This supports biochemical data showing
allosteric interactions between Ca2+ and lipid binding which is similar to the
case of synaptotagmin. In addition, the accepted model of protein kinase C
activation also involves conformational change (Bazzi and Nelsestuen
1990, Orr and Newton 1994). In the inactive form, protein kinase C holds
part of its own peptide sequence in the active site forming a
pseudosubstrate. Binding of phosphatidyl serine to the C2 domain which is
allosterically increased by the binding of Ca2+ causes a conformational
change which removes the pseudosubstrate sequence from the active site,
allowing the enzyme to carry out its function. It is therefore a strong
possibility that Ca2+ functions in the same way for synaptotagmin,
causing a conformational change exposing residues which allow the protein
to bind phospholipids. The resultant conformational change from the
allosteric binding of these two molecules would then cause the 'active site',
possibly the point of contact between synaptotagmin and another protein,
to become functional.
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The secondary and quaternary structural changes measured depended on
quite different concentrations of Ca2+. This could be explained simply by
the relative sensitivities of the two techniques in which case the two
structural changes might actually occur at similar [Ca2+] in the cell.
Alternatively, the difference may be a result of the presence of
phospholipids in the CD measurements but not in the light scattering
experiments. If this is so, then interaction of the phospholipids may
'desensitize' the protein allowing levels of Ca2+ to rise higher before
exocytosis is triggered. This would be in keeping with the idea that
synaptotagmin controls fusion by preventing it and would suggest that
synaptotagmin may effect its role by a multi-stage conformational change
depending on its position in the cell and the time-point during exocytosis. In
such a scheme, the fraction of synaptotagmin molecules associated with
the docking complex at the plasma membrane would undergo a fast
secondary structural change caused by the relatively high [Ca2+] likely to
be present at the plasma membrane near Ca2+ channels. Synaptotagmin
in vesicles deeper in the cell would experience lower [Ca2+] due to diffusion
of the ion inward from the plasma membrane. A quaternary structural
change at this point may be a potential contribution to the mobilisation of
vesicles to the membrane or the formation of an early complex with
SNAP/SNARE proteins. Alternatively, quaternary structural changes
could occur at lower Ca2+ levels at the very beginning of the inward calcium
flow providing a switch from an inactive dimer to an active monomer which
can undergo secondary structural shift preceding fusion of the vesicle. Two
levels of structural change in this way provide increased control over fusion
and provide a mechanism to absorb 'false' signals by giving two energy
barriers to be overcome before fusion can take place, thus increasing
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fidelity of stimulus-secretion coupling.
210
Appendix
Appendix 1 Bacterial strains used in this study
Strain Genotype
NM522 supE thi-1 Ailac-proAB) A(mcrB-hsdSM)5
rK" niK~) [F ' proAB ZacIqZAM15]
BL21 (DE3) B F" dcm ompT hsdS(rg" hib") gal X,(DE3)
BL21 (DE3) B F" dcm ompT hsdSixb" dib") gal ^(DE3)
pLysS [pLysS Cam1"]
DH5a supEAA AZact/169 (<J>80 ZacZAM15) hsdRll Gibco, BRL








Appendix 2 Plasmids used in this study
Table A2a Plasmids obtained from others
Plasmid Supplier Reference
pAXll A. Boyd Zueco & Boyd (1992)
pGEM-T Promega
pET16b Novagen Studier et al (1990)
Table A2b Plasmids constructed in this study
Plasmid Cloning strategy
pGEMlOO 1 kb PCR product obtained using the two oligonucleotides
5'-ATG AAA GTC GAC TTA CTT CTT GAC GGC GAG CAT
GGC
&
5'-AAG TTT GAA TTC GGC CCG CGC GGA GGA AAG AAC
GCG ATT AAC as primers and bovine adrenal cDNA plasmid
library as template. Cloned into pGEM-T linear vector with 5'
T extensions (fragment has 3' A extensions added by Taq
polymerase).
pLClOO 1 kb fragment with cohesive ends created following
EcoRI / Sal I digestion of pGEMlOO cloned into EcoRI / Sal I
digested pAXll.
pGEM 600 1 kb PCR product using two oligonucleotides 5'-AAG TTT CAT
ATG GGA GGA AAG AAC GCG ATT AAC
&
5'-ATG AAA GGA TCC TTA CTT CTT GAC GGC GAG CAT as
primers and bovine adrenal cDNA plasmid library as
template DNA. Cloned into pGEM-T linear vector with 5' T
extensions (fragment has 3' A extensions added by Taq
polymerase).
pLC600 1 kb fragment with cohesive ends created following Ndel /
BamHl digestion of pGEM600 cloned into Ndel / BamHl
digested pET16b.
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Appendix 3 DNA and aminoacid sequence of synaptotagmin
The DNA sequence cloned and the corresponding aminoacid sequence is
underlined. The first six aminoacid residues of the recombinant SytC are in








Met Val Ser Glu Ser His His Glu Ala Leu Ala Ala Pro Pro Val Thr Thr 17
424 ATG GTG AGC GAG AGC CAT CAC GAG GCG CTG GCA GCC CCG CCG GTC ACC ACT
Val Ala Thr Val Leu Pro His Asn Ala Thr Glu Pro Ala Ser Pro Gly Glu 34
476 GTG GCG ACG GTC CTG CCA CAC AAC GCC ACA GAG CCA GCC AGT CCC GGG GAA
Gly Lys Glu Asp Ala Phe Ser Lys Leu Lys Glu Lys Phe Met Asn Glu Leu 51
527 GGG AAG GAG GAT GCC TTC TCC AAG CTG AAG GAG AAG TTT ATG AAT GAG TTG
His Lys lie Pro Leu Pro Pro Trp Ala Leu lie Ala lie Ala lie Val Ala 68
578 CAT AAA ATT CCA TTG CCA CCA TGG GCC TTA ATT GCC ATA GCC ATA GTT GCG
Val Leu Leu Val Leu Thr Cys Cys Phe Cys lie Cys Lys Lys Cys Leu Phe 85
629 GTC CTT TTA GTC CTG ACC TGC TGC TTT TGT ATC TGT AAG AAA TGC TTA TTC
Lys Lys Lys Asn Lys Lys Lys Gly Lys Glu Lys G1y GlY Lvs Asn Ala Tie 102
680 AAA AAG AAA AAC AAG AAG AAG GGA AAG GAA AAG GGA GGG AAG AAT GCC ATT
Asn Met Lvs Asd Val Lvs Asd Leu Glv Lvs Thr Met Lvs Asd Gin Ala Leu 119
731 AAC ATG AAG GAT GTG AAA GAC TTG GGG AAG ACC ATG AAA GAT CAG GCC CTG
Lvs Asd Asd Asd Ala Glu Thr Gly Leu Thr Asd Gly Glu Glu Lvs Glu Glu 136
782 AAG GAT GAT GAT GCT GAA ACC GGA TTG ACT GAT GGT GAA GAG AAA GAA GAA
Pro Lvs Glu Glu Glu Lvs Leu Gly Lvs Leu Gin Tvr Ser Leu Asd Tvr Asd 153
833 CCC AAA GAA GAA GAG AAA CTG GGA AAA CTT CAG TAC TCA CTG GAT TAT GAT
Phe Gin Asn Asn Gin Leu Leu Val Gly lie lie Gin Ala Ala Glu Leu Pro 170
884 TTC CAG AAT AAC CAG GTG CTG GTA GGA ATC ATC CAG GCT GCC GAG TTG CCC
Ala Leu Asd Met Gly Glv Thr Ser Asd Pro Tvr Val Lvs Val Phe Leu Leu 187
935 GCC TTG GAC ATG GGG GGC ACC TCT GAT CCC TAT GTG AAG GTT TTT CTG CTG
Pro Asd Lvs Lvs Lvs Lvs Phe Glu Ttjr Lvs Val His Ara Lvs Thr Leu Asn 204
986 CCC GAT AAA AAG AAG AAA TTT GAG ACA AAA GTC CAC CGA AAG ACC CTT AAT
Pro Val Phe Asn Glu Gin Phe Thr Phe Lvs Val Pro Tvr Ser Glu Leu Glv 221
1037 CCT GTG TTG AAG GAG GAA TTT ACT TTC AAG GTG CCA TAT TCG GAA TTG GGT
Gly Lvs Thr Leu Val Met Ala Val Tvr Asd Phe Asd Ara Phe Ser Lvs His 238
1088 GGC AAA ACT CTG GTG ATG GCC GTC TAT GAT TTT GAT CGC TTC TCA AAG CAT
ASO T1 fi lie Glv Glu Phe Lvs Val Pro Met Asn Thr Val ASD Phe Gly His 255
1139 GAC ATC ATT GGG GAA TTT AAA GTC CCC ATG AAC ACG GTG GAT TTC GGT CAC
Val Thr Glu Glu TrD Ara Asd Leu Gin Ser Ala Glu Lvs Glu Glu Gin Glu 272
1190 GTA ACT GAG GAG TGG GGT GAT CTG CAA AGT GCA GAG AAG GAA GAG CAA GAG
Lvs Leu G1 y Asd lie Cvs Phe Ser Leu Ara Tvr Val Pro Thr Ala Glv Lvs 289
1241 AAA TTG GGT GAT ATC TGC TTC TCC CTT CGC TAT GTA CCT ACT GCT GGC AAG
Leu Thr Val Val He Leu GlU Ala Lvs Asn Leu Lvs Lvs Met Asd Val Glv 306
1292 CTG ACT GTT GTC ATT CTG GAG GCA AAG AAC CTG AAG AAG ATG GAT GTG GGT
Glv Leu Ser Asd Pro Tvr Val Lvs lie His Leu Met Gin Asn Glv Lvs Ara 323
1343 GGC TTG TCT GAT GGT TAT GTG AAG ATT CAT CTG ATG CAG AAT GGC AAG AGG
Leu Lvs LVS Lvs Lvs Thr Thr lie Lvs Lvs Asn Thr Leu Asn Pro Tvr Tvr 340
1394 CTG AAG AAG AAA AAG ACA ACA ATT AAA AAG .AAT ACA CTT AAC CCC TAC TAC
Asn Glu Set Phe Ser Phe Glu Val Pr<? Phe Glu Gin lie Gin Lys Val Gin 357
214
1445 AAT GAG TCA TTC AGC TTT GAA GTA CCC TTT GAG CAA ATC CAG AAA GTG CAA
Val Val Val Thr Val Leu Asp Tvr Asp Lvs lie Glv Lvs Asn Asp Ala He 374
1496 GTG GTG GTA ACT GTT TTG GAC TAT GAC AAG ATT GGC AAG AAC GAT GCC ATC
Glv Lvs Val Phe Val Glv Tvr Asn Ser Thr Glv Ala Glu Leu Arcr His Trn 391
1547 GGC AAA GTG TTG GTG GGC TAC AAC AGC ACC GGG GCG GAG CTG CGA CAC TGG
Ser Asp Met Leu Ala Asn Pro Arcr Ara Pro lie Ala Gin Trp His Thr Leu 408
1598 TCA GAC ATG CTG GCT AAC CCC CGG CGC CCC ATC GCC CAG TGG CAC ACC CTG
Gin Val Glu Glu Glu Val Asp Ala Met Leu Ala Val Lvs Lvs Stop 422
















Appendix 4 Sequence analysis of gene encoding HislO-SytC
Schematic representation of the gene construct showing






The arrows indicate direction of translation. The sequence shows three
potential start codons 1, 2 and 3. Translation from Metl gives a protein
containing both the His 10 and SytC portion of the fusion and is therefore
easily purified on Ni-NTA agarose. Translation from either Met2 or Met3
gives rise to a protein consisting mainly of SytC. The resulting protein is
seen on a Western blot using a SytC specific antibody but cannot be
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